<journal><article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" dtd-version="3.0" role="ECC" store="2" contenteditable="false"><front store="3" contenteditable="false"><jou role="ECC" store="4" contenteditable="false"><name1 role="ECC" store="5" contenteditable="false">Endocrine Connections</name1></jou><!--<journal-meta><journal-id journal-id-type="CATS">IJCL</journal-id><journal-id journal-id-type="publisher-code">JCL</journal-id><journal-title-group><journal-title>Journal of Cosmetic and Laser Therapy</journal-title><abbrev-journal-title abbrev-type="pubmed">J Cosmet Laser Ther</abbrev-journal-title></journal-title-group><issn pub-type="ppub">1476-4172</issn><issn pub-type="epub">1476-4180</issn><publisher><publisher-name>Informa Healthcare</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta>--><article-meta store="6" contenteditable="false"><!--<article-id pub-id-type="doi">10.3109/14764172.2015.2222222</article-id>--><!--<article-id pub-id-type="publisher-id">2222222</article-id>--><!--punc--><oa store="7" contenteditable="true">CC BY NC</oa><!--punc--><article-categories store="8" contenteditable="true"><subj-group subj-group-type="heading" store="9" contenteditable="true"><subject store="10" contenteditable="true">Research</subject></subj-group></article-categories><title-group store="11" contenteditable="true"><article-title store="12" contenteditable="true">Long-term efficacy of metformin in overweight-obese PCOS: longitudinal follow<span class="del cts-1" data-cid="145" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733105208" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:55am" contenteditable="false"> </span><span class="ins cts-1" data-cid="146" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733105215" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:55am" contenteditable="true">-</span>up of retrospective cohort<query title="Please check and approve the title." data-time="1576308917" data-username="Editor" id="1" contenteditable="false" changetime="14/12/2019 13:05:16" store="13"><i class="fa fa-question-circle fa-1x fa-1x" style="color:red;" onclick="addQueryText(1);" contenteditable="true" store="14"></i></query></article-title><alt-title alt-title-type="rrh" store="15" contenteditable="true">Long-term metformin therapy in PCOS</alt-title><alt-title alt-title-type="lrh" store="16" contenteditable="true">J Mojca <i store="17" contenteditable="true">et al.</i></alt-title></title-group><contrib-group store="18" contenteditable="true"><contrib contrib-type="author" corresp="no" store="19" contenteditable="true"><name store="20" contenteditable="true"><surname store="21" contenteditable="true">Mojca</surname> <given-names store="22" contenteditable="true">Jensterle</given-names></name><xref ref-type="aff" rid="AF0001" store="23" contenteditable="true"><sup store="24" contenteditable="true">1</sup></xref><!--punc--><sup store="25" contenteditable="true">,</sup><!--punc--><xref ref-type="aff" rid="AF0002" store="26" contenteditable="true"><sup store="27" contenteditable="true">2</sup></xref></contrib><!--punc-->, <!--punc--><contrib contrib-type="author" corresp="no" store="28" contenteditable="true"><name store="29" contenteditable="true"><surname store="30" contenteditable="true">Nika Aleksandra</surname> <given-names store="31" contenteditable="true">Kravos</given-names></name><xref ref-type="aff" rid="AF0001" store="32" contenteditable="true"><sup store="33" contenteditable="true">1</sup></xref></contrib><!--punc-->, <!--punc--><contrib contrib-type="author" corresp="no" store="34" contenteditable="true"><name store="35" contenteditable="true"><surname store="36" contenteditable="true">Simona</surname> <given-names store="37" contenteditable="true">Ferjan</given-names></name><xref ref-type="aff" rid="AF0001" store="38" contenteditable="true"><sup store="39" contenteditable="true">1</sup></xref><!--punc--><sup store="40" contenteditable="true">,</sup><!--punc--><xref ref-type="aff" rid="AF0002" store="41" contenteditable="true"><sup store="42" contenteditable="true">2</sup></xref></contrib><!--punc-->, <!--punc--><contrib contrib-type="author" corresp="no" store="43" contenteditable="true"><name store="44" contenteditable="true"><surname store="45" contenteditable="true">Katja</surname> <given-names store="46" contenteditable="true">Goricar</given-names></name><xref ref-type="aff" rid="AF0003" store="47" contenteditable="true"><sup store="48" contenteditable="true">3</sup></xref></contrib><!--punc-->, <!--punc--><contrib contrib-type="author" corresp="no" store="49" contenteditable="true"><name store="50" contenteditable="true"><surname store="51" contenteditable="true">Vita</surname> <given-names store="52" contenteditable="true">Dolzan<query title="Please check and approve the author list." data-time="1576308918" data-username="Editor" id="2" contenteditable="false" changetime="14/12/2019 13:05:16" store="53"><i class="fa fa-question-circle fa-1x fa-1x" style="color:red;" onclick="addQueryText(2);" contenteditable="true" store="54"></i></query></given-names></name><xref ref-type="aff" rid="AF0003" store="55" contenteditable="true"><sup store="56" contenteditable="true">3</sup></xref></contrib><!--punc--> and <!--punc--><contrib contrib-type="author" corresp="no" store="57" contenteditable="true"><name store="58" contenteditable="true"><surname store="59" contenteditable="true">Andrej</surname> <given-names store="60" contenteditable="true">Janez</given-names></name><xref ref-type="aff" rid="AF0001" store="61" contenteditable="true"><sup store="62" contenteditable="true">1</sup></xref><!--punc--><sup store="63" contenteditable="true">,</sup><!--punc--><xref ref-type="aff" rid="AF0002" store="64" contenteditable="true"><sup store="65" contenteditable="true">2</sup></xref></contrib><aff id="AF0001" store="66" contenteditable="true"><sup store="67" contenteditable="true">1</sup> Department of Endocrinology, Diabetes and Metabolic Diseases, <institution store="68" contenteditable="true">University Medical Centre</institution>, Ljubljana, <country store="69" contenteditable="true">Slovenia</country></aff><aff id="AF0002" store="70" contenteditable="true"><sup store="71" contenteditable="true">2</sup> <institution store="72" contenteditable="true">University of Ljubljana, Faculty of Medicine<query title="Please check and approve the affiliation details." data-time="1576308919" data-username="Editor" id="3" contenteditable="false" changetime="14/12/2019 13:05:16" store="73"><i class="fa fa-question-circle fa-1x fa-1x" style="color:red;" onclick="addQueryText(3);" contenteditable="true" store="74"></i></query></institution>, Ljubljana, <country store="75" contenteditable="true">Slovenia</country></aff><aff id="AF0003" store="76" contenteditable="true"><sup store="77" contenteditable="true">3</sup> <institution store="78" contenteditable="true">University of Ljubljana, Faculty of Medicine, Institute of Biochemistry, Pharmacogenetics Laboratory</institution>, Ljubljana, <country store="79" contenteditable="true">Slovenia</country></aff></contrib-group><author-notes store="80" contenteditable="true"><corresp id="c1" store="81" contenteditable="true">Correspondence should be addressed to A Janez: andrej.janez@kclj.si</corresp></author-notes><pub-date pub-type="ppub" store="82" contenteditable="true"><month store="83" contenteditable="true"></month><year store="84" contenteditable="true">2015</year></pub-date><pub-date pub-type="epub" store="85" contenteditable="true"><month store="86" contenteditable="true"></month><year store="87" contenteditable="true">2015</year></pub-date><volume1 store="88" contenteditable="true">9</volume1><issue store="89" contenteditable="true">1</issue><fpage store="90" contenteditable="true">1</fpage><lpage store="91" contenteditable="true"></lpage><permissions store="92" contenteditable="true"><copyright-statement store="93" contenteditable="true">© 2019 The authors, Published by Bioscientifica Ltd</copyright-statement><copyright-year store="94" contenteditable="true">https://doi.org/10.1530/EC-19-0449</copyright-year><vol store="95" contenteditable="true">Volume: 9</vol><iss store="96" contenteditable="true">Issue: 1</iss><copyright-holder store="97" contenteditable="true">Informa UK, Ltd.</copyright-holder></permissions><!--<self-uri content-type="pdf" xlinkhref="14764172.2015.2222222.pdf" store="98"></self>--><hr store="99" contenteditable="true"/><abstract1 store="100" contenteditable="true"><title1 store="101" contenteditable="true">Abstract</title1><pp1 store="102" contenteditable="true"><i store="103" contenteditable="true">Objective:</i> Long-term efficacy of metformin in polycystic ovarian syndrome (PCOS) apart from in those with impaired glucose tolerance or diabetes remains unproven. We aimed to evaluate the impact of metformin in overweight-obese patients with PCOS and normal baseline glycemic homeostasis.</pp1><pp1 store="104" contenteditable="true"><i store="105" contenteditable="true">Methods:</i> <span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731837000_dfound0_regex_style36" common_tag="1576731837000_ifound0_regex_style36" contenteditable="false">10 year </span><span store="1576731837000_i0" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731837000_ifound0_regex_style36" common_tag="1576731837000_ifound0_regex_style36" contenteditable="true">A 10-year </span>longitudinal follow<span class="del cts-1" data-cid="147" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733112054" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:55am" contenteditable="false"> </span><span class="ins cts-1" data-cid="148" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733112063" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:55am" contenteditable="true">-</span>up of <span class="ins cts-1" data-cid="195" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576734065529" title="Inserted by Annapoorni Swamynathan - 12/19/2019 11:11am" contenteditable="true">a </span>retrospective cohort comprising <span class="del cts-1" data-cid="9" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576813177524" title="Deleted by Annapoorni Swamynathan - 12/20/2019 9:09am" contenteditable="false">of </span>159 patients with PCOS defined by Rotterdam criteria, BMI ≥25 kg/m<sup store="106" contenteditable="true">2</sup> and normal initial glucose homeostasis (age 28.4 ± 6.4 years, BMI 34.9 ± 6.6 kg/m<sup store="107" contenteditable="true">2</sup>) that had been receiving metformin <span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731845000_dfound0_regex_style99" common_tag="1576731845000_ifound0_regex_style99" contenteditable="false">1000 mg </span><span store="1576731845000_i0" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731845000_ifound0_regex_style99" common_tag="1576731845000_ifound0_regex_style99" contenteditable="true">1000 mg </span>BID. Collection data contained 6085 time-points including anthropometric, hormonal and metabolic parameters.</pp1><pp1 store="108" contenteditable="true"><i store="109" contenteditable="true">Results:</i> After the <span class="del cts-1" data-cid="197" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576734110318" title="Deleted by Annapoorni Swamynathan - 12/19/2019 11:11am" contenteditable="false">1</span><span class="ins cts-1" data-cid="198" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576734110333" title="Inserted by Annapoorni Swamynathan - 12/19/2019 11:11am" contenteditable="true">fir</span>st year body mass (BM<query title="Please check that only approved gene and protein nomenclature is used in your paper (human genes in uppercase italics, human proteins in uppercase roman; mouse/rat genes with initial uppercase italics, mouse/rat proteins all uppercase roman). For more details, see https://ec.bioscientifica.com/page/author/author-guidelines#genes and correct if necessary." data-time="1576308920" data-username="Editor" id="4" contenteditable="false" changetime="14/12/2019 13:05:16" store="110"><i class="fa fa-question-circle fa-1x fa-1x" style="color:red;" onclick="addQueryText(4);" contenteditable="true" store="111"></i></query>) decreased for 3.9 ± 6.<span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731844000_dfound0_regex_style93" common_tag="1576731844000_ifound0_regex_style93" contenteditable="false">8 kg </span><span store="1576731844000_i0" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731844000_ifound0_regex_style93" common_tag="1576731844000_ifound0_regex_style93" contenteditable="true">8 kg </span>(<span class="del cts-1" data-cid="38" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732489204" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:44am" contenteditable="false">p</span><span class="ins cts-1" data-cid="39" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732489221" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:44am" contenteditable="true"><i data-time="1576732490000" data-username="Annapoorni Swamynathan" contenteditable="true">P</i></span> &lt; 0.001) and remained stable during the following 3 years. Menstrual frequency (MF) increased <span class="del cts-1" data-cid="201" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576734162915" title="Deleted by Annapoorni Swamynathan - 12/19/2019 11:12am" contenteditable="false">f</span><span class="ins cts-1" data-cid="202" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576734162926" title="Inserted by Annapoorni Swamynathan - 12/19/2019 11:12am" contenteditable="true">t</span>o<span class="del cts-1" data-cid="203" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576734165549" title="Deleted by Annapoorni Swamynathan - 12/19/2019 11:12am" contenteditable="false">r</span> 3.0 ± 3.9 bleeds/year (<span class="del cts-1" data-cid="40" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732494375" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:44am" contenteditable="false">p</span><span class="ins cts-1" data-cid="41" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732494386" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:44am" contenteditable="true"><i data-time="1576732495000" data-username="Annapoorni Swamynathan" contenteditable="true">P</i></span> &lt; 0.001) after <span class="del cts-1" data-cid="204" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576734171628" title="Deleted by Annapoorni Swamynathan - 12/19/2019 11:12am" contenteditable="false">1</span><span class="ins cts-1" data-cid="205" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576734171638" title="Inserted by Annapoorni Swamynathan - 12/19/2019 11:12am" contenteditable="true">fir</span>st year to over 11 bleeds/year in the following years. The total testosterone and androstenedione decreased<span class="ins cts-1" data-cid="208" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576734184466" title="Inserted by Annapoorni Swamynathan - 12/19/2019 11:13am" contenteditable="true"> </span><span class="del cts-1" data-cid="216" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576734207647" title="Deleted by Annapoorni Swamynathan - 12/19/2019 11:13am" contenteditable="false">f</span><span class="ins cts-1" data-cid="215" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576734206794" title="Inserted by Annapoorni Swamynathan - 12/19/2019 11:13am" contenteditable="true">t</span>o<span class="del cts-1" data-cid="217" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576734209117" title="Deleted by Annapoorni Swamynathan - 12/19/2019 11:13am" contenteditable="false">r</span><span class="ins cts-1" data-cid="209" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576734185857" title="Inserted by Annapoorni Swamynathan - 12/19/2019 11:13am" contenteditable="true"> </span>15.4 ± 47.9% and 11.3 ± 46.4% within <span class="del cts-1" data-cid="218" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576734217695" title="Deleted by Annapoorni Swamynathan - 12/19/2019 11:13am" contenteditable="false">1</span><span class="ins cts-1" data-cid="219" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576734217706" title="Inserted by Annapoorni Swamynathan - 12/19/2019 11:13am" contenteditable="true">fir</span>st year, with further decrease in total testosterone and androstenedione <span class="del cts-1" data-cid="222" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576734252310" title="Deleted by Annapoorni Swamynathan - 12/19/2019 11:14am" contenteditable="false">f</span><span class="ins cts-1" data-cid="223" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576734252325" title="Inserted by Annapoorni Swamynathan - 12/19/2019 11:14am" contenteditable="true">t</span>o<span class="del cts-1" data-cid="224" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576734253851" title="Deleted by Annapoorni Swamynathan - 12/19/2019 11:14am" contenteditable="false">r</span> 37.8 ± 61.8 and 24.8 ± 40.5% at the <span class="del cts-1" data-cid="225" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576734258020" title="Deleted by Annapoorni Swamynathan - 12/19/2019 11:14am" contenteditable="false">5</span><span class="ins cts-1" data-cid="226" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576734258031" title="Inserted by Annapoorni Swamynathan - 12/19/2019 11:14am" contenteditable="true">fif</span>th year of the follow<span class="del cts-1" data-cid="149" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733115341" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:55am" contenteditable="false"> </span><span class="ins cts-1" data-cid="150" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733115353" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:55am" contenteditable="true">-</span>up. The total conversion rate to prediabetes and diabetes was extremely low throughout observation period. Less than 25% of patients continued with metformin for more than <span class="del cts-1" data-cid="229" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576734303365" title="Deleted by Annapoorni Swamynathan - 12/19/2019 11:15am" contenteditable="false">five</span><span class="ins cts-1" data-cid="230" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576734303377" title="Inserted by Annapoorni Swamynathan - 12/19/2019 11:15am" contenteditable="true">5</span> years with further dropout to only 6% on metformin therapy at the <span class="del cts-1" data-cid="231" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576734314241" title="Deleted by Annapoorni Swamynathan - 12/19/2019 11:15am" contenteditable="false">10</span><span class="ins cts-1" data-cid="232" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576734314254" title="Inserted by Annapoorni Swamynathan - 12/19/2019 11:15am" contenteditable="true">ten</span>th year of follow<span class="del cts-1" data-cid="151" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733118577" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:55am" contenteditable="false"> </span><span class="ins cts-1" data-cid="152" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733118595" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:55am" contenteditable="true">-</span>up.</pp1><pp1 store="112" contenteditable="true"><i store="113" contenteditable="true">Conclusions:</i> Long-term metformin treatment of overweight-obese women with PCOS and normal baseline glycemic homeostasis resulted in reduction and stabilization of BM, improvements of MF and androgen profile and low conversion rate to diabetes.</pp1></abstract1><kwd-group store="114" contenteditable="true"><title1 store="115" contenteditable="true">Key Words</title1><!--punc--> <!--punc--><kwd1 store="116" contenteditable="true">metformin</kwd1><!--punc-->, <!--punc--><kwd1 store="117" contenteditable="true">PCOS</kwd1><!--punc-->, <!--punc--><kwd1 store="118" contenteditable="true">obesity</kwd1><!--punc-->, <!--punc--><kwd1 store="119" contenteditable="true">diabetes</kwd1><!--punc-->, <!--punc--><kwd1 store="120" contenteditable="true">impaired glucose tolerance</kwd1></kwd-group></article-meta></front><hr store="121" contenteditable="true"/><body1 store="122" contenteditable="true"><sec sec-type="H1" store="123" contenteditable="true"><title1 title="H1" store="124" contenteditable="true">Introduction</title1><pp1 store="125" contenteditable="true">Polycystic<query title="Please check and approve the identification of the section level headings." data-time="1576308921" data-username="Editor" id="5" contenteditable="false" changetime="14/12/2019 13:05:16" store="126"><i class="fa fa-question-circle fa-1x fa-1x" style="color:red;" onclick="addQueryText(5);" contenteditable="true" store="127"></i></query> ovarian syndrome (PCOS) brings significant heterogeneity of cardio-metabolic risk at the time of the confirmed diagnosis (<xref ref-type="bibr" rid="CIT00001" title="1. BatesGWLegroRS. Long-term management of polycystic ovarian syndrome (PCOS). Molecular and Cellular Endocrinology 2013 373 91–97. (https://doi.org/10.1016/j.mce.2012.10.029)" store="128" contenteditable="true">1</xref>). Obesity, menstrual irregularity and <xref ref-type="scheme" language="US" store="129" contenteditable="true"><xref ref-type="scheme" language="UK" store="130" contenteditable="true">hyperandrogenism</xref></xref> are recognized as the most important clinical predictors of progressive metabolic burden (<xref ref-type="bibr" rid="CIT00002" title="2. KakolyNSEarnestATeedeHJMoranLJJohamAE. The impact of obesity on the incidence of Type 2 diabetes among women with polycystic ovary syndrome. Diabetes Care 2019 42 560–567. (https://doi.org/10.2337/dc18-1738)" store="131" contenteditable="true">2</xref>). Metformin that has been used in PCOS over the past few decades (<xref ref-type="bibr" rid="CIT00003 CIT00004" store="132" contenteditable="true">3, 4</xref>)<span class="del cts-1" data-cid="235" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576735248902" title="Deleted by Annapoorni Swamynathan - 12/19/2019 11:30am" contenteditable="false">,</span> may decrease the metabolic risk (<xref ref-type="bibr" rid="CIT00001" title="1. BatesGWLegroRS. Long-term management of polycystic ovarian syndrome (PCOS). Molecular and Cellular Endocrinology 2013 373 91–97. (https://doi.org/10.1016/j.mce.2012.10.029)" store="133" contenteditable="true">1</xref>), yet the majority of therapeutic studies in this population have been small and <span class="ins cts-1" data-cid="236" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576735259685" title="Inserted by Annapoorni Swamynathan - 12/19/2019 11:30am" contenteditable="true">have </span>used metformin for a relatively brief period (<xref ref-type="bibr" rid="CIT00005 CIT00006" store="134" contenteditable="true">5, 6</xref>).</pp1><pp1 store="135" contenteditable="true">Low<span class="del cts-1" data-cid="10" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576813359607" title="Deleted by Annapoorni Swamynathan - 12/20/2019 9:12am" contenteditable="false"> </span><span class="ins cts-1" data-cid="11" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576813360843" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:12am">-</span>quality evidence supports <span class="ins cts-1" data-cid="241" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576735271184" title="Inserted by Annapoorni Swamynathan - 12/19/2019 11:31am" contenteditable="true">the </span>use of metformin for women with PCOS and glucose intolerance when lifestyle intervention (LSI) is insufficient and for the management of menstrual irregularity if women are unable to take oral contraceptives (OCPs) (<xref ref-type="bibr" rid="CIT00007 CIT00008" store="136" contenteditable="true">7, 8</xref>). The latest international guidelines update recommends to consider metformin in addition to LSI also in women with PCOS with <span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731458000_dfound2_regex_style576" common_tag="1576731458000_ifound2_regex_style576" contenteditable="false">body mass index</span><span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731565300" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:29am" contenteditable="false"> (</span>BMI<span class="del cts-1" data-cid="3" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731568894" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:29am" contenteditable="false">)</span> ≥25 kg/m<sup store="137" contenteditable="true">2</sup>, independent<span class="del cts-1" data-cid="245" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576735731615" title="Deleted by Annapoorni Swamynathan - 12/19/2019 11:38am" contenteditable="false">ly</span> of the presence of glucose disturbances and menstrual irregularity (<xref ref-type="bibr" rid="CIT00007" title="7. TeedeHJMissoMLCostelloMFDokrasALavenJMoranLPiltonenTNormanRJ &amp; International PCOS Network. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Human Reproduction 2018 33 1602–1618. (https://doi.org/10.1093/humrep/dey256)" store="138" contenteditable="true">7</xref>). However, there is no clear answer for how long metformin should be prescribed in these subsets of patients, who would <span class="del cts-1" data-cid="247" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576735873605" title="Deleted by Annapoorni Swamynathan - 12/19/2019 11:41am" contenteditable="false">have </span>clear<span class="ins cts-1" data-cid="248" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576735877129" title="Inserted by Annapoorni Swamynathan - 12/19/2019 11:41am" contenteditable="true">ly</span> benefit from long<span class="del cts-1" data-cid="850" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576750440483" title="Deleted by Annapoorni Swamynathan - 12/19/2019 3:44pm" contenteditable="false"> </span><span class="ins cts-1" data-cid="851" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576750440514" title="Inserted by Annapoorni Swamynathan - 12/19/2019 3:44pm" contenteditable="true">-</span>term use of metformin in PCOS<span class="ins cts-1" data-cid="250" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576735896054" title="Inserted by Annapoorni Swamynathan - 12/19/2019 11:41am" contenteditable="true">,</span> and whether long<span class="del cts-1" data-cid="852" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576750445871" title="Deleted by Annapoorni Swamynathan - 12/19/2019 3:44pm" contenteditable="false"> </span><span class="ins cts-1" data-cid="853" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576750445901" title="Inserted by Annapoorni Swamynathan - 12/19/2019 3:44pm" contenteditable="true">-</span>term treatment with metformin is of benefit above and beyond lifestyle modification (<xref ref-type="bibr" rid="CIT00001 CIT00008 CIT00009" store="139" contenteditable="true">1, 8, 9</xref>).</pp1><pp1 store="140" contenteditable="true">The possibilities of preventing or delaying <xref ref-type="scheme" language="US" store="141" contenteditable="true"><xref ref-type="scheme" language="UK" store="142" contenteditable="true">cardiometabolic</xref></xref> diseases in adults at high risk had been hypothesized for many years. <span class="del cts-1" data-cid="251" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576736291308" title="Deleted by Annapoorni Swamynathan - 12/19/2019 11:48am" contenteditable="false">In t</span><span class="ins cts-1" data-cid="252" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576736291344" title="Inserted by Annapoorni Swamynathan - 12/19/2019 11:48am" contenteditable="true">T</span>he largest and longest trial in general population at high risk of developing type 2 diabetes (T2D) includ<span class="del cts-1" data-cid="253" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576736298678" title="Deleted by Annapoorni Swamynathan - 12/19/2019 11:48am" contenteditable="false">ing</span><span class="ins cts-1" data-cid="254" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576736298705" title="Inserted by Annapoorni Swamynathan - 12/19/2019 11:48am" contenteditable="true">ed</span> 3234 participants<span class="del cts-1" data-cid="256" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576736319290" title="Deleted by Annapoorni Swamynathan - 12/19/2019 11:48am" contenteditable="false">,</span> with impaired glucose tolerance, elevated fasting plasma glucose and BMI of ≥24 kg/m<sup store="143" contenteditable="true">2</sup>, <span class="ins cts-1" data-cid="257" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576736328329" title="Inserted by Annapoorni Swamynathan - 12/19/2019 11:48am" contenteditable="true">and </span>metformin reduced the incidence of T2D by 31% compared with placebo after an average follow-up of 2.<span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731838000_dfound0_regex_style39" common_tag="1576731838000_ifound0_regex_style39" contenteditable="false">8 years </span><span store="1576731838000_i0" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731838000_ifound0_regex_style39" common_tag="1576731838000_ifound0_regex_style39" contenteditable="true">8 years </span>and by 18% over 10 and <span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731838000_dfound1_regex_style39" common_tag="1576731838000_ifound1_regex_style39" contenteditable="false">15 years </span><span store="1576731838000_i1" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731838000_ifound1_regex_style39" common_tag="1576731838000_ifound1_regex_style39" contenteditable="true">15 years </span>post<span class="del cts-1" data-cid="12" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576813417985" title="Deleted by Annapoorni Swamynathan - 12/20/2019 9:13am" contenteditable="false">-</span><span class="ins cts-1" data-cid="13" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576813418035" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:13am"> </span>randomization (<xref ref-type="bibr" rid="CIT00010" title="10. ArodaVRKnowlerWCCrandallJPPerreaultLEdelsteinSLJeffriesSLMolitchMEPi-SunyerXDarwinCHeckman-StoddardBM, et al. Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study. Diabetologia 2017 60 1601–1611. (https://doi.org/10.1007/s00125-017-4361-9)" store="144" contenteditable="true">10</xref>). The subgroups that benefited the most<span class="del cts-1" data-cid="261" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576736488188" title="Deleted by Annapoorni Swamynathan - 12/19/2019 11:51am" contenteditable="false">,</span> included subjects with obesity, higher baseline fasting glucose or HbA1c and women with history of gestational diabetes mellitus (<xref ref-type="bibr" rid="CIT00010 CIT00011" store="145" contenteditable="true">10, 11</xref>). Furthermore, a recent systemic review demonstrated that adults using metformin experienced and maintained greater decreases in weight/BMI when compared with subjects on placebo, irrespective of duration of intervention and of the prescribed daily dosage (<xref ref-type="bibr" rid="CIT00012" title="12. LentferinkYEKnibbeCAJvan der VorstMMJ. Efficacy of metformin treatment with respect to weight reduction in children and adults with obesity: a systematic review. Drugs 2018 78 1887–1901. (https://doi.org/10.1007/s40265-018-1025-0)" store="146" contenteditable="true">12</xref>). One of the major determinants of the efficacy of metformin used as a preventive measures seems to be adherence (<xref ref-type="bibr" rid="CIT00012" title="12. LentferinkYEKnibbeCAJvan der VorstMMJ. Efficacy of metformin treatment with respect to weight reduction in children and adults with obesity: a systematic review. Drugs 2018 78 1887–1901. (https://doi.org/10.1007/s40265-018-1025-0)" store="147" contenteditable="true">12</xref>) that is usually observed to be low in long-term settings.</pp1><pp1 store="148" contenteditable="true">We evaluated the long-term efficacy of metformin in overweight-obese patients with PCOS and normal baseline <xref ref-type="scheme" language="UK" store="149" contenteditable="true">glycemic</xref> homeostasis on body mass (BM), menstrual frequencies (MF), metabolic and hormonal outcomes. This allows us to summarize our perspective in future research that can help to identify the optimal candidates and optimal duration for treatment with metformin in overweight-obese PCOS with normal baseline glucose homeostasis, where currently a long-term efficacy of metformin remains unproven.</pp1></sec><sec sec-type="H1" store="150" contenteditable="true"><title1 title="H1" store="151" contenteditable="true">Materials and methods</title1><sec sec-type="H2" store="152" contenteditable="true"><title1 title="H2" store="153" contenteditable="true">Study design</title1><pp1 store="154" contenteditable="true">We conducted a retrospective review of medical records of all women with PCOS referred to a specialized endocrinology outpatient clinics at the Department of Endocrinology, Diabetes and Metabolism in University Medical Centre, from January 2006 to December 2008. Study protocol was approved by the National Ethics Committee and registered with ClinicalTrials.gov identifier NCT04043221.</pp1></sec><sec sec-type="H2" store="155" contenteditable="true"><title1 title="H2" store="156" contenteditable="true">Study cohort</title1><pp1 store="157" contenteditable="true" data-time="1576737317000" data-username="Annapoorni Swamynathan">We identified 800 patients diagnosed with PCOS referred to first endocrine check-up during the selected 3-year period. The medical records of all patients were reviewed by the authors to confirm the diagnosis of PCOS based on the Rotterdam criteria and phenotype <span class="ins cts-1" data-cid="15" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576813702405" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:18am">them</span><span class="del cts-1" data-cid="263" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576737258729" title="Deleted by Annapoorni Swamynathan - 12/19/2019 12:04pm" contenteditable="false">them </span>from A<span class="del cts-1" data-cid="264" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576737267478" title="Deleted by Annapoorni Swamynathan - 12/19/2019 12:04pm" contenteditable="false">-</span><span class="ins cts-1" data-cid="265" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576737267507" title="Inserted by Annapoorni Swamynathan - 12/19/2019 12:04pm" contenteditable="true"> to </span>D. Phenotype A is defined as concomitant presence of <xref ref-type="scheme" language="US" store="158" contenteditable="true"><xref ref-type="scheme" language="UK" store="159" contenteditable="true">hyperandrogenism</xref></xref>, ovulatory dysfunction and polycystic ovarian morphology (PCOM) and represents the classical form of the syndrome. Phenotype B presents<span class="del cts-1" data-cid="269" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576737289335" title="Deleted by Annapoorni Swamynathan - 12/19/2019 12:04pm" contenteditable="false"> as</span> <xref ref-type="scheme" language="US" store="160" contenteditable="true"><xref ref-type="scheme" language="UK" store="161" contenteditable="true">hyperandrogenism</xref></xref> and ovulatory dysfunction, without PCOM. Phenotype C is the so-called <span role="1576737300000" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576737300000" contenteditable="true">‘</span><span class="del cts-1" data-cid="270" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576737302091" title="Deleted by Annapoorni Swamynathan - 12/19/2019 12:05pm" contenteditable="false">“</span>ovulatory<span class="del cts-1" data-cid="271" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576737305279" title="Deleted by Annapoorni Swamynathan - 12/19/2019 12:05pm" contenteditable="false">”</span><span role="1576737304000" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576737304000" contenteditable="true">’</span> PCOS (<xref ref-type="scheme" language="US" store="162" contenteditable="true"><xref ref-type="scheme" language="UK" store="163" contenteditable="true">hyperandrogenism</xref></xref> and PCOM only) and phenotype D is often referred to as <span role="1576737313000" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576737313000" contenteditable="true">‘</span><span class="del cts-1" data-cid="272" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576737314570" title="Deleted by Annapoorni Swamynathan - 12/19/2019 12:05pm" contenteditable="false">“</span><xref ref-type="scheme" language="US" store="164" contenteditable="true"><xref ref-type="scheme" language="UK" store="165" contenteditable="true">nonhyperandrogenic</xref></xref><span class="del cts-1" data-cid="273" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576737317984" title="Deleted by Annapoorni Swamynathan - 12/19/2019 12:05pm" contenteditable="false">”</span><span role="1576737317000" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576737317000" contenteditable="true">’</span> PCOS (ovulatory dysfunction and PCOM only) (<xref ref-type="bibr" rid="CIT00013" title="13. AzzizR. Introduction: determinants of polycystic ovary syndrome. Fertility and Sterility 2016 106 4–5. (https://doi.org/10.1016/j.fertnstert.2016.05.009)" store="166" contenteditable="true">13</xref>). After the review of the medical records we recruited the patients. Eligibility criteria included phenotype A, BMI ≥25 kg/m<sup store="167" contenteditable="true">2</sup>, normal glucose homeostasis, introduction of <xref ref-type="scheme" language="US" store="168" contenteditable="true"><xref ref-type="scheme" language="UK" store="169" contenteditable="true">monotherapy</xref></xref> with metformin <span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731845000_dfound1_regex_style99" common_tag="1576731845000_ifound1_regex_style99" contenteditable="false">1000 mg </span><span store="1576731845000_i1" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731845000_ifound1_regex_style99" common_tag="1576731845000_ifound1_regex_style99" contenteditable="true">1000 mg </span>BID and follow<span class="del cts-1" data-cid="141" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733091185" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:54am" contenteditable="false"> </span><span class="ins cts-1" data-cid="142" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733091211" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:54am" contenteditable="true">-</span>up period for at least 1 year. Patients were excluded from the study if they showed the following: (a) phenotype B, C or D; (b) BMI &lt;25 kg/m<sup store="170" contenteditable="true">2</sup>; (c) impaired fasting glucose (IFG), impaired glucose tolerance (IGT) or T2Dat baseline; (d) had been treated with spironolactone and/or OCPs within the last <span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731840000_dfound0_regex_style45" common_tag="1576731840000_ifound0_regex_style45" contenteditable="false">6 months </span><span store="1576731840000_i0" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731840000_ifound0_regex_style45" common_tag="1576731840000_ifound0_regex_style45" contenteditable="true">6 months </span>before recruitment; (e) had history of bariatric surgery; (f) became pregnant during the observation period<span class="del cts-1" data-cid="274" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576737642571" title="Deleted by Annapoorni Swamynathan - 12/19/2019 12:10pm" contenteditable="false">;</span><span class="ins cts-1" data-cid="275" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576737642618" title="Inserted by Annapoorni Swamynathan - 12/19/2019 12:10pm" contenteditable="true"> or</span> (g) had <span class="ins cts-1" data-cid="278" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576737648600" title="Inserted by Annapoorni Swamynathan - 12/19/2019 12:10pm" contenteditable="true">the </span>inability to tolerate metformin that led to the cessation of drug therapy within first follow<span class="del cts-1" data-cid="143" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733096528" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:54am" contenteditable="false"> </span><span class="ins cts-1" data-cid="144" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733096558" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:54am" contenteditable="true">-</span>up year (<xref ref-type="fig" rid="F1" store="171" contenteditable="true">Fig. 1</xref>).<fig fig-type="figure" id="F1" position="float" store="172" contenteditable="true"><label1 store="173" contenteditable="true"><b store="174" contenteditable="true">Figure 1</b></label1><caption1 store="175" contenteditable="true"><p1 store="176" contenteditable="true"> Flowchart of the study. PCOS<span class="ins cts-1" data-cid="19" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576813819527" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:20am">,</span> polycystic ovar<span class="ins cts-1" data-cid="282" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576737675111" title="Inserted by Annapoorni Swamynathan - 12/19/2019 12:11pm" contenteditable="true">ian</span> syndrome; N numerus; BMI body mass index; BID<span class="ins cts-1" data-cid="20" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576813830194" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:20am">,</span> bis in die, twice a day; IFG<span class="ins cts-1" data-cid="21" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576813834391" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:20am">,</span> impaired fasting glucose; IGT<span class="ins cts-1" data-cid="22" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576813837911" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:20am">,</span> impaired glucose tolerance; T2DM<span class="ins cts-1" data-cid="23" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576813841738" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:20am">,</span> type 2 diabetes mellitus.</p1></caption1><img src="http://78.137.168.31:8080/oxygenxml-web-author/plugins-dispatcher/webdav-server/xmlfiles/docbook/5914/10470/finaloutput/images/ECC_190449_f001.jpg" store="177" contenteditable="false"/></fig></pp1></sec><sec sec-type="H2" store="178" contenteditable="true"><title1 title="H2" store="179" contenteditable="true">Data collection</title1><pp1 store="180" contenteditable="true" data-time="1576737947000" data-username="Annapoorni Swamynathan">Each patient’s age and height were recorded at baseline. In addition<span class="ins cts-1" data-cid="291" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576737951292" title="Inserted by Annapoorni Swamynathan - 12/19/2019 12:15pm" contenteditable="true">,</span> each patient<span role="1576737947000" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576737947000" contenteditable="true">’</span><span class="ins cts-1" data-cid="290" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576737947473" title="Inserted by Annapoorni Swamynathan - 12/19/2019 12:15pm" contenteditable="true">s</span> weight, blood pressure, menstrual frequency, fasting glucose, <xref ref-type="scheme" language="US" store="181" contenteditable="true"><xref ref-type="scheme" language="UK" store="182" contenteditable="true">androstenedione</xref></xref>, <xref ref-type="scheme" language="US" store="183" contenteditable="true"><xref ref-type="scheme" language="UK" store="184" contenteditable="true">dehydroepiandrosterone</xref></xref> sulphate (DHEAS), free and total testosterone, follicle-stimulating hormone (FSH), luteinizing hormone (LH) were identified at baseline and at<span class="del cts-1" data-cid="292" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576737965129" title="Deleted by Annapoorni Swamynathan - 12/19/2019 12:16pm" contenteditable="false"> the</span> every follow<span class="del cts-1" data-cid="153" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733125475" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:55am" contenteditable="false"> </span><span class="ins cts-1" data-cid="154" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733125503" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:55am" contenteditable="true">-</span>up visit at <span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731837000_dfound1_regex_style36" common_tag="1576731837000_ifound1_regex_style36" contenteditable="false">1 year </span><span store="1576731837000_i1" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731837000_ifound1_regex_style36" common_tag="1576731837000_ifound1_regex_style36" contenteditable="true">1-year </span>intervals where available. Oral glucose tolerance test was performed at baseline and then rescreened periodically over 2<span class="del cts-1" data-cid="293" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576738310397" title="Deleted by Annapoorni Swamynathan - 12/19/2019 12:21pm" contenteditable="false">-</span><span class="ins cts-1" data-cid="294" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576738310492" title="Inserted by Annapoorni Swamynathan - 12/19/2019 12:21pm" contenteditable="true">–</span>3 years. Waist circumference, <xref ref-type="scheme" language="US" store="186" contenteditable="true"><xref ref-type="scheme" language="UK" store="187" contenteditable="true">Ferriman</xref></xref><span class="del cts-1" data-cid="297" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576738337916" title="Deleted by Annapoorni Swamynathan - 12/19/2019 12:22pm" contenteditable="false"> </span><xref ref-type="scheme" language="US" store="188" contenteditable="true"><xref ref-type="scheme" language="UK" store="189" contenteditable="true"><span class="ins cts-1" data-cid="298" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576738337972" title="Inserted by Annapoorni Swamynathan - 12/19/2019 12:22pm" contenteditable="true">–</span>Gallwey</xref></xref> score, serum insulin levels and lipid profile were not consistently assessed as part of the standard clinical care in women with PCOS at that time and sufficient data are unavailable for analysis.</pp1><pp1 store="190" contenteditable="true">Glucose levels were determined using a standard glucose oxidase method (Beckman Coulter Glucose <xref ref-type="scheme" language="UK" store="191" contenteditable="true">Analyzer</xref>, Beckman Coulter <xref ref-type="scheme" language="US" store="192" contenteditable="true"><xref ref-type="scheme" language="UK" store="193" contenteditable="true">Inc</xref></xref> CA, USA). <xref ref-type="scheme" language="US" store="194" contenteditable="true"><xref ref-type="scheme" language="UK" store="195" contenteditable="true">Androstenedione</xref></xref> and DHEAS were measured by specific double antibody RIA using 125 I-<xref ref-type="scheme" language="UK" store="196" contenteditable="true">labeled</xref> hormones (Diagnostic Systems Laboratories, Webster, <xref ref-type="scheme" language="US" store="197" contenteditable="true"><xref ref-type="scheme" language="UK" store="198" contenteditable="true">Tx</xref></xref>). Total and free testosterone levels were measured by coated tube RIA (<xref ref-type="scheme" language="US" store="199" contenteditable="true"><xref ref-type="scheme" language="UK" store="200" contenteditable="true">DiaSorin</xref></xref>, S. p. A, <xref ref-type="scheme" language="US" store="201" contenteditable="true"><xref ref-type="scheme" language="UK" store="202" contenteditable="true">Salluggia</xref></xref>, Italy and Diagnostic Products Corporation, LA, respectively). LH and FSH were measured using <xref ref-type="scheme" language="US" store="203" contenteditable="true"><xref ref-type="scheme" language="UK" store="204" contenteditable="true">immunometric</xref></xref> assay (Diagnostic Products Corporation, LA). Intra-assay coefficient <span class="ins cts-1" data-cid="26" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576813926430" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:22am">of </span>variation (CV) for <xref ref-type="scheme" language="US" store="205" contenteditable="true"><xref ref-type="scheme" language="UK" store="206" contenteditable="true">androstenedione</xref></xref> ranges from 5.0 to 7.5% and inter-assay CV from 4.1 to 11.3%, <span class="ins cts-1" data-cid="299" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576738455331" title="Inserted by Annapoorni Swamynathan - 12/19/2019 12:24pm" contenteditable="true">and </span>intra-assay CV for DHEAS from 4.9 to 9.8% and inter-assay CV from 7.9 to 13.0%. Intra-assay CV for free testosterone is 7.7<span class="del cts-1" data-cid="29" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576813944270" title="Deleted by Annapoorni Swamynathan - 12/20/2019 9:22am" contenteditable="false">-</span><span class="ins cts-1" data-cid="30" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576813944408" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:22am">–</span>19.3% and inter-assay CV is 6.4<span class="del cts-1" data-cid="31" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576813950587" title="Deleted by Annapoorni Swamynathan - 12/20/2019 9:22am" contenteditable="false">-</span><span class="ins cts-1" data-cid="32" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576813950663" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:22am">–</span>13.2%. Intra-assay CV for total testosterone is 5.1<span class="del cts-1" data-cid="305" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576738713072" title="Deleted by Annapoorni Swamynathan - 12/19/2019 12:28pm" contenteditable="false">-</span><span class="ins cts-1" data-cid="306" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576738713178" title="Inserted by Annapoorni Swamynathan - 12/19/2019 12:28pm" contenteditable="true">–</span>16.3% and inter-assay CV is 7.2<span class="del cts-1" data-cid="307" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576738720436" title="Deleted by Annapoorni Swamynathan - 12/19/2019 12:28pm" contenteditable="false">-</span><span class="ins cts-1" data-cid="308" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576738720490" title="Inserted by Annapoorni Swamynathan - 12/19/2019 12:28pm" contenteditable="true">–</span>24.3%. Intra-assay CV for SHBG is 2.5<span class="del cts-1" data-cid="309" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576738730612" title="Deleted by Annapoorni Swamynathan - 12/19/2019 12:28pm" contenteditable="false">-</span><span class="ins cts-1" data-cid="310" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576738730668" title="Inserted by Annapoorni Swamynathan - 12/19/2019 12:28pm" contenteditable="true">–</span>5.3% and inter-assay CV is 4<span class="del cts-1" data-cid="311" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576738735880" title="Deleted by Annapoorni Swamynathan - 12/19/2019 12:28pm" contenteditable="false">-</span><span class="ins cts-1" data-cid="312" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576738735935" title="Inserted by Annapoorni Swamynathan - 12/19/2019 12:28pm" contenteditable="true">–</span>6.6%. BMI was calculated as the weight in kilograms divided by square of height in meters. Menstrual regularity was defined as number of bleeds per year using self reported menstrual intervals based on dairy review. According to World Health Organization (WHO) criteria<span class="del cts-1" data-cid="316" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576738784923" title="Deleted by Annapoorni Swamynathan - 12/19/2019 12:29pm" contenteditable="false">,</span> <span class="ins cts-1" data-cid="317" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576738786819" title="Inserted by Annapoorni Swamynathan - 12/19/2019 12:29pm" contenteditable="true">(</span>available from: http://www.who.int/diabetes/publications/diagnosis_diabetes2006/en/<span class="ins cts-1" data-cid="318" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576738791631" title="Inserted by Annapoorni Swamynathan - 12/19/2019 12:29pm" contenteditable="true">),</span> <span class="ins cts-1" data-cid="333" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576739348599" title="Inserted by Annapoorni Swamynathan - 12/19/2019 12:39pm" contenteditable="true">during OGTT, </span>normal glucose tolerance (NGT) was defined as fasting glucose levels below 6.<span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731853000_dfound0_regex_style168" common_tag="1576731853000_ifound0_regex_style168" contenteditable="false">1 mmol/l </span><span store="1576731853000_i0" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731853000_ifound0_regex_style168" common_tag="1576731853000_ifound0_regex_style168" contenteditable="true">1 mmol/L </span>and 2-h glucose in 75<span class="ins cts-1" data-cid="35" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576813974803" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:22am"> </span>g-OGTT &lt;7.8 <xref ref-type="scheme" language="US" store="209" contenteditable="true"><xref ref-type="scheme" language="UK" store="210" contenteditable="true">mmol</xref></xref>/L, impaired fasting glucose (IFG) as fasting glucose between 6.1 and 6.<span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731853000_dfound2_regex_style168" common_tag="1576731853000_ifound2_regex_style168" contenteditable="false">9 mmol/l </span><span store="1576731853000_i1" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731853000_ifound2_regex_style168" common_tag="1576731853000_ifound2_regex_style168" contenteditable="true">9 mmol/L </span>and 2-h glucose in 75g-OGTT &lt;7.8 <xref ref-type="scheme" language="US" store="213" contenteditable="true"><xref ref-type="scheme" language="UK" store="214" contenteditable="true">mmol</xref></xref>/L, impaired glucose tolerance (IGT) was identified by <span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731841000_dfound0_regex_style60" common_tag="1576731841000_ifound0_regex_style60" contenteditable="false">2 h </span><span store="1576731841000_i0" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731841000_ifound0_regex_style60" common_tag="1576731841000_ifound0_regex_style60" contenteditable="true">2-h </span>glucose levels in 75<span class="ins cts-1" data-cid="122" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576813995191" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:23am"> </span>g-OGTT between 7.8 and 11 <xref ref-type="scheme" language="US" store="215" contenteditable="true"><xref ref-type="scheme" language="UK" store="216" contenteditable="true">mmol</xref></xref>/<span class="del cts-1" data-cid="123" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576813999008" title="Deleted by Annapoorni Swamynathan - 12/20/2019 9:23am" contenteditable="false">l</span><span class="del cts-1" data-cid="332" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576739237188" title="Deleted by Annapoorni Swamynathan - 12/19/2019 12:37pm" contenteditable="false">,</span><span class="ins cts-1" data-cid="124" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576814000556" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:23am">L</span> <span class="ins cts-1" data-cid="328" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576739234069" title="Inserted by Annapoorni Swamynathan - 12/19/2019 12:37pm" contenteditable="true">and </span>T2D as fasting glucose level ≥7.<span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731853000_dfound3_regex_style168" common_tag="1576731853000_ifound3_regex_style168" contenteditable="false">0 mmol/l </span><span store="1576731853000_i2" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731853000_ifound3_regex_style168" common_tag="1576731853000_ifound3_regex_style168" contenteditable="true">0 mmol/L </span>or 2-h glucose ≥11.<span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731853000_dfound1_regex_style168" common_tag="1576731853000_ifound1_regex_style168" contenteditable="false">1 mmol/l </span><span store="1576731853000_i3" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731853000_ifound1_regex_style168" common_tag="1576731853000_ifound1_regex_style168" contenteditable="true">1 mmol/L</span><span class="del cts-1" data-cid="348" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576739364531" title="Deleted by Annapoorni Swamynathan - 12/19/2019 12:39pm" contenteditable="false">during OGTT</span>. Conversion was viewed as worsening of category from NGT to IFG, IGT or T2D, a change from IFG to T2D<span class="del cts-1" data-cid="349" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576739411776" title="Deleted by Annapoorni Swamynathan - 12/19/2019 12:40pm" contenteditable="false">,</span> or a change from IGT to T2D over time, and reversion was viewed as an improvement from IFG, IGT or<span class="ins cts-1" data-cid="350" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576739427526" title="Inserted by Annapoorni Swamynathan - 12/19/2019 12:40pm" contenteditable="true"> </span>T2D to NGT or from T2D to IGT or IFG.</pp1></sec><sec sec-type="H2" store="221" contenteditable="true"><title1 title="H2" store="222" contenteditable="true">Metformin therapy</title1><pp1 store="223" contenteditable="true">All participants began treatment with metformin at baseline<i store="224" contenteditable="true">.</i> Metformin was commenced at <span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731845000_dfound2_regex_style99" common_tag="1576731845000_ifound2_regex_style99" contenteditable="false">500 mg </span><span store="1576731845000_i2" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731845000_ifound2_regex_style99" common_tag="1576731845000_ifound2_regex_style99" contenteditable="true">500 mg </span>once daily, with <span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731845000_dfound3_regex_style99" common_tag="1576731845000_ifound3_regex_style99" contenteditable="false">500 mg </span><span store="1576731845000_i3" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731845000_ifound3_regex_style99" common_tag="1576731845000_ifound3_regex_style99" contenteditable="true">500 mg </span>increments <span class="del cts-1" data-cid="362" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576739519635" title="Deleted by Annapoorni Swamynathan - 12/19/2019 12:41pm" contenteditable="false">1-</span>weekly up to <span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731845000_dfound4_regex_style99" common_tag="1576731845000_ifound4_regex_style99" contenteditable="false">2000 mg </span><span store="1576731845000_i4" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731845000_ifound4_regex_style99" common_tag="1576731845000_ifound4_regex_style99" contenteditable="true">2000 mg </span>in most patients. As part of <span class="ins cts-1" data-cid="363" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576739527331" title="Inserted by Annapoorni Swamynathan - 12/19/2019 12:42pm" contenteditable="true">the </span>routine clinical care, all patients were <xref ref-type="scheme" language="UK" store="225" contenteditable="true">counseled</xref> regarding lifestyle changes at every visit.</pp1></sec><sec sec-type="H2" store="226" contenteditable="true"><title1 title="H2" store="227" contenteditable="true">Statistical analysis</title1><pp1 store="228" contenteditable="true" data-time="1576732672000" data-username="Annapoorni Swamynathan">Continuous variables <span class="del cts-1" data-cid="130" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576814043601" title="Deleted by Annapoorni Swamynathan - 12/20/2019 9:24am" contenteditable="false">we</span><span class="ins cts-1" data-cid="132" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576814043667" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:24am">a</span>re represented as mean ± <span class="" contenteditable="true"><span class="del cts-1" data-cid="126" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733029287" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:53am" contenteditable="false">SD</span></span><sc class="small_capstag" data-time="1576733032000" data-username="Annapoorni Swamynathan" contenteditable="true">s.d.</sc>, while categorical variables <span class="del cts-1" data-cid="133" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576814048788" title="Deleted by Annapoorni Swamynathan - 12/20/2019 9:24am" contenteditable="false">we</span><span class="ins cts-1" data-cid="134" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576814048854" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:24am">a</span>re described using frequencies. Nonparametric Wilcoxon signed-rank test was used for comparison of clinical parameters for related samples. Spearman’s rho was used to calculate correlations between continuous variables. Nonparametric<span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731825000_dfound0_regex_style18" common_tag="1576731825000_ifound0_regex_style18" contenteditable="false"> Mann-Whitney </span><span store="1576731825000_i0" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731825000_ifound0_regex_style18" common_tag="1576731825000_ifound0_regex_style18" contenteditable="true"> Mann–Whitney </span>or <xref ref-type="scheme" language="US" store="229" contenteditable="true"><xref ref-type="scheme" language="UK" store="230" contenteditable="true">Kruskal</xref></xref><span class="del cts-1" data-cid="135" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576814063476" title="Deleted by Annapoorni Swamynathan - 12/20/2019 9:24am" contenteditable="false">-</span><span class="ins cts-1" data-cid="137" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576814063607" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:24am">–</span>Wallis tests <span class="del cts-1" data-cid="138" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576814068064" title="Deleted by Annapoorni Swamynathan - 12/20/2019 9:24am" contenteditable="false">test </span>w<span class="del cts-1" data-cid="139" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576814071546" title="Deleted by Annapoorni Swamynathan - 12/20/2019 9:24am" contenteditable="false">as</span><span class="ins cts-1" data-cid="140" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576814071613" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:24am">ere</span> used to compare the distribution of continuous variables among different groups. <i data-time="1576732676000" data-username="Annapoorni Swamynathan" contenteditable="true">P</i> values of &lt;0.05 were considered statistically significant. IBM SPSS Statistics, version 21.0 (IBM Corporation<span class="del cts-1" data-cid="189" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576814091926" title="Deleted by Annapoorni Swamynathan - 12/20/2019 9:24am" contenteditable="false">, Armonk, NY, USA</span>) was used for all statistical analyses.</pp1></sec></sec><sec sec-type="H1" store="231" contenteditable="true"><title1 title="H1" store="232" contenteditable="true">Results</title1><pp1 store="233" contenteditable="true">During the selected 3-year period, 800 women with the diagnosis of PCOS underwent assessment<span class="ins cts-1" data-cid="191" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576814119313" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:25am">,</span><span class="del cts-1" data-cid="367" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576739691058" title="Deleted by Annapoorni Swamynathan - 12/19/2019 12:44pm" contenteditable="false">,</span><span class="ins cts-1" data-cid="368" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576739691096" title="Inserted by Annapoorni Swamynathan - 12/19/2019 12:44pm" contenteditable="true"> </span> 159 among them fulfilled the eligibility criteria. The mean values of their baseline characteristics are outlined in <xref ref-type="table" rid="T1" store="234" contenteditable="true">Table 1</xref>. Longitudinal follow<span class="del cts-1" data-cid="156" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733133788" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:55am" contenteditable="false"> </span><span class="ins cts-1" data-cid="157" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733133820" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:55am" contenteditable="true">-</span>up included 6085 time-points with a subset of anthropometric, reproductive, hormonal and metabolic parameters.<table-wrap id="T1" position="float" store="235" contenteditable="true"><label1 store="236" contenteditable="true"><b store="237" contenteditable="true">Table 1</b></label1><caption1 store="238" contenteditable="true"><p1 store="239" contenteditable="true"> Baseline characteristic and longitudinal follow-up to 7th year of therapy with metformin of clinical parameters in women with PCOS, treated with metformin.<span class="del cts-1" data-cid="192" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576814154171" title="Deleted by Annapoorni Swamynathan - 12/20/2019 9:25am" contenteditable="false">*</span><span class="ins cts-1" data-cid="193" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576814154248" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:25am"><sup data-time="1576814157000" data-username="Annapoorni Swamynathan">a</sup></span></p1></caption1><table frame="box" store="240" id="table_1" contenteditable="false"><thead store="241" contenteditable="true"><tr store="242" contenteditable="true"><td rowspan="3" store="243" contenteditable="true"><tp store="244" contenteditable="true">Clinical parameter mean ± <span class="" contenteditable="true"><span class="del cts-1" data-cid="131" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733041644" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:54am" contenteditable="false">SD</span><sc class="small_capstag" data-time="1576733044000" data-username="Annapoorni Swamynathan" contenteditable="true">s.d.</sc></span></tp></td><td rowspan="2" store="245" contenteditable="true"><tp store="246" contenteditable="true">Baseline characteristic</tp></td><td colspan="7" store="247" contenteditable="true"><tp store="248" contenteditable="true">Years of metformin therapy</tp></td></tr><tr store="249" contenteditable="true"><td store="250" contenteditable="true"><tp store="251" contenteditable="true">1</tp></td><td store="252" contenteditable="true"><tp store="253" contenteditable="true">2</tp></td><td store="254" contenteditable="true"><tp store="255" contenteditable="true">3</tp></td><td store="256" contenteditable="true"><tp store="257" contenteditable="true">4</tp></td><td store="258" contenteditable="true"><tp store="259" contenteditable="true">5</tp></td><td store="260" contenteditable="true"><tp store="261" contenteditable="true">6</tp></td><td store="262" contenteditable="true"><tp store="263" contenteditable="true">7</tp></td></tr><tr store="264" contenteditable="true"><td store="265" contenteditable="true"><tp store="266" contenteditable="true"><span class="" contenteditable="true"><span class="del cts-1" data-cid="106" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732729853" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:48am" contenteditable="false">N</span></span><span class="ins cts-1" data-cid="107" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732729863" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:48am" contenteditable="true"><i data-time="1576732731000" data-username="Annapoorni Swamynathan" contenteditable="true">n</i></span> = 159</tp></td><td store="267" contenteditable="true" class=""><tp store="268" contenteditable="true"><span class="" contenteditable="true"><span class="del cts-1" data-cid="108" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732742831" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:49am" contenteditable="false">N</span></span><span class="ins cts-1" data-cid="109" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732742843" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:49am" contenteditable="true"><i data-time="1576732744000" data-username="Annapoorni Swamynathan" contenteditable="true">n</i></span> = 141</tp></td><td store="269" contenteditable="true" class=""><tp store="270" contenteditable="true"><span class="" contenteditable="true"><span class="del cts-1" data-cid="110" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732829453" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:50am" contenteditable="false">N</span></span><span class="ins cts-1" data-cid="111" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732829468" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:50am" contenteditable="true"><i data-time="1576732831000" data-username="Annapoorni Swamynathan" contenteditable="true">n</i></span> = 103</tp></td><td store="271" contenteditable="true"><tp store="272" contenteditable="true"><span class="" contenteditable="true"><span class="del cts-1" data-cid="112" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732835441" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:50am" contenteditable="false">N</span></span><span class="ins cts-1" data-cid="113" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732835465" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:50am" contenteditable="true"><i data-time="1576732837000" data-username="Annapoorni Swamynathan" contenteditable="true">n</i></span> = 78</tp></td><td store="273" contenteditable="true"><tp store="274" contenteditable="true"><span class="" contenteditable="true"><span class="del cts-1" data-cid="114" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732841014" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:50am" contenteditable="false">N</span></span><span class="ins cts-1" data-cid="115" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732841032" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:50am" contenteditable="true"><i data-time="1576732843000" data-username="Annapoorni Swamynathan" contenteditable="true">n</i></span> = 56</tp></td><td store="275" contenteditable="true"><tp store="276" contenteditable="true"><span class="" contenteditable="true"><span class="del cts-1" data-cid="116" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732846850" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:50am" contenteditable="false">N</span></span><span class="ins cts-1" data-cid="117" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732846862" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:50am" contenteditable="true"><i data-time="1576732848000" data-username="Annapoorni Swamynathan" contenteditable="true">n</i></span> = 35</tp></td><td store="277" contenteditable="true"><tp store="278" contenteditable="true"><span class="" contenteditable="true"><span class="del cts-1" data-cid="118" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732851559" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:50am" contenteditable="false">N</span></span><span class="ins cts-1" data-cid="119" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732851569" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:50am" contenteditable="true"><i data-time="1576732853000" data-username="Annapoorni Swamynathan" contenteditable="true">n</i></span> = 30</tp></td><td store="279" contenteditable="true"><tp store="280" contenteditable="true"><span class="" contenteditable="true"><span class="del cts-1" data-cid="120" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732857300" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:50am" contenteditable="false">N</span></span><span class="ins cts-1" data-cid="121" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732857311" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:50am" contenteditable="true"><i data-time="1576732860000" data-username="Annapoorni Swamynathan" contenteditable="true">n</i></span> = 18</tp></td></tr></thead><tbody store="281" contenteditable="true"><tr store="282" contenteditable="true"><td store="283" contenteditable="true"><tp store="284" contenteditable="true">Age (years)</tp></td><td store="285" contenteditable="true" class=""><tp store="286" contenteditable="true">28.4 ± 6.4</tp></td><td store="287" contenteditable="true" class=""><tp store="288" contenteditable="true"></tp></td><td store="289" contenteditable="true"><tp store="290" contenteditable="true"></tp></td><td store="291" contenteditable="true"><tp store="292" contenteditable="true"></tp></td><td store="293" contenteditable="true"><tp store="294" contenteditable="true"></tp></td><td store="295" contenteditable="true"><tp store="296" contenteditable="true"></tp></td><td store="297" contenteditable="true"><tp store="298" contenteditable="true"></tp></td><td store="299" contenteditable="true"><tp store="300" contenteditable="true"></tp></td></tr><tr store="301" contenteditable="true"><td store="302" contenteditable="true"><tp store="303" contenteditable="true">Weight (kg)</tp></td><td store="304" contenteditable="true"><tp store="305" contenteditable="true">96.1 ± 19.2 </tp></td><td store="306" contenteditable="true"><tp store="307" contenteditable="true">92.4 ± 18</tp></td><td store="308" contenteditable="true"><tp store="309" contenteditable="true">91.1 ± 18.1</tp></td><td store="310" contenteditable="true"><tp store="311" contenteditable="true">92.7 ± 19.2</tp></td><td store="312" contenteditable="true"><tp store="313" contenteditable="true">92.7 ± 19.5 </tp></td><td store="314" contenteditable="true"><tp store="315" contenteditable="true">95.1 ± 18.1 </tp></td><td store="316" contenteditable="true"><tp store="317" contenteditable="true">93 ± 15.3 </tp></td><td store="318" contenteditable="true"><tp store="319" contenteditable="true">90.4 ± 13.6</tp></td></tr><tr store="320" contenteditable="true"><td store="321" contenteditable="true"><tp store="322" contenteditable="true">BMI (kg/m<sup store="323" contenteditable="true">2</sup>)</tp></td><td store="324" contenteditable="true"><tp store="325" contenteditable="true">34.9 ± 6.6 </tp></td><td store="326" contenteditable="true"><tp store="327" contenteditable="true">33.5 ± 6.3 </tp></td><td store="328" contenteditable="true"><tp store="329" contenteditable="true">33.2 ± 6.6 </tp></td><td store="330" contenteditable="true"><tp store="331" contenteditable="true">33.5 ± 6.6 </tp></td><td store="332" contenteditable="true"><tp store="333" contenteditable="true">33.4 ± 6.6 </tp></td><td store="334" contenteditable="true"><tp store="335" contenteditable="true">34.5 ± 6.6 </tp></td><td store="336" contenteditable="true"><tp store="337" contenteditable="true">34 ± 6.2 </tp></td><td store="338" contenteditable="true"><tp store="339" contenteditable="true">32.8 ± 4.8</tp></td></tr><tr store="340" contenteditable="true"><td store="341" contenteditable="true" class=""><tp store="342" contenteditable="true">FPG (mmol/<span class="del cts-1" data-cid="194" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576814206486" title="Deleted by Annapoorni Swamynathan - 12/20/2019 9:26am" contenteditable="false">l</span><span class="ins cts-1" data-cid="196" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576814207773" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:26am">L</span>)</tp></td><td store="343" contenteditable="true"><tp store="344" contenteditable="true">4.9 ± 0.5</tp></td><td store="345" contenteditable="true"><tp store="346" contenteditable="true">4.9 ± 0.7 </tp></td><td store="347" contenteditable="true"><tp store="348" contenteditable="true">4.9 ± 0.6 </tp></td><td store="349" contenteditable="true"><tp store="350" contenteditable="true">4.9 ± 0.8 </tp></td><td store="351" contenteditable="true"><tp store="352" contenteditable="true">5.2 ± 0.8 </tp></td><td store="353" contenteditable="true"><tp store="354" contenteditable="true">5.5 ± 1.4 </tp></td><td store="355" contenteditable="true"><tp store="356" contenteditable="true">5.2 ± 1 </tp></td><td store="357" contenteditable="true"><tp store="358" contenteditable="true">5.6 ± 1.6 </tp></td></tr><tr store="359" contenteditable="true"><td store="360" contenteditable="true"><tp store="361" contenteditable="true">MF (number of cycles/year)</tp></td><td store="362" contenteditable="true"><tp store="363" contenteditable="true">7.6 ± 3.8 </tp></td><td store="364" contenteditable="true"><tp store="365" contenteditable="true">10.8 ± 2.7 </tp></td><td store="366" contenteditable="true"><tp store="367" contenteditable="true">10.6 ± 3 </tp></td><td store="368" contenteditable="true"><tp store="369" contenteditable="true">11.3 ± 1.7 </tp></td><td store="370" contenteditable="true"><tp store="371" contenteditable="true">10.6 ± 2.9 </tp></td><td store="372" contenteditable="true"><tp store="373" contenteditable="true">11 ± 2.4 </tp></td><td store="374" contenteditable="true"><tp store="375" contenteditable="true">11 ± 2.9 </tp></td><td store="376" contenteditable="true"><tp store="377" contenteditable="true">11.6 ± 0.6 </tp></td></tr><tr store="378" contenteditable="true"><td store="379" contenteditable="true" class=""><tp store="380" contenteditable="true">DHEAS (μmol/<span class="del cts-1" data-cid="199" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576814212045" title="Deleted by Annapoorni Swamynathan - 12/20/2019 9:26am" contenteditable="false">l</span><span class="ins cts-1" data-cid="200" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576814213476" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:26am">L</span>)</tp></td><td store="381" contenteditable="true"><tp store="382" contenteditable="true">6.5 ± 3.2 </tp></td><td store="383" contenteditable="true"><tp store="384" contenteditable="true">7.3 ± 9.2 </tp></td><td store="385" contenteditable="true"><tp store="386" contenteditable="true">6.9 ± 3 </tp></td><td store="387" contenteditable="true"><tp store="388" contenteditable="true">6.4 ± 3.4 </tp></td><td store="389" contenteditable="true"><tp store="390" contenteditable="true">6.8 ± 3.6 </tp></td><td store="391" contenteditable="true"><tp store="392" contenteditable="true">5.8 ± 3.2 </tp></td><td store="393" contenteditable="true"><tp store="394" contenteditable="true">6.3 ± 3.2 </tp></td><td store="395" contenteditable="true"><tp store="396" contenteditable="true">9.5 ± 10.9 </tp></td></tr><tr store="397" contenteditable="true"><td store="398" contenteditable="true" class=""><tp store="399" contenteditable="true">Total testosterone (nmol/<span class="del cts-1" data-cid="206" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576814216630" title="Deleted by Annapoorni Swamynathan - 12/20/2019 9:26am" contenteditable="false">l</span><span class="ins cts-1" data-cid="207" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576814217941" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:26am">L</span>)</tp></td><td store="400" contenteditable="true"><tp store="401" contenteditable="true">2 ± 1 </tp></td><td store="402" contenteditable="true"><tp store="403" contenteditable="true">1.5 ± 0.8 </tp></td><td store="404" contenteditable="true"><tp store="405" contenteditable="true">1.6 ± 1 </tp></td><td store="406" contenteditable="true"><tp store="407" contenteditable="true">1.3 ± 0.9 </tp></td><td store="408" contenteditable="true"><tp store="409" contenteditable="true">1.3 ± 0.8 </tp></td><td store="410" contenteditable="true"><tp store="411" contenteditable="true">1.4 ± 1.2 </tp></td><td store="412" contenteditable="true"><tp store="413" contenteditable="true">1.7 ± 1.3 </tp></td><td store="414" contenteditable="true"><tp store="415" contenteditable="true">2 ± 2.3 </tp></td></tr><tr store="416" contenteditable="true"><td store="417" contenteditable="true" class=""><tp store="418" contenteditable="true">Free testosterone (pmol/<span class="del cts-1" data-cid="210" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576814221848" title="Deleted by Annapoorni Swamynathan - 12/20/2019 9:27am" contenteditable="false">l</span><span class="ins cts-1" data-cid="211" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576814223161" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:27am">L</span>)</tp></td><td store="419" contenteditable="true"><tp store="420" contenteditable="true">6.6 ± 4.3 </tp></td><td store="421" contenteditable="true"><tp store="422" contenteditable="true">5.2 ± 3.6 </tp></td><td store="423" contenteditable="true"><tp store="424" contenteditable="true">5.3 ± 3.7</tp></td><td store="425" contenteditable="true"><tp store="426" contenteditable="true">5.9 ± 4.1 </tp></td><td store="427" contenteditable="true"><tp store="428" contenteditable="true">6.1 ± 4.1 </tp></td><td store="429" contenteditable="true"><tp store="430" contenteditable="true">4.9 ± 2.8 </tp></td><td store="431" contenteditable="true"><tp store="432" contenteditable="true">5.2 ± 3.7</tp></td><td store="433" contenteditable="true"><tp store="434" contenteditable="true">4.5 ± 2.8 </tp></td></tr><tr store="435" contenteditable="true"><td store="436" contenteditable="true" class=""><tp store="437" contenteditable="true">Androstenedione (nmol/<span class="del cts-1" data-cid="212" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576814237206" title="Deleted by Annapoorni Swamynathan - 12/20/2019 9:27am" contenteditable="false">l</span><span class="ins cts-1" data-cid="213" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576814238546" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:27am">L</span>)</tp></td><td store="438" contenteditable="true"><tp store="439" contenteditable="true">10 ± 9.9 </tp></td><td store="440" contenteditable="true"><tp store="441" contenteditable="true">7.3 ± 3.5 </tp></td><td store="442" contenteditable="true"><tp store="443" contenteditable="true">8.3 ± 4.4 </tp></td><td store="444" contenteditable="true"><tp store="445" contenteditable="true">6.8 ± 3.5 </tp></td><td store="446" contenteditable="true"><tp store="447" contenteditable="true">7.4 ± 4.4 </tp></td><td store="448" contenteditable="true"><tp store="449" contenteditable="true">7.4 ± 4.4 </tp></td><td store="450" contenteditable="true"><tp store="451" contenteditable="true">6.9 ± 3.6 </tp></td><td store="452" contenteditable="true"><tp store="453" contenteditable="true">5.9 ± 2 </tp></td></tr><tr store="454" contenteditable="true"><td store="455" contenteditable="true" class=""><tp store="456" contenteditable="true">FSH (IU/<span class="del cts-1" data-cid="214" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576814244841" title="Deleted by Annapoorni Swamynathan - 12/20/2019 9:27am" contenteditable="false">l</span><span class="ins cts-1" data-cid="220" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576814246683" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:27am">L</span>)</tp></td><td store="457" contenteditable="true"><tp store="458" contenteditable="true">5.4 ± 5.8</tp></td><td store="459" contenteditable="true"><tp store="460" contenteditable="true">5.1 ± 2.3 </tp></td><td store="461" contenteditable="true"><tp store="462" contenteditable="true">5.2 ± 2.5 </tp></td><td store="463" contenteditable="true"><tp store="464" contenteditable="true">5.2 ± 2.2 </tp></td><td store="465" contenteditable="true"><tp store="466" contenteditable="true">5.7 ± 3.2 </tp></td><td store="467" contenteditable="true"><tp store="468" contenteditable="true">7.8 ± 12.6 </tp></td><td store="469" contenteditable="true"><tp store="470" contenteditable="true">5.3 ± 2.6 </tp></td><td store="471" contenteditable="true"><tp store="472" contenteditable="true">6.5 ± 2.6 </tp></td></tr><tr store="473" contenteditable="true"><td store="474" contenteditable="true" class=" otherclass" style="background-color: rgb(155, 179, 218);"><tp store="475" contenteditable="true">LH (IU/<span class="del cts-1" data-cid="221" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576814250504" title="Deleted by Annapoorni Swamynathan - 12/20/2019 9:27am" contenteditable="false">l</span><span class="ins cts-1" data-cid="227" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576814251781" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:27am">L</span>)</tp></td><td store="476" contenteditable="true"><tp store="477" contenteditable="true">9.1 ± 7.3 </tp></td><td store="478" contenteditable="true"><tp store="479" contenteditable="true">7.5 ± 8.5 </tp></td><td store="480" contenteditable="true"><tp store="481" contenteditable="true">8 ± 7.2 </tp></td><td store="482" contenteditable="true"><tp store="483" contenteditable="true">7.1 ± 6.5 </tp></td><td store="484" contenteditable="true"><tp store="485" contenteditable="true">7.9 ± 8.8 </tp></td><td store="486" contenteditable="true"><tp store="487" contenteditable="true">12.3 ± 12.1 </tp></td><td store="488" contenteditable="true"><tp store="489" contenteditable="true">6.6 ± 5.1 </tp></td><td store="490" contenteditable="true"><tp store="491" contenteditable="true">8.6 ± 10.3</tp></td></tr></tbody></table><table-wrap-foot store="492" contenteditable="true"><fn id="fn1" store="493" contenteditable="true"><label1 store="494" contenteditable="true"></label1><pp1 store="495" contenteditable="true"><span class="del cts-1" data-cid="228" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576814269390" title="Deleted by Annapoorni Swamynathan - 12/20/2019 9:27am" contenteditable="false">*</span><span class="ins cts-1" data-cid="233" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576814269480" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:27am"><sup data-time="1576814272000" data-username="Annapoorni Swamynathan">a</sup></span>The data analyses beyond <span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731838000_dfound2_regex_style39" common_tag="1576731838000_ifound2_regex_style39" contenteditable="false">7 years </span><span store="1576731838000_i2" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731838000_ifound2_regex_style39" common_tag="1576731838000_ifound2_regex_style39" contenteditable="true">7 years </span>are truncated because less than 10% of the participants continued with metformin therapy for more than 7 years.</pp1></fn><fn id="fn2" store="496" contenteditable="true"><label1 store="497" contenteditable="true"></label1><pp1 store="498" contenteditable="true"><span class="ins cts-1" data-cid="410" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576740367008" title="Inserted by Annapoorni Swamynathan - 12/19/2019 12:56pm" contenteditable="true">BMI, body mass index; </span><span class="" contenteditable="true"><span class="del cts-1" data-cid="136" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733051102" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:54am" contenteditable="false">SD</span></span><sc class="small_capstag" data-time="1576733053000" data-username="Annapoorni Swamynathan" contenteditable="true"><span class="del cts-1" data-cid="444" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576740452493" title="Deleted by Annapoorni Swamynathan - 12/19/2019 12:57pm" contenteditable="false">s.d.</span></sc><span class="del cts-1" data-cid="444" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576740452493" title="Deleted by Annapoorni Swamynathan - 12/19/2019 12:57pm" contenteditable="false">, </span><span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731467000_dfound2_regex_style801" common_tag="1576731467000_ifound2_regex_style801" contenteditable="false">standard deviation</span><span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731458000_dfound3_regex_style576" common_tag="1576731458000_ifound3_regex_style576" contenteditable="false">; BMI, body mass index</span><span class="del cts-1" data-cid="434" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576740384545" title="Deleted by Annapoorni Swamynathan - 12/19/2019 12:56pm" contenteditable="false">; </span><span class="ins cts-1" data-cid="479" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576740526199" title="Inserted by Annapoorni Swamynathan - 12/19/2019 12:58pm" contenteditable="true">DHEAS, DHEA sulphate; </span>FBG, fasting plasma glucose; <span class="ins cts-1" data-cid="436" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576740407250" title="Inserted by Annapoorni Swamynathan - 12/19/2019 12:56pm" contenteditable="true">FSH, follicle-stimulating hormone; <span class="ins cts-1" data-cid="440" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576740421203" title="Inserted by Annapoorni Swamynathan - 12/19/2019 12:57pm" contenteditable="true">LH, luteinizing hormone; </span></span>MF, menstrual frequencies;<span class="ins cts-1" data-cid="445" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576740458106" title="Inserted by Annapoorni Swamynathan - 12/19/2019 12:57pm" contenteditable="true"> <span class="ins cts-1" data-cid="446" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576740459066" title="Inserted by Annapoorni Swamynathan - 12/19/2019 12:57pm" contenteditable="true"><sc class="small_capstag" data-time="1576740467000" data-username="Annapoorni Swamynathan" contenteditable="true">S.D.</sc>, standard deviation</span></span><span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731460000_dfound2_regex_style621" common_tag="1576731460000_ifound2_regex_style621" contenteditable="false"> DHEAS dehydroepiandrosterone</span><span class="del cts-1" data-cid="435" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576740403059" title="Deleted by Annapoorni Swamynathan - 12/19/2019 12:56pm" contenteditable="false"> sulphate; FSH, follicle-stimulating hormone; LH, luteinizing hormone</span>.</pp1></fn></table-wrap-foot></table-wrap></pp1><sec sec-type="H2" store="499" contenteditable="true"><title1 title="H2" store="500" contenteditable="true">Anthropometric parameters</title1><pp1 store="501" contenteditable="true">BM decreased for 3.9 ± 6.<span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731844000_dfound1_regex_style93" common_tag="1576731844000_ifound1_regex_style93" contenteditable="false">8 kg </span><span store="1576731844000_i1" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731844000_ifound1_regex_style93" common_tag="1576731844000_ifound1_regex_style93" contenteditable="true">8 kg </span>(<span class="del cts-1" data-cid="42" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732501902" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:45am" contenteditable="false">p</span><span class="ins cts-1" data-cid="43" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732501941" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:45am" contenteditable="true"><i data-time="1576732503000" data-username="Annapoorni Swamynathan" contenteditable="true">P</i></span> &lt; 0.001) in the <span class="del cts-1" data-cid="488" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576740721618" title="Deleted by Annapoorni Swamynathan - 12/19/2019 1:02pm" contenteditable="false">1</span><span class="ins cts-1" data-cid="489" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576740721664" title="Inserted by Annapoorni Swamynathan - 12/19/2019 1:02pm" contenteditable="true">fir</span>st year of follow<span class="del cts-1" data-cid="158" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733138634" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:55am" contenteditable="false"> </span><span class="ins cts-1" data-cid="159" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733138687" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:55am" contenteditable="true">-</span>up. BMI decreased for 1.5 ± 2.3 kg/m<sup store="502" contenteditable="true">2</sup> (<span class="del cts-1" data-cid="44" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732506109" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:45am" contenteditable="false">p</span><span class="ins cts-1" data-cid="45" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732506145" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:45am" contenteditable="true"><i data-time="1576732507000" data-username="Annapoorni Swamynathan" contenteditable="true">P</i></span> &lt; 0.001) in the <span class="del cts-1" data-cid="492" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576740731638" title="Deleted by Annapoorni Swamynathan - 12/19/2019 1:02pm" contenteditable="false">1</span><span class="ins cts-1" data-cid="493" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576740731683" title="Inserted by Annapoorni Swamynathan - 12/19/2019 1:02pm" contenteditable="true">fir</span>st year of follow<span class="del cts-1" data-cid="160" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733141230" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:55am" contenteditable="false"> </span><span class="ins cts-1" data-cid="161" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733141288" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:55am" contenteditable="true">-</span>up. Altogether in the <span class="del cts-1" data-cid="496" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576740736192" title="Deleted by Annapoorni Swamynathan - 12/19/2019 1:02pm" contenteditable="false">1</span><span class="ins cts-1" data-cid="497" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576740736238" title="Inserted by Annapoorni Swamynathan - 12/19/2019 1:02pm" contenteditable="true">fir</span>st year, 104 patients lost weight, 8 remained the same and 28 patients gained weight. Change of the BM after the <span class="del cts-1" data-cid="503" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576740766889" title="Deleted by Annapoorni Swamynathan - 12/19/2019 1:02pm" contenteditable="false">1</span><span class="ins cts-1" data-cid="504" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576740766936" title="Inserted by Annapoorni Swamynathan - 12/19/2019 1:02pm" contenteditable="true">fir</span>st year was inversely correlated with baseline BM (Spearman’s rho = −0.337; <span class="del cts-1" data-cid="46" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732510607" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:45am" contenteditable="false">p</span><span class="ins cts-1" data-cid="47" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732510646" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:45am" contenteditable="true"><i data-time="1576732511000" data-username="Annapoorni Swamynathan" contenteditable="true">P</i></span> &lt; 0.001)<span class="del cts-1" data-cid="507" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576740786866" title="Deleted by Annapoorni Swamynathan - 12/19/2019 1:03pm" contenteditable="false">,</span> and BMI (Spearman’s rho = −0.308; <span class="del cts-1" data-cid="48" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732518737" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:45am" contenteditable="false">p</span><span class="ins cts-1" data-cid="49" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732518784" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:45am" contenteditable="true"><i data-time="1576732520000" data-username="Annapoorni Swamynathan" contenteditable="true">P</i></span> &lt; 0.001). Patients who lost weight in the <span class="del cts-1" data-cid="508" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576740793447" title="Deleted by Annapoorni Swamynathan - 12/19/2019 1:03pm" contenteditable="false">1</span><span class="ins cts-1" data-cid="509" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576740793496" title="Inserted by Annapoorni Swamynathan - 12/19/2019 1:03pm" contenteditable="true">fir</span>st year had significantly less frequent menstrual bleeding at baseline (Spearman’s rho = 0.190; <span class="del cts-1" data-cid="50" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732522895" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:45am" contenteditable="false">p</span><span class="ins cts-1" data-cid="51" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732522937" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:45am" contenteditable="true"><i data-time="1576732523000" data-username="Annapoorni Swamynathan" contenteditable="true">P</i></span> = 0.045). <span class="del cts-1" data-cid="512" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576740806487" title="Deleted by Annapoorni Swamynathan - 12/19/2019 1:03pm" contenteditable="false">25</span><span class="ins cts-1" data-cid="513" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576740806534" title="Inserted by Annapoorni Swamynathan - 12/19/2019 1:03pm" contenteditable="true">Twenty-five</span> patients gained weight after 1 year, 60% of those <span class="ins cts-1" data-cid="530" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576740831603" title="Inserted by Annapoorni Swamynathan - 12/19/2019 1:03pm" contenteditable="true">who </span>had 11 or 12 menstrual bleedings at baseline. There was no correlation between body weight change and fasting plasma glucose level or hormonal status (level of LH, FSH, DHEAS, <xref ref-type="scheme" language="US" store="503" contenteditable="true"><xref ref-type="scheme" language="UK" store="504" contenteditable="true">androstenedione</xref></xref>, total and free testosterone). Patients who lost weight in the <span class="del cts-1" data-cid="534" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576740848646" title="Deleted by Annapoorni Swamynathan - 12/19/2019 1:04pm" contenteditable="false">1</span><span class="ins cts-1" data-cid="535" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576740848696" title="Inserted by Annapoorni Swamynathan - 12/19/2019 1:04pm" contenteditable="true">fir</span>st year had significantly less frequent menstrual bleeding at baseline (6.9 ± 3.8<span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731470000_dfound0_regex_style876" common_tag="1576731470000_ifound0_regex_style876" contenteditable="false"> vs. </span><span store="1576731470000_i0" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731470000_ifound0_regex_style876" common_tag="1576731470000_ifound0_regex_style876" contenteditable="true"> vs </span>9.2 ± 3.6 numbers of bleedings/year (<span class="del cts-1" data-cid="52" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732528813" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:45am" contenteditable="false">p</span><span class="ins cts-1" data-cid="53" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732528868" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:45am" contenteditable="true"><i data-time="1576732530000" data-username="Annapoorni Swamynathan" contenteditable="true">P</i></span> = 0.003)) when compared to patients that gained weight or remained stable. The two groups did not differ at baseline BM, BMI, fasting plasma glucose level and hormonal status (level of LH, FSH, DHEAS, <xref ref-type="scheme" language="US" store="505" contenteditable="true"><xref ref-type="scheme" language="UK" store="506" contenteditable="true">androstenedione</xref></xref>, total and free testosterone). Decrease of BM and BMI remained significant up to visit (V) 4 when compared with baseline. From V5 up to V10<span class="ins cts-1" data-cid="538" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576740890672" title="Inserted by Annapoorni Swamynathan - 12/19/2019 1:04pm" contenteditable="true">,</span> no significant change in BM was observed when compared with baseline (<xref ref-type="fig" rid="F2" store="507" contenteditable="true">Fig. 2A</xref>).<fig fig-type="figure" id="F2" position="float" store="508" contenteditable="true"><label1 store="509" contenteditable="true"><b store="510" contenteditable="true">Figure 2</b></label1><caption1 store="511" contenteditable="true"><p1 store="512" contenteditable="true"> Change in body weight (A), number of menstrual cycles (periods) (B), total plasma testosterone levels (C)<span class="del cts-1" data-cid="539" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576740899747" title="Deleted by Annapoorni Swamynathan - 12/19/2019 1:04pm" contenteditable="false">,</span> and plasma androstenedione levels (D) during the time. Values are means with 95% CI shown by vertical lines. Comparisons to pretreatment values were calculated using Wilcoxon test for paired samples. *The values beyond 7 years are truncated because less than 10% of the participants continued with metformin therapy for more than 7 years.</p1></caption1><img src="http://78.137.168.31:8080/oxygenxml-web-author/plugins-dispatcher/webdav-server/xmlfiles/docbook/5914/10470/finaloutput/images/ECC_190449_f002.jpg" store="513" contenteditable="false"/></fig></pp1></sec><sec sec-type="H2" store="514" contenteditable="true"><title1 title="H2" store="515" contenteditable="true">Menstrual regularity</title1><pp1 store="516" contenteditable="true">Menstrual frequency increased from 7.6 ± 3.8 to 10.8 ± 2.7 bleeds/year (<span class="del cts-1" data-cid="54" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732532950" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:45am" contenteditable="false">p</span><span class="ins cts-1" data-cid="55" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732532991" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:45am" contenteditable="true"><i data-time="1576732534000" data-username="Annapoorni Swamynathan" contenteditable="true">P</i></span> &lt; 0.001) after <span class="del cts-1" data-cid="540" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576740935848" title="Deleted by Annapoorni Swamynathan - 12/19/2019 1:05pm" contenteditable="false">1</span><span class="ins cts-1" data-cid="541" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576740935914" title="Inserted by Annapoorni Swamynathan - 12/19/2019 1:05pm" contenteditable="true">fir</span>st year to over 11 bleeds/year from V5 up to V7 (<xref ref-type="fig" rid="F2" store="517" contenteditable="true">Fig. 2B</xref> and <xref ref-type="table" rid="T1" store="518" contenteditable="true">Table 1</xref>). The increase in menstrual frequency was statistically significant from V1<span class="del cts-1" data-cid="544" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576740948913" title="Deleted by Annapoorni Swamynathan - 12/19/2019 1:05pm" contenteditable="false">-</span><span class="ins cts-1" data-cid="545" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576740949019" title="Inserted by Annapoorni Swamynathan - 12/19/2019 1:05pm" contenteditable="true">–</span>V7 when compared to baseline (<xref ref-type="fig" rid="F2" store="519" contenteditable="true">Fig. 2B</xref>).</pp1><pp1 store="520" contenteditable="true">We also stratified patients by age and evaluated menstrual frequency in patients younger than <span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731838000_dfound3_regex_style39" common_tag="1576731838000_ifound3_regex_style39" contenteditable="false">35 years </span><span store="1576731838000_i3" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731838000_ifound3_regex_style39" common_tag="1576731838000_ifound3_regex_style39" contenteditable="true">35 years </span>at baseline and patients <span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731838000_dfound4_regex_style39" common_tag="1576731838000_ifound4_regex_style39" contenteditable="false">35 years </span><span store="1576731838000_i4" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731838000_ifound4_regex_style39" common_tag="1576731838000_ifound4_regex_style39" contenteditable="true">35 years </span>old or older at baseline. In patients younger than 35 years, menstrual frequency increased from 7.4 ± 3.9 to 10.7 ± 2.9 bleeds/year (<span class="del cts-1" data-cid="56" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732536954" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:45am" contenteditable="false">p</span><span class="ins cts-1" data-cid="57" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732536994" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:45am" contenteditable="true"><i data-time="1576732539000" data-username="Annapoorni Swamynathan" contenteditable="true">P</i></span> &lt; 0.001) after <span class="del cts-1" data-cid="546" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576741021968" title="Deleted by Annapoorni Swamynathan - 12/19/2019 1:07pm" contenteditable="false">1</span><span class="ins cts-1" data-cid="547" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576741022017" title="Inserted by Annapoorni Swamynathan - 12/19/2019 1:07pm" contenteditable="true">fir</span>st year and to 11 bleeds/year or more from V5 up to V7. In patients ≥35 years, menstrual frequency increased from 9.0 ± 3.1 to 11.1 ± 1 bleeds/year (<span class="del cts-1" data-cid="58" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732545715" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:45am" contenteditable="false">p</span><span class="ins cts-1" data-cid="59" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732545753" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:45am" contenteditable="true"><i data-time="1576732546000" data-username="Annapoorni Swamynathan" contenteditable="true">P</i></span> &lt; 0.026) after <span class="del cts-1" data-cid="550" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576741037557" title="Deleted by Annapoorni Swamynathan - 12/19/2019 1:07pm" contenteditable="false">1</span><span class="ins cts-1" data-cid="553" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576741038789" title="Inserted by Annapoorni Swamynathan - 12/19/2019 1:07pm" contenteditable="true">fir</span>st year.</pp1><pp1 store="521" contenteditable="true">Change in menstrual frequency after <span class="del cts-1" data-cid="556" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576741043921" title="Deleted by Annapoorni Swamynathan - 12/19/2019 1:07pm" contenteditable="false">1</span><span class="ins cts-1" data-cid="557" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576741043970" title="Inserted by Annapoorni Swamynathan - 12/19/2019 1:07pm" contenteditable="true">fir</span>st year negatively correlated with the menstrual frequency at baseline (Spearman’s rho = −0.803; <span class="del cts-1" data-cid="60" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732550224" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:45am" contenteditable="false">p</span><span class="ins cts-1" data-cid="61" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732550263" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:45am" contenteditable="true"><i data-time="1576732551000" data-username="Annapoorni Swamynathan" contenteditable="true">P</i></span> &lt; 0.001) and age (Spearman’s rho = −0.221; <span class="del cts-1" data-cid="62" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732554229" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:45am" contenteditable="false">p</span><span class="ins cts-1" data-cid="63" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732554268" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:45am" contenteditable="true"><i data-time="1576732555000" data-username="Annapoorni Swamynathan" contenteditable="true">P</i></span> = 0.044). Correlation with menstrual frequency at baseline was significant both in patients younger than <span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731838000_dfound5_regex_style39" common_tag="1576731838000_ifound5_regex_style39" contenteditable="false">35 years </span><span store="1576731838000_i5" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731838000_ifound5_regex_style39" common_tag="1576731838000_ifound5_regex_style39" contenteditable="true">35 years </span>(Spearman’s rho = −0.792; <span class="del cts-1" data-cid="64" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732558076" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:45am" contenteditable="false">p</span><span class="ins cts-1" data-cid="65" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732558132" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:45am" contenteditable="true"><i data-time="1576732559000" data-username="Annapoorni Swamynathan" contenteditable="true">P</i></span> &lt; 0.001) and in patients ≥<span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731838000_dfound6_regex_style39" common_tag="1576731838000_ifound6_regex_style39" contenteditable="false">35 years </span><span store="1576731838000_i6" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731838000_ifound6_regex_style39" common_tag="1576731838000_ifound6_regex_style39" contenteditable="true">35 years </span>(Spearman’s rho = −0.805; <span class="del cts-1" data-cid="66" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732564655" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:46am" contenteditable="false">p</span><span class="ins cts-1" data-cid="67" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732564699" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:46am" contenteditable="true"><i data-time="1576732565000" data-username="Annapoorni Swamynathan" contenteditable="true">P</i></span> = 0.009).</pp1><pp1 store="522" contenteditable="true">Increased menstrual frequency after <span class="del cts-1" data-cid="560" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576741059510" title="Deleted by Annapoorni Swamynathan - 12/19/2019 1:07pm" contenteditable="false">1</span><span class="ins cts-1" data-cid="561" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576741059560" title="Inserted by Annapoorni Swamynathan - 12/19/2019 1:07pm" contenteditable="true">fir</span>st year correlated with the decreases in BM (<span class="del cts-1" data-cid="68" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732569491" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:46am" contenteditable="false">p</span><span class="ins cts-1" data-cid="69" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732569530" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:46am" contenteditable="true"><i data-time="1576732571000" data-username="Annapoorni Swamynathan" contenteditable="true">P</i></span> = 0.008) and decrease in total testosterone (<span class="del cts-1" data-cid="70" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732574533" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:46am" contenteditable="false">p</span><span class="ins cts-1" data-cid="71" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732574578" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:46am" contenteditable="true"><i data-time="1576732575000" data-username="Annapoorni Swamynathan" contenteditable="true">P</i></span> = 0.035), with no correlation with the change in LH/FSH ratio after <span class="del cts-1" data-cid="564" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576741069580" title="Deleted by Annapoorni Swamynathan - 12/19/2019 1:07pm" contenteditable="false">1</span><span class="ins cts-1" data-cid="565" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576741069631" title="Inserted by Annapoorni Swamynathan - 12/19/2019 1:07pm" contenteditable="true">fir</span>st year. Correlation with BM and total testosterone was significant only in patients younger than <span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731838000_dfound7_regex_style39" common_tag="1576731838000_ifound7_regex_style39" contenteditable="false">35 years </span><span store="1576731838000_i7" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731838000_ifound7_regex_style39" common_tag="1576731838000_ifound7_regex_style39" contenteditable="true">35 years </span>(<span class="del cts-1" data-cid="72" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732578844" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:46am" contenteditable="false">p</span><span class="ins cts-1" data-cid="73" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732578904" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:46am" contenteditable="true"><i data-time="1576732580000" data-username="Annapoorni Swamynathan" contenteditable="true">P</i></span> = 0.023 and <span class="del cts-1" data-cid="74" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732583478" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:46am" contenteditable="false">p</span><span class="ins cts-1" data-cid="75" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732583518" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:46am" contenteditable="true"><i data-time="1576732584000" data-username="Annapoorni Swamynathan" contenteditable="true">P</i></span> = 0.015, respectively) and not in patients ≥<span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731838000_dfound8_regex_style39" common_tag="1576731838000_ifound8_regex_style39" contenteditable="false">35 years </span><span store="1576731838000_i8" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731838000_ifound8_regex_style39" common_tag="1576731838000_ifound8_regex_style39" contenteditable="true">35 years </span>(<span class="del cts-1" data-cid="76" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732587626" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:46am" contenteditable="false">p</span><span class="ins cts-1" data-cid="77" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732587667" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:46am" contenteditable="true"><i data-time="1576732589000" data-username="Annapoorni Swamynathan" contenteditable="true">P</i></span> = 0.062 and <span class="del cts-1" data-cid="78" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732593457" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:46am" contenteditable="false">p</span><span class="ins cts-1" data-cid="79" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732593500" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:46am" contenteditable="true"><i data-time="1576732594000" data-username="Annapoorni Swamynathan" contenteditable="true">P</i></span> = 0.639, respectively).</pp1><pp1 store="523" contenteditable="true">Patients in whom menstrual regularity improved after <span class="del cts-1" data-cid="568" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576741088052" title="Deleted by Annapoorni Swamynathan - 12/19/2019 1:08pm" contenteditable="false">1</span><span class="ins cts-1" data-cid="569" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576741088104" title="Inserted by Annapoorni Swamynathan - 12/19/2019 1:08pm" contenteditable="true">fir</span>st year had significantly less frequent bleedings<span class="del cts-1" data-cid="572" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576741127823" title="Deleted by Annapoorni Swamynathan - 12/19/2019 1:08pm" contenteditable="false"> at baseline</span> (5.8 ± 3.3<span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731470000_dfound1_regex_style876" common_tag="1576731470000_ifound1_regex_style876" contenteditable="false"> vs. </span><span store="1576731470000_i1" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731470000_ifound1_regex_style876" common_tag="1576731470000_ifound1_regex_style876" contenteditable="true"> vs </span>11.0 ± 2.2 numbers of bleedings/year (<span class="del cts-1" data-cid="80" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732598962" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:46am" contenteditable="false">p</span><span class="ins cts-1" data-cid="81" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732599015" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:46am" contenteditable="true"><i data-time="1576732600000" data-username="Annapoorni Swamynathan" contenteditable="true">P</i></span> &lt; 0.001)) and lower DHEAS (5.9 ± 3.0 <xref ref-type="scheme" language="US" store="524" contenteditable="true"><xref ref-type="scheme" language="UK" store="525" contenteditable="true">vs</xref></xref> 7.7 ± 3.7 <xref ref-type="scheme" language="US" store="526" contenteditable="true"><xref ref-type="scheme" language="UK" store="527" contenteditable="true">μmol</xref></xref>/<span class="del cts-1" data-cid="237" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576814753583" title="Deleted by Annapoorni Swamynathan - 12/20/2019 9:35am" contenteditable="false">l</span><span class="ins cts-1" data-cid="238" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576814755551" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:35am">L</span>, <span class="del cts-1" data-cid="82" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732603309" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:46am" contenteditable="false">p</span><span class="ins cts-1" data-cid="83" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732603350" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:46am" contenteditable="true"><i data-time="1576732604000" data-username="Annapoorni Swamynathan" contenteditable="true">P</i></span> = 0.040) at baseline when compared with those with no improvement in menstrual frequencies. After stratification by age, only association of number of bleedings/year in patients younger than <span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731838000_dfound9_regex_style39" common_tag="1576731838000_ifound9_regex_style39" contenteditable="false">35 years </span><span store="1576731838000_i9" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731838000_ifound9_regex_style39" common_tag="1576731838000_ifound9_regex_style39" contenteditable="true">35 years </span>was significant (5.3 ± 3.2<span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731470000_dfound2_regex_style876" common_tag="1576731470000_ifound2_regex_style876" contenteditable="false"> vs. </span><span store="1576731470000_i2" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731470000_ifound2_regex_style876" common_tag="1576731470000_ifound2_regex_style876" contenteditable="true"> vs </span>11.0 ± 2.3 number of bleedings/year (<span class="del cts-1" data-cid="84" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732607157" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:46am" contenteditable="false">p</span><span class="ins cts-1" data-cid="85" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732607205" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:46am" contenteditable="true"><i data-time="1576732608000" data-username="Annapoorni Swamynathan" contenteditable="true">P</i></span> &lt; 0.001)).</pp1></sec><sec sec-type="H2" store="528" contenteditable="true"><title1 title="H2" store="529" contenteditable="true">Metabolic parameters</title1><pp1 store="530" contenteditable="true">Mean levels of fasting glucose did not change<span class="del cts-1" data-cid="573" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747278534" title="Deleted by Annapoorni Swamynathan - 12/19/2019 2:51pm" contenteditable="false">d</span> significantly after <span class="del cts-1" data-cid="574" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747285157" title="Deleted by Annapoorni Swamynathan - 12/19/2019 2:51pm" contenteditable="false">1</span><span class="ins cts-1" data-cid="575" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747285214" title="Inserted by Annapoorni Swamynathan - 12/19/2019 2:51pm" contenteditable="true">fir</span>st year follow<span class="del cts-1" data-cid="162" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733146335" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:55am" contenteditable="false"> </span><span class="ins cts-1" data-cid="163" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733146380" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:55am" contenteditable="true">-</span>up and not during the following years. The mean values were in the normal range throughout the follow<span class="del cts-1" data-cid="164" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733153734" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:55am" contenteditable="false"> </span><span class="ins cts-1" data-cid="165" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733153778" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:55am" contenteditable="true">-</span>up (<xref ref-type="table" rid="T1" store="531" contenteditable="true">Table 1</xref>). Patients in whom fasting glucose significantly decreased after <span class="del cts-1" data-cid="578" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747302878" title="Deleted by Annapoorni Swamynathan - 12/19/2019 2:51pm" contenteditable="false">1</span><span class="ins cts-1" data-cid="579" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747302934" title="Inserted by Annapoorni Swamynathan - 12/19/2019 2:51pm" contenteditable="true">fir</span>st year had significantly higher fasting glucose at baseline<span class="ins cts-1" data-cid="239" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576814791266" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:36am"> </span>(5.0 ± 0.4<span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731470000_dfound3_regex_style876" common_tag="1576731470000_ifound3_regex_style876" contenteditable="false"> vs. </span><span store="1576731470000_i3" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731470000_ifound3_regex_style876" common_tag="1576731470000_ifound3_regex_style876" contenteditable="true"> vs </span>4.8 ± 0.<span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731853000_dfound4_regex_style168" common_tag="1576731853000_ifound4_regex_style168" contenteditable="false">5 mmol/l </span><span store="1576731853000_i4" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731853000_ifound4_regex_style168" common_tag="1576731853000_ifound4_regex_style168" contenteditable="true">5 mmol/l </span>(<span class="del cts-1" data-cid="86" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732611495" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:46am" contenteditable="false">p</span><span class="ins cts-1" data-cid="87" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732611538" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:46am" contenteditable="true"><i data-time="1576732612000" data-username="Annapoorni Swamynathan" contenteditable="true">P</i></span> = 0.007)) and significantly lower menstrual frequency (6.3 ± 3.7<span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731470000_dfound4_regex_style876" common_tag="1576731470000_ifound4_regex_style876" contenteditable="false"> vs. </span><span store="1576731470000_i4" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731470000_ifound4_regex_style876" common_tag="1576731470000_ifound4_regex_style876" contenteditable="true"> vs </span>8.5 ± 3.7 numbers of bleedings/year (<span class="del cts-1" data-cid="88" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732616879" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:46am" contenteditable="false">p</span><span class="ins cts-1" data-cid="89" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732616929" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:46am" contenteditable="true"><i data-time="1576732618000" data-username="Annapoorni Swamynathan" contenteditable="true">P</i></span> = 0.006)) when compared with women in whom fasting glucose increased or remained unchanged after <span class="del cts-1" data-cid="582" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747318629" title="Deleted by Annapoorni Swamynathan - 12/19/2019 2:51pm" contenteditable="false">1</span><span class="ins cts-1" data-cid="583" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747318708" title="Inserted by Annapoorni Swamynathan - 12/19/2019 2:51pm" contenteditable="true">fir</span>st year. Fasting glucose after <span class="del cts-1" data-cid="586" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747323672" title="Deleted by Annapoorni Swamynathan - 12/19/2019 2:52pm" contenteditable="false">1</span><span class="ins cts-1" data-cid="587" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747323726" title="Inserted by Annapoorni Swamynathan - 12/19/2019 2:52pm" contenteditable="true">fir</span>st year was negatively correlated with fasting glucose at baseline (Spearman’s rho = −0.326; <span class="del cts-1" data-cid="90" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732621126" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:47am" contenteditable="false">p</span><span class="ins cts-1" data-cid="91" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732621168" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:47am" contenteditable="true"><i data-time="1576732622000" data-username="Annapoorni Swamynathan" contenteditable="true">P</i></span> = 0.001) and positively correlated with <span class="ins cts-1" data-cid="590" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747336939" title="Inserted by Annapoorni Swamynathan - 12/19/2019 2:52pm" contenteditable="true">the </span>number of menstrual bleeding per year (Spearman’s rho = −0.305; <span class="del cts-1" data-cid="92" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732627317" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:47am" contenteditable="false">p</span><span class="ins cts-1" data-cid="93" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732627358" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:47am" contenteditable="true"><i data-time="1576732629000" data-username="Annapoorni Swamynathan" contenteditable="true">P</i></span> = 0.005).</pp1><pp1 store="534" contenteditable="true">An overall conversion rate to IFG was 6.2% (10 women), to IGT 1.2% (2 women), to IFG and IGT 1.2% (2 women) and to T2D <span class="ins cts-1" data-cid="594" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747354830" title="Inserted by Annapoorni Swamynathan - 12/19/2019 2:52pm" contenteditable="true">was </span>4.4% (7 women), among them 3% (5 women) developed T2D from previously NGT<span class="del cts-1" data-cid="598" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747365984" title="Deleted by Annapoorni Swamynathan - 12/19/2019 2:52pm" contenteditable="false">,</span> and 2 from IFG<span class="ins cts-1" data-cid="599" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747368901" title="Inserted by Annapoorni Swamynathan - 12/19/2019 2:52pm" contenteditable="true">.</span> The highest conversion rate was observed in the <span class="del cts-1" data-cid="600" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747373355" title="Deleted by Annapoorni Swamynathan - 12/19/2019 2:52pm" contenteditable="false">1</span><span class="ins cts-1" data-cid="601" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747373414" title="Inserted by Annapoorni Swamynathan - 12/19/2019 2:52pm" contenteditable="true">fir</span>st year, when 4 women developed IFG (one of them developed T2D in the <span class="del cts-1" data-cid="240" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576814838193" title="Deleted by Annapoorni Swamynathan - 12/20/2019 9:37am" contenteditable="false">2nd</span><span class="ins cts-1" data-cid="242" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576814838301" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:37am">second</span> year), 2 women developed IGT, 2 women developed IFG and IGT (one of them developed T2D in <span class="del cts-1" data-cid="258" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576814849993" title="Deleted by Annapoorni Swamynathan - 12/20/2019 9:37am" contenteditable="false">4th</span><span class="ins cts-1" data-cid="259" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576814850102" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:37am">fourth</span> year) and one woman developed T2D. In the <span class="del cts-1" data-cid="604" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747383631" title="Deleted by Annapoorni Swamynathan - 12/19/2019 2:53pm" contenteditable="false">2</span><span class="ins cts-1" data-cid="605" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747383686" title="Inserted by Annapoorni Swamynathan - 12/19/2019 2:53pm" contenteditable="true">seco</span>nd year IFG developed in 2 women, in the <span class="del cts-1" data-cid="609" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747407858" title="Deleted by Annapoorni Swamynathan - 12/19/2019 2:53pm" contenteditable="false">3</span><span class="ins cts-1" data-cid="610" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747407913" title="Inserted by Annapoorni Swamynathan - 12/19/2019 2:53pm" contenteditable="true">thi</span>rd year in one, in <span class="del cts-1" data-cid="613" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747413004" title="Deleted by Annapoorni Swamynathan - 12/19/2019 2:53pm" contenteditable="false">4</span><span class="ins cts-1" data-cid="614" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747413062" title="Inserted by Annapoorni Swamynathan - 12/19/2019 2:53pm" contenteditable="true">four</span>th year in 2 and in <span class="del cts-1" data-cid="618" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747417873" title="Deleted by Annapoorni Swamynathan - 12/19/2019 2:53pm" contenteditable="false">6</span><span class="ins cts-1" data-cid="619" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747417935" title="Inserted by Annapoorni Swamynathan - 12/19/2019 2:53pm" contenteditable="true">six</span>th year in one woman. T2D was developed from previously NGT in 2 women in <span class="del cts-1" data-cid="622" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747434922" title="Deleted by Annapoorni Swamynathan - 12/19/2019 2:53pm" contenteditable="false">1</span><span class="ins cts-1" data-cid="623" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747434978" title="Inserted by Annapoorni Swamynathan - 12/19/2019 2:53pm" contenteditable="true">fir</span>st<span class="ins cts-1" data-cid="626" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747437049" title="Inserted by Annapoorni Swamynathan - 12/19/2019 2:53pm" contenteditable="true"> </span>year, in 1 woman in <span class="del cts-1" data-cid="627" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747441188" title="Deleted by Annapoorni Swamynathan - 12/19/2019 2:54pm" contenteditable="false">4</span><span class="ins cts-1" data-cid="628" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747441260" title="Inserted by Annapoorni Swamynathan - 12/19/2019 2:54pm" contenteditable="true">four</span>th year and in 2 women in <span class="del cts-1" data-cid="632" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747445755" title="Deleted by Annapoorni Swamynathan - 12/19/2019 2:54pm" contenteditable="false">5</span><span class="ins cts-1" data-cid="633" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747445812" title="Inserted by Annapoorni Swamynathan - 12/19/2019 2:54pm" contenteditable="true">fif</span>th year. Only in one patient remission from T2D (which occurred in <span class="del cts-1" data-cid="277" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576814879212" title="Deleted by Annapoorni Swamynathan - 12/20/2019 9:37am" contenteditable="false">2nd</span><span class="ins cts-1" data-cid="279" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576814879323" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:37am">second</span> year after developing IFG in first year) to IFG was observed in <span class="del cts-1" data-cid="636" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747460083" title="Deleted by Annapoorni Swamynathan - 12/19/2019 2:54pm" contenteditable="false">6</span><span class="ins cts-1" data-cid="637" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747460142" title="Inserted by Annapoorni Swamynathan - 12/19/2019 2:54pm" contenteditable="true">six</span>th year<span class="ins cts-1" data-cid="640" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747463735" title="Inserted by Annapoorni Swamynathan - 12/19/2019 2:54pm" contenteditable="true">,</span> but in <span class="del cts-1" data-cid="286" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576814887536" title="Deleted by Annapoorni Swamynathan - 12/20/2019 9:38am" contenteditable="false">7th</span><span class="ins cts-1" data-cid="287" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576814887649" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:38am">seventh</span> year T2D reoccurred.</pp1></sec><sec sec-type="H2" store="535" contenteditable="true"><title1 title="H2" store="536" contenteditable="true">Hormonal parameters</title1><pp1 store="537" contenteditable="true">Total testosterone and <xref ref-type="scheme" language="US" store="538" contenteditable="true"><xref ref-type="scheme" language="UK" store="539" contenteditable="true">androstenedione</xref></xref> decreased for 15.4 ± 47.9% and 11.3 ± 46.4% respectively after the <span class="del cts-1" data-cid="641" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747508477" title="Deleted by Annapoorni Swamynathan - 12/19/2019 2:55pm" contenteditable="false">1</span><span class="ins cts-1" data-cid="642" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747508533" title="Inserted by Annapoorni Swamynathan - 12/19/2019 2:55pm" contenteditable="true">fir</span>st year (<xref ref-type="fig" rid="F2" store="540" contenteditable="true">Fig. 2C</xref> and <xref ref-type="fig" rid="F2" store="541" contenteditable="true">D</xref>), with further decrease in total testosterone and <xref ref-type="scheme" language="US" store="542" contenteditable="true"><xref ref-type="scheme" language="UK" store="543" contenteditable="true">androstenedione</xref></xref> for 37.8 ± 61.8 and 24.8 ± 40.5% from the initial values at the <span class="del cts-1" data-cid="645" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747522656" title="Deleted by Annapoorni Swamynathan - 12/19/2019 2:55pm" contenteditable="false">5</span><span class="ins cts-1" data-cid="646" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747522714" title="Inserted by Annapoorni Swamynathan - 12/19/2019 2:55pm" contenteditable="true">fif</span>th year of the follow<span class="del cts-1" data-cid="166" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733160761" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:56am" contenteditable="false"> </span><span class="ins cts-1" data-cid="167" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733160816" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:56am" contenteditable="true">-</span>up. After a decrease in the <span class="del cts-1" data-cid="649" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747530461" title="Deleted by Annapoorni Swamynathan - 12/19/2019 2:55pm" contenteditable="false">1</span><span class="ins cts-1" data-cid="650" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747530519" title="Inserted by Annapoorni Swamynathan - 12/19/2019 2:55pm" contenteditable="true">fir</span>st year, value of total testosterone remained stable over the treatment period (<xref ref-type="fig" rid="F1" store="544" contenteditable="true">Fig. 1D</xref>). The changes of total testosterone and <xref ref-type="scheme" language="US" store="545" contenteditable="true"><xref ref-type="scheme" language="UK" store="546" contenteditable="true">androstenedione</xref></xref> after <span class="del cts-1" data-cid="653" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747537950" title="Deleted by Annapoorni Swamynathan - 12/19/2019 2:55pm" contenteditable="false">1</span><span class="ins cts-1" data-cid="654" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747538009" title="Inserted by Annapoorni Swamynathan - 12/19/2019 2:55pm" contenteditable="true">fir</span>st year were inversely correlated with baseline total testosterone and <xref ref-type="scheme" language="US" store="547" contenteditable="true"><xref ref-type="scheme" language="UK" store="548" contenteditable="true">androstenedione<span class="ins cts-1" data-cid="657" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747542501" title="Inserted by Annapoorni Swamynathan - 12/19/2019 2:55pm" contenteditable="true"> </span></xref></xref>(Spearman’s rho = −0.541, <span class="del cts-1" data-cid="94" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732633006" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:47am" contenteditable="false">p</span><span class="ins cts-1" data-cid="95" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732633051" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:47am" contenteditable="true"><i data-time="1576732634000" data-username="Annapoorni Swamynathan" contenteditable="true">P</i></span> &lt; 0.001 and <span class="del cts-1" data-cid="302" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576814922146" title="Deleted by Annapoorni Swamynathan - 12/20/2019 9:38am" contenteditable="false">(</span>Spearman’s rho = −0.302, <span class="del cts-1" data-cid="96" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732636711" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:47am" contenteditable="false">p</span><span class="ins cts-1" data-cid="97" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732636762" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:47am" contenteditable="true"><i data-time="1576732637000" data-username="Annapoorni Swamynathan" contenteditable="true">P</i></span> = 0.009 respectively). In addition, the change of <xref ref-type="scheme" language="US" store="549" contenteditable="true"><xref ref-type="scheme" language="UK" store="550" contenteditable="true">androstenedione</xref></xref> after <span class="del cts-1" data-cid="658" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747553811" title="Deleted by Annapoorni Swamynathan - 12/19/2019 2:55pm" contenteditable="false">1</span><span class="ins cts-1" data-cid="659" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747553872" title="Inserted by Annapoorni Swamynathan - 12/19/2019 2:55pm" contenteditable="true">fir</span>st year was inversely correlated with baseline <xref ref-type="scheme" language="US" store="551" contenteditable="true"><xref ref-type="scheme" language="UK" store="552" contenteditable="true">androstenedione</xref></xref> (Spearman’s rho = −0.582; <span class="del cts-1" data-cid="98" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732640869" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:47am" contenteditable="false">p</span><span class="ins cts-1" data-cid="99" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732640913" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:47am" contenteditable="true"><i data-time="1576732642000" data-username="Annapoorni Swamynathan" contenteditable="true">P</i></span> &lt; 0.001). In comparison with the women in whom the total testosterone and <xref ref-type="scheme" language="US" store="553" contenteditable="true"><xref ref-type="scheme" language="UK" store="554" contenteditable="true">androstenedione</xref></xref> remained unchanged or increase<span class="ins cts-1" data-cid="662" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747564383" title="Inserted by Annapoorni Swamynathan - 12/19/2019 2:56pm" contenteditable="true">d</span>, women in whom total testosterone and <xref ref-type="scheme" language="US" store="555" contenteditable="true"><xref ref-type="scheme" language="UK" store="556" contenteditable="true">androstenedione</xref></xref> significantly decreased had higher <xref ref-type="scheme" language="US" store="557" contenteditable="true"><xref ref-type="scheme" language="UK" store="558" contenteditable="true">androstenedione</xref></xref> at baseline <span class="del cts-1" data-cid="303" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576814962918" title="Deleted by Annapoorni Swamynathan - 12/20/2019 9:39am" contenteditable="false">(</span>(10.2 ± 3.7<span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731470000_dfound5_regex_style876" common_tag="1576731470000_ifound5_regex_style876" contenteditable="false"> vs. </span><span store="1576731470000_i5" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731470000_ifound5_regex_style876" common_tag="1576731470000_ifound5_regex_style876" contenteditable="true"> vs </span>6.7 ± 3.<span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731853000_dfound0_regex_style171" common_tag="1576731853000_ifound0_regex_style171" contenteditable="false">4 nmol/l </span><span store="1576731853000_i0" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731853000_ifound0_regex_style171" common_tag="1576731853000_ifound0_regex_style171" contenteditable="true">4 nmol/l </span>(<span class="del cts-1" data-cid="100" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732645604" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:47am" contenteditable="false">p</span><span class="ins cts-1" data-cid="101" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732645650" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:47am" contenteditable="true"><i data-time="1576732647000" data-username="Annapoorni Swamynathan" contenteditable="true">P</i></span> &lt; 0.001) in patients with significant decrease of <xref ref-type="scheme" language="US" store="561" contenteditable="true"><xref ref-type="scheme" language="UK" store="562" contenteditable="true">androstenedione</xref></xref> and 10.3 ± 3.8<span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731470000_dfound6_regex_style876" common_tag="1576731470000_ifound6_regex_style876" contenteditable="false"> vs. </span><span store="1576731470000_i6" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731470000_ifound6_regex_style876" common_tag="1576731470000_ifound6_regex_style876" contenteditable="true"> vs </span>7.4 ± 3.<span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731853000_dfound1_regex_style171" common_tag="1576731853000_ifound1_regex_style171" contenteditable="false">4 nmol/l </span><span store="1576731853000_i1" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731853000_ifound1_regex_style171" common_tag="1576731853000_ifound1_regex_style171" contenteditable="true">4 nmol/l </span>(<span class="del cts-1" data-cid="102" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732650279" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:47am" contenteditable="false">p</span><span class="ins cts-1" data-cid="103" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576732650328" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:47am" contenteditable="true"><i data-time="1576732651000" data-username="Annapoorni Swamynathan" contenteditable="true">P</i></span> = 0.001) in patients with significant decrease of total testosterone). Women in whom total testosterone significantly decreased after <span class="del cts-1" data-cid="663" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747587938" title="Deleted by Annapoorni Swamynathan - 12/19/2019 2:56pm" contenteditable="false">1</span><span class="ins cts-1" data-cid="664" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747587999" title="Inserted by Annapoorni Swamynathan - 12/19/2019 2:56pm" contenteditable="true">fir</span>st year were significantly younger (28.2 ± 7.0<span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731470000_dfound7_regex_style876" common_tag="1576731470000_ifound7_regex_style876" contenteditable="false"> vs. </span><span store="1576731470000_i7" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731470000_ifound7_regex_style876" common_tag="1576731470000_ifound7_regex_style876" contenteditable="true"> vs </span>31.5 ± 5.6 years) and <span class="ins cts-1" data-cid="667" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747601351" title="Inserted by Annapoorni Swamynathan - 12/19/2019 2:56pm" contenteditable="true">also </span>had <span class="del cts-1" data-cid="672" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576747605569" title="Deleted by Annapoorni Swamynathan - 12/19/2019 2:56pm" contenteditable="false">also </span>significantly higher testosterone at baseline, when compared with non-responders in this regard. Values of LH and FSH decreased slightly over the treatment period, although the difference was not statistically significant yet. Values of DHEAS did not changed significantly during follow<span class="del cts-1" data-cid="168" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733163783" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:56am" contenteditable="false"> </span><span class="ins cts-1" data-cid="169" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733163831" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:56am" contenteditable="true">-</span>up period. (<xref ref-type="table" rid="T1" store="565" contenteditable="true">Table 1</xref>).</pp1></sec><sec sec-type="H2" store="566" contenteditable="true"><title1 title="H2" store="567" contenteditable="true">Adherence</title1><pp1 store="568" contenteditable="true">From 159 subjects, the dropout rate was 10.4% (18 patients) in the <span class="del cts-1" data-cid="673" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576748512714" title="Deleted by Annapoorni Swamynathan - 12/19/2019 3:11pm" contenteditable="false">1</span><span class="ins cts-1" data-cid="674" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576748512798" title="Inserted by Annapoorni Swamynathan - 12/19/2019 3:11pm" contenteditable="true">fir</span>st year, 35.3% (56 patients) in the <span class="del cts-1" data-cid="677" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576748517867" title="Deleted by Annapoorni Swamynathan - 12/19/2019 3:11pm" contenteditable="false">2</span><span class="ins cts-1" data-cid="678" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576748517928" title="Inserted by Annapoorni Swamynathan - 12/19/2019 3:11pm" contenteditable="true">seco</span>nd year, 51% (81 patients) in the <span class="del cts-1" data-cid="681" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576748526824" title="Deleted by Annapoorni Swamynathan - 12/19/2019 3:12pm" contenteditable="false">3</span><span class="ins cts-1" data-cid="682" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576748526886" title="Inserted by Annapoorni Swamynathan - 12/19/2019 3:12pm" contenteditable="true">thi</span>rd year, 64.2% (103 patients) in the <span class="del cts-1" data-cid="685" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576748531700" title="Deleted by Annapoorni Swamynathan - 12/19/2019 3:12pm" contenteditable="false">4</span><span class="ins cts-1" data-cid="686" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576748531786" title="Inserted by Annapoorni Swamynathan - 12/19/2019 3:12pm" contenteditable="true">four</span>th and 78% (124 patients) in the <span class="del cts-1" data-cid="690" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576748538450" title="Deleted by Annapoorni Swamynathan - 12/19/2019 3:12pm" contenteditable="false">5</span><span class="ins cts-1" data-cid="691" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576748538511" title="Inserted by Annapoorni Swamynathan - 12/19/2019 3:12pm" contenteditable="true">fif</span>th year. Only 22% (35 subjects) continued with metformin therapy until <span class="del cts-1" data-cid="694" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576748571653" title="Deleted by Annapoorni Swamynathan - 12/19/2019 3:12pm" contenteditable="false">5</span><span class="ins cts-1" data-cid="695" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576748571734" title="Inserted by Annapoorni Swamynathan - 12/19/2019 3:12pm" contenteditable="true">fif</span>th year of follow<span class="del cts-1" data-cid="170" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733169435" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:56am" contenteditable="false"> </span><span class="ins cts-1" data-cid="171" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733169496" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:56am" contenteditable="true">-</span>up. <span class="ins cts-1" data-cid="704" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576748902994" title="Inserted by Annapoorni Swamynathan - 12/19/2019 3:18pm" contenteditable="true">About </span>18% (30 subjects) continuously received metformin for more than <span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731838000_dfound13_regex_style39" common_tag="1576731838000_ifound13_regex_style39" contenteditable="false">5 years </span><span store="1576731838000_i10" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731838000_ifound13_regex_style39" common_tag="1576731838000_ifound13_regex_style39" contenteditable="true">5 years </span>with further dropout to 5.6% (9 subjects) on metformin therapy at the <span class="del cts-1" data-cid="710" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576748913126" title="Deleted by Annapoorni Swamynathan - 12/19/2019 3:18pm" contenteditable="false">10</span><span class="ins cts-1" data-cid="711" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576748913213" title="Inserted by Annapoorni Swamynathan - 12/19/2019 3:18pm" contenteditable="true">ten</span>th year of follow<span class="del cts-1" data-cid="172" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733173055" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:56am" contenteditable="false"> </span><span class="ins cts-1" data-cid="173" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733173103" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:56am" contenteditable="true">-</span>up.</pp1><pp1 store="569" contenteditable="true" data-time="1576748950000" data-username="Annapoorni Swamynathan">The drop out in this cohort was not associated with metformin intolerance, adverse effects, bariatric surgery or pregnancy since those were the exclusion criteria. As reported by the patients, the main reason for discontinuation after the <span class="del cts-1" data-cid="714" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576748932319" title="Deleted by Annapoorni Swamynathan - 12/19/2019 3:18pm" contenteditable="false">3</span><span class="ins cts-1" data-cid="715" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576748932403" title="Inserted by Annapoorni Swamynathan - 12/19/2019 3:18pm" contenteditable="true">thi</span>rd year<span class="del cts-1" data-cid="720" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576748936478" title="Deleted by Annapoorni Swamynathan - 12/19/2019 3:18pm" contenteditable="false">,</span> was <span class="ins cts-1" data-cid="721" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576748939075" title="Inserted by Annapoorni Swamynathan - 12/19/2019 3:18pm" contenteditable="true">the </span>lack of motivation. As seen from the patient<span role="1576748950000" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576748950000" contenteditable="true">’</span><span class="ins cts-1" data-cid="725" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576748951005" title="Inserted by Annapoorni Swamynathan - 12/19/2019 3:19pm" contenteditable="true">s</span> perspective, maximal treatment response achieved after <span class="del cts-1" data-cid="726" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576748958328" title="Deleted by Annapoorni Swamynathan - 12/19/2019 3:19pm" contenteditable="false">1</span><span class="ins cts-1" data-cid="727" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576748958394" title="Inserted by Annapoorni Swamynathan - 12/19/2019 3:19pm" contenteditable="true">fir</span>st year was followed by a steady state and then the benefits of the steady state and other potential beneficial effects of long-term treatment were not sufficiently discussed with them.</pp1><pp1 store="570" contenteditable="true">There were no statistically significant changes in the baseline characteristic between patients that drop<span class="ins cts-1" data-cid="730" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576748996391" title="Inserted by Annapoorni Swamynathan - 12/19/2019 3:19pm" contenteditable="true">ped</span> out after <span class="del cts-1" data-cid="733" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576749002792" title="Deleted by Annapoorni Swamynathan - 12/19/2019 3:20pm" contenteditable="false">3</span><span class="ins cts-1" data-cid="734" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576749002877" title="Inserted by Annapoorni Swamynathan - 12/19/2019 3:20pm" contenteditable="true">thi</span>rd year and the patients who were continuing with the therapy after the <span class="del cts-1" data-cid="737" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576749009096" title="Deleted by Annapoorni Swamynathan - 12/19/2019 3:20pm" contenteditable="false">3</span><span class="ins cts-1" data-cid="738" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576749009161" title="Inserted by Annapoorni Swamynathan - 12/19/2019 3:20pm" contenteditable="true">thi</span>rd year. No baseline characteristics were associated with drop out or non-drop out status.</pp1></sec><sec sec-type="H2" store="571" contenteditable="true"><title1 title="H2" store="572" contenteditable="true">Adverse events</title1><pp1 store="573" contenteditable="true">Among the 800 women, 3% had intolerable side effects that resulted in cessation of therapy within the <span class="del cts-1" data-cid="747" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576749025272" title="Deleted by Annapoorni Swamynathan - 12/19/2019 3:20pm" contenteditable="false">1</span><span class="ins cts-1" data-cid="748" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576749025337" title="Inserted by Annapoorni Swamynathan - 12/19/2019 3:20pm" contenteditable="true">fir</span>st year. They were not included in the study. Although several women that were eligible for the study reported mild<span class="del cts-1" data-cid="313" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576815060825" title="Deleted by Annapoorni Swamynathan - 12/20/2019 9:41am" contenteditable="false"> </span><span class="ins cts-1" data-cid="314" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576815062225" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:41am">-</span>to<span class="del cts-1" data-cid="315" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576815063899" title="Deleted by Annapoorni Swamynathan - 12/20/2019 9:41am" contenteditable="false"> </span><span class="ins cts-1" data-cid="319" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576815064387" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:41am">-</span>moderate nausea and <xref ref-type="scheme" language="UK" store="574" contenteditable="true">diarrhea</xref> at <span class="del cts-1" data-cid="751" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576749038527" title="Deleted by Annapoorni Swamynathan - 12/19/2019 3:20pm" contenteditable="false">1</span><span class="ins cts-1" data-cid="752" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576749038612" title="Inserted by Annapoorni Swamynathan - 12/19/2019 3:20pm" contenteditable="true">fir</span>st year of follow<span class="del cts-1" data-cid="174" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733181657" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:56am" contenteditable="false"> </span><span class="ins cts-1" data-cid="175" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733181705" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:56am" contenteditable="true">-</span>up, the symptoms were transient and disappeared after 4<span class="del cts-1" data-cid="320" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576815074013" title="Deleted by Annapoorni Swamynathan - 12/20/2019 9:41am" contenteditable="false"> to </span><span class="ins cts-1" data-cid="321" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576815074213" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:41am">–</span>8 weeks. No case of lactic acidosis or significant <xref ref-type="scheme" language="UK" store="575" contenteditable="true">anemia</xref> due to vitamin B12 deficiency was documented within the study group during the observational period. Development of mild <xref ref-type="scheme" language="UK" store="576" contenteditable="true">anemia</xref> with normal mean corpuscular volume (MCV) values were documented in <span class="del cts-1" data-cid="755" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576749056982" title="Deleted by Annapoorni Swamynathan - 12/19/2019 3:20pm" contenteditable="false">5</span><span class="ins cts-1" data-cid="756" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576749057047" title="Inserted by Annapoorni Swamynathan - 12/19/2019 3:20pm" contenteditable="true">five</span> patients, all had normal levels of vitamin B12.</pp1></sec></sec><sec sec-type="H1" store="577" contenteditable="true"><title1 title="H1" store="578" contenteditable="true">Discussion</title1><pp1 store="579" contenteditable="true">Long-term metformin treatment of women with PCOS, BMI ≥25 kg/m<sup store="580" contenteditable="true">2</sup> and normal baseline glucose homeostasis resulted in significant treatment response after the <span class="del cts-1" data-cid="760" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576749080333" title="Deleted by Annapoorni Swamynathan - 12/19/2019 3:21pm" contenteditable="false">1</span><span class="ins cts-1" data-cid="761" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576749080400" title="Inserted by Annapoorni Swamynathan - 12/19/2019 3:21pm" contenteditable="true">fir</span>st year, with weight loss, increased menstrual regularity and improved androgen profile. In majority of women that subsequently remained on therapy<span class="ins cts-1" data-cid="764" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576749090369" title="Inserted by Annapoorni Swamynathan - 12/19/2019 3:21pm" contenteditable="true">,</span> an overall beneficial steady state was observed throughout the follow<span class="del cts-1" data-cid="176" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733187078" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:56am" contenteditable="false"> </span><span class="ins cts-1" data-cid="177" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733187130" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:56am" contenteditable="true">-</span>up. Conversion rate to IFG and T2D was low during the observation period, with the highest conversion observed within the <span class="del cts-1" data-cid="765" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576749100790" title="Deleted by Annapoorni Swamynathan - 12/19/2019 3:21pm" contenteditable="false">1</span><span class="ins cts-1" data-cid="766" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576749100858" title="Inserted by Annapoorni Swamynathan - 12/19/2019 3:21pm" contenteditable="true">fir</span>st year. Those with higher baseline BM, BMI, less frequent menstrual bleedings and higher levels of androgens were identified as subgroups where metformin’s effect seemed to be enhanced. Notably, after <span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731838000_dfound14_regex_style39" common_tag="1576731838000_ifound14_regex_style39" contenteditable="false">2 years </span><span store="1576731838000_i11" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731838000_ifound14_regex_style39" common_tag="1576731838000_ifound14_regex_style39" contenteditable="true">2 years, </span>remarkable drop out that had not been related to metformin intolerance or side effects<span class="del cts-1" data-cid="770" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576749222602" title="Deleted by Annapoorni Swamynathan - 12/19/2019 3:23pm" contenteditable="false">,</span> was seen in this real-life setting.</pp1><sec sec-type="H2" store="581" contenteditable="true"><title1 title="H2" store="582" contenteditable="true">Impact on body weight</title1><pp1 store="583" contenteditable="true"><span class="del cts-1" data-cid="771" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576749555351" title="Deleted by Annapoorni Swamynathan - 12/19/2019 3:29pm" contenteditable="false">As far as</span><span class="ins cts-1" data-cid="772" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576749555425" title="Inserted by Annapoorni Swamynathan - 12/19/2019 3:29pm" contenteditable="true">With regard to</span> weight loss<span class="del cts-1" data-cid="788" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576749567950" title="Deleted by Annapoorni Swamynathan - 12/19/2019 3:29pm" contenteditable="false"> regard</span>, it is often questioned whether long-term treatment with metformin is of benefit above and beyond LSI in overweight-obese patients with PCOS (<xref ref-type="bibr" rid="CIT00001 CIT00006 CIT00008 CIT00009 CIT00014" store="584" contenteditable="true">1, 6, 8, 9, 14</xref>). In our study, mean BM decreased for 3.7% after the <span class="del cts-1" data-cid="789" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576749589490" title="Deleted by Annapoorni Swamynathan - 12/19/2019 3:29pm" contenteditable="false">1</span><span class="ins cts-1" data-cid="790" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576749589560" title="Inserted by Annapoorni Swamynathan - 12/19/2019 3:29pm" contenteditable="true">fir</span>st year and remained stable up to <span class="del cts-1" data-cid="793" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576749594314" title="Deleted by Annapoorni Swamynathan - 12/19/2019 3:29pm" contenteditable="false">4</span><span class="ins cts-1" data-cid="794" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576749594382" title="Inserted by Annapoorni Swamynathan - 12/19/2019 3:29pm" contenteditable="true">four</span>th year of follow<span class="del cts-1" data-cid="178" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733190338" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:56am" contenteditable="false"> </span><span class="ins cts-1" data-cid="179" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733190443" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:56am" contenteditable="true">-</span>up. A meta-analysis of 630 participants with PCOS treated with metformin for <span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731840000_dfound1_regex_style45" common_tag="1576731840000_ifound1_regex_style45" contenteditable="false">6 months </span><span store="1576731840000_i1" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731840000_ifound1_regex_style45" common_tag="1576731840000_ifound1_regex_style45" contenteditable="true">6 months </span>reported no evidence of its effect on BMI (<xref ref-type="bibr" rid="CIT00015" title="15. TangTLordJMNormanRJYasminEBalenAH. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database of Systematic Reviews 2012 5 CD003053. (https://doi.org/10.1002/14651858.CD003053.pub5)" store="585" contenteditable="true">15</xref>). On the other hand, another meta-analysis comparing the effect of metformin with or without LSI to LSI with or without placebo<span class="del cts-1" data-cid="798" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576749656741" title="Deleted by Annapoorni Swamynathan - 12/19/2019 3:30pm" contenteditable="false">,</span> concluded that metformin in combination with LSI was associated with lower BMI (<xref ref-type="bibr" rid="CIT00006 CIT00016 CIT00017" store="586" contenteditable="true">6, 16, 17</xref>). Similarly, and in line with our observation, when only participants with BMI ≥25 kg/m<sup store="587" contenteditable="true">2</sup> were combined in a subgroup analysis, it was demonstrated that metformin offered additive benefits for weight and BMI when compared to LSI alone (<xref ref-type="bibr" rid="CIT00018" title="18. TeedeHTassoneECPiltonenTMalhotraJMolBWPeñaAWitchelSFJohamAMcAllisterVRomualdiD, et al. Effect of the combined oral contraceptive pill and/or metformin in the management of polycystic ovary syndrome: a systematic review with meta-analyses. Clinical Endocrinology 2019 91 479–489. (https://doi.org/10.1111/cen.14013)" store="588" contenteditable="true">18</xref>). Also, in concordance with our observation, metformin added to LSI offered success in sustainability of weight reduction over <span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731838000_dfound15_regex_style39" common_tag="1576731838000_ifound15_regex_style39" contenteditable="false">4 years </span><span store="1576731838000_i12" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731838000_ifound15_regex_style39" common_tag="1576731838000_ifound15_regex_style39" contenteditable="true">4 years </span>in prospective cohort of 74 PCOS women (<xref ref-type="bibr" rid="CIT00019" title="19. GlueckCJAregawiDAgloriaMWiniarskaMSieveLWangP. Sustainability of 8% weight loss, reduction of insulin resistance, and amelioration of atherogenic-metabolic risk factors over 4 years by metformin-diet in women with polycystic ovary syndrome. Metabolism: Clinical and Experimental 2006 55 1582–1589. (https://doi.org/10.1016/j.metabol.2006.08.001)" store="589" contenteditable="true">19</xref>), whereas LSI alone is in general not very successful in preventing body weight regain after initial weight loss (<xref ref-type="bibr" rid="CIT00020 CIT00021 CIT00022 CIT00023 CIT00024" store="590" contenteditable="true">20, 21, 22, 23, 24</xref>). Given that PCOS is characterized by progressive weight gain from menarche<span class="del cts-1" data-cid="800" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576749759667" title="Deleted by Annapoorni Swamynathan - 12/19/2019 3:32pm" contenteditable="false"> on</span> (<xref ref-type="bibr" rid="CIT00025 CIT00026 CIT00027" store="591" contenteditable="true">25, 26, 27</xref>), the difficulty in stabilization of BM is expected to be even more pronounced in PCOS when compared to general population. Potential goal of long-term treatment with metformin in overweight-obese women with PCOS<span class="del cts-1" data-cid="801" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576749906959" title="Deleted by Annapoorni Swamynathan - 12/19/2019 3:35pm" contenteditable="false">,</span> should therefore be a stabilization of BM through <span class="ins cts-1" data-cid="802" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576749948750" title="Inserted by Annapoorni Swamynathan - 12/19/2019 3:35pm" contenteditable="true">the </span>years rather than weight reduction itself.</pp1><pp1 store="592" contenteditable="true">The amount of weight loss in our study correlated with <span class="ins cts-1" data-cid="806" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576749972249" title="Inserted by Annapoorni Swamynathan - 12/19/2019 3:36pm" contenteditable="true">the </span>initial body weight and baseline number of menstrual bleedings per year. Women who lost weight in the <span class="del cts-1" data-cid="810" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576749977380" title="Deleted by Annapoorni Swamynathan - 12/19/2019 3:36pm" contenteditable="false">1</span><span class="ins cts-1" data-cid="811" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576749977452" title="Inserted by Annapoorni Swamynathan - 12/19/2019 3:36pm" contenteditable="true">fir</span>st year had higher BM and less frequent menstrual bleeding at baseline. Greater capacity to lose weight in patients with higher BMI than in patients with slighter obesity was confirmed also in another real-life setting investigated metformin use in PCOS (<xref ref-type="bibr" rid="CIT00028" title="28. SeifarthCSchehlerBSchneiderHJ. Effectiveness of metformin on weight loss in non-diabetic individuals with obesity. Experimental and Clinical Endocrinology and Diabetes 2013 121 27–31. (https://doi.org/10.1055/s-0032-1327734)" store="593" contenteditable="true">28</xref>). Interestingly, correlation with BM and total testosterone was significant only in our patients younger than <span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731838000_dfound10_regex_style39" common_tag="1576731838000_ifound10_regex_style39" contenteditable="false">35 years </span><span store="1576731838000_i13" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731838000_ifound10_regex_style39" common_tag="1576731838000_ifound10_regex_style39" contenteditable="true">35 years </span>and not in patients ≥35 years. This finding may be explained by the lower levels of testosterone in women older than 35 years, which may reduce the strength of the association between the two parameters. The data on the relationship between adiposity and total testosterone in PCOS from other studies are scarce and controversial (<xref ref-type="bibr" rid="CIT00029" title="29. TosiFDi SarraDKaufmanJMBoninCMorettaRBonoraEZanolinEMoghettiP. Total body fat and central fat mass independently predict insulin resistance but not hyperandrogenemia in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2015 100 661–669. (https://doi.org/10.1210/jc.2014-2786)" store="594" contenteditable="true">29</xref>).</pp1></sec><sec sec-type="H2" store="595" contenteditable="true"><title1 title="H2" store="596" contenteditable="true">Impact on menstrual regularity</title1><pp1 store="597" contenteditable="true">Metformin use in PCOS is not consistently associated with improvements in menstrual regularity. In a <xref ref-type="scheme" language="US" store="598" contenteditable="true"><xref ref-type="scheme" language="UK" store="599" contenteditable="true">Cohrane</xref></xref> review that include<span class="del cts-1" data-cid="817" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576750144093" title="Deleted by Annapoorni Swamynathan - 12/19/2019 3:39pm" contenteditable="false">s</span><span class="ins cts-1" data-cid="818" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576750144190" title="Inserted by Annapoorni Swamynathan - 12/19/2019 3:39pm" contenteditable="true">d</span> a meta-analysis of 38 RCT of 3495 women with PCOS, metformin therapy only marginally improved menstrual pattern (<xref ref-type="bibr" rid="CIT00015" title="15. TangTLordJMNormanRJYasminEBalenAH. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database of Systematic Reviews 2012 5 CD003053. (https://doi.org/10.1002/14651858.CD003053.pub5)" store="600" contenteditable="true">15</xref>). In our cohort menstrual frequency increased after <span class="del cts-1" data-cid="322" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576815216399" title="Deleted by Annapoorni Swamynathan - 12/20/2019 9:43am" contenteditable="false">1st</span><span class="ins cts-1" data-cid="323" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576815216541" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:43am">first</span> year and normalized in the majority of patients in the following years. In <span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731839000_dfound0_regex_style42" common_tag="1576731839000_ifound0_regex_style42" contenteditable="false">24 month </span><span store="1576731839000_i0" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731839000_ifound0_regex_style42" common_tag="1576731839000_ifound0_regex_style42" contenteditable="true">the 24-month </span>study conducted with prospective cohort, metformin was also associated with improvements in the menstrual cycle in overweight and normal weight women with PCOS (<xref ref-type="bibr" rid="CIT00030" title="30. YangPKHsuCYChenMJLaiMYLiZRChenCHChenSUHoHN. The efficacy of 24-month metformin for improving menses, hormones, and metabolic profiles in polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2018 103 890–899. (https://doi.org/10.1210/jc.2017-01739)" store="601" contenteditable="true">30</xref>). Our patients in whom menstrual regularity improved after <span class="del cts-1" data-cid="823" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576750172476" title="Deleted by Annapoorni Swamynathan - 12/19/2019 3:39pm" contenteditable="false">1</span><span class="ins cts-1" data-cid="824" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576750172549" title="Inserted by Annapoorni Swamynathan - 12/19/2019 3:39pm" contenteditable="true">fir</span>st year had less frequent bleedings at baseline when compared with those with no improvement in menstrual frequencies. Increased menstrual frequency correlated with the decrease<span class="del cts-1" data-cid="827" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576750196470" title="Deleted by Annapoorni Swamynathan - 12/19/2019 3:39pm" contenteditable="false">s</span> in BM and total testosterone, whereas no correlation with the change in LH/FSH ratio was demonstrated. Weight, insulin resistance, testosterone and LH/FSH disturbances are established determinants of menstrual regularity (<xref ref-type="bibr" rid="CIT00031" title="31. Van AndersSMWatsonNV. Menstrual cycle irregularities are associated with testosterone levels in healthy premenopausal women. American Journal of Human Biology 2006 18 841–844. (https://doi.org/10.1002/ajhb.20555)" store="602" contenteditable="true">31</xref>)<span class="del cts-1" data-cid="331" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576815252623" title="Deleted by Annapoorni Swamynathan - 12/20/2019 9:44am" contenteditable="false">,</span><span class="ins cts-1" data-cid="334" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576815254244" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:44am">;</span> yet<span class="ins cts-1" data-cid="335" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576815258086" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:44am">,</span> the relative contributions of those parameters on menstrual regularity across the different phenotypes of PCOS and the consequences of metformin impact on these different spectrums are currently unknown (<xref ref-type="bibr" rid="CIT00030" title="30. YangPKHsuCYChenMJLaiMYLiZRChenCHChenSUHoHN. The efficacy of 24-month metformin for improving menses, hormones, and metabolic profiles in polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2018 103 890–899. (https://doi.org/10.1210/jc.2017-01739)" store="603" contenteditable="true">30</xref>). As menstrual irregularity in PCOS typically improves with time, we also stratified patients by age and confirmed the increase in patients younger than <span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731838000_dfound11_regex_style39" common_tag="1576731838000_ifound11_regex_style39" contenteditable="false">35 years </span><span store="1576731838000_i14" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731838000_ifound11_regex_style39" common_tag="1576731838000_ifound11_regex_style39" contenteditable="true">35 years </span>and in patients ≥<span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731838000_dfound12_regex_style39" common_tag="1576731838000_ifound12_regex_style39" contenteditable="false">35 years </span><span store="1576731838000_i15" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731838000_ifound12_regex_style39" common_tag="1576731838000_ifound12_regex_style39" contenteditable="true">35 years </span>old at baseline.</pp1></sec><sec sec-type="H2" store="604" contenteditable="true"><title1 title="H2" store="605" contenteditable="true">Impact on androgens</title1><pp1 store="606" contenteditable="true">Metformin lowered testosterone levels by approximately 20<span class="del cts-1" data-cid="336" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576815283321" title="Deleted by Annapoorni Swamynathan - 12/20/2019 9:44am" contenteditable="false"> to </span><span class="ins cts-1" data-cid="337" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576815283486" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:44am">–</span>25% in women with PCOS (<xref ref-type="bibr" rid="CIT00005" title="5. McCartneyCRMarshallJC. CLINICAL PRACTICE. Polycystic ovary syndrome. New England Journal of Medicine 2016 375 54–64. (https://doi.org/10.1056/NEJMcp1514916)" store="607" contenteditable="true">5</xref>). In accordance with these reports (<xref ref-type="bibr" rid="CIT00005" title="5. McCartneyCRMarshallJC. CLINICAL PRACTICE. Polycystic ovary syndrome. New England Journal of Medicine 2016 375 54–64. (https://doi.org/10.1056/NEJMcp1514916)" store="608" contenteditable="true">5</xref>), mean total testosterone and <xref ref-type="scheme" language="US" store="609" contenteditable="true"><xref ref-type="scheme" language="UK" store="610" contenteditable="true">androstenedione</xref></xref> decreased up to 15% after the <span class="del cts-1" data-cid="828" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576750254203" title="Deleted by Annapoorni Swamynathan - 12/19/2019 3:40pm" contenteditable="false">1</span><span class="ins cts-1" data-cid="829" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576750254295" title="Inserted by Annapoorni Swamynathan - 12/19/2019 3:40pm" contenteditable="true">fir</span>st year, with further decrease in total testosterone and <xref ref-type="scheme" language="US" store="611" contenteditable="true"><xref ref-type="scheme" language="UK" store="612" contenteditable="true">androstenedione</xref></xref> from 25 to up to 40% from the initial values at the <span class="del cts-1" data-cid="832" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576750263444" title="Deleted by Annapoorni Swamynathan - 12/19/2019 3:41pm" contenteditable="false">5</span><span class="ins cts-1" data-cid="833" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576750263537" title="Inserted by Annapoorni Swamynathan - 12/19/2019 3:41pm" contenteditable="true">fif</span>th year of the follow<span class="del cts-1" data-cid="180" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733199518" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:56am" contenteditable="false"> </span><span class="ins cts-1" data-cid="181" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733199586" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:56am" contenteditable="true">-</span>up. Importantly, the potential effect of aging that results in improvement of <xref ref-type="scheme" language="US" store="613" contenteditable="true"><xref ref-type="scheme" language="UK" store="614" contenteditable="true">hyperandogenism</xref></xref> as well as <span class="ins cts-1" data-cid="836" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576750274574" title="Inserted by Annapoorni Swamynathan - 12/19/2019 3:41pm" contenteditable="true">the </span>well-known methodological difficulties related to RIA assays should be taken into account when interpreting the observed impact on the androgen status. In comparison with the women in whom androgens remained unchanged or increase<span class="ins cts-1" data-cid="840" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576750307339" title="Inserted by Annapoorni Swamynathan - 12/19/2019 3:41pm" contenteditable="true">d</span>, women in whom androgens decreased had worst androgen profile at baseline. It is believed that metformin lower<span class="ins cts-1" data-cid="841" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576750319186" title="Inserted by Annapoorni Swamynathan - 12/19/2019 3:41pm" contenteditable="true">ed</span> testosterone levels by reducing <xref ref-type="scheme" language="US" store="615" contenteditable="true"><xref ref-type="scheme" language="UK" store="616" contenteditable="true">hyperinsulinemia</xref></xref> (<xref ref-type="bibr" rid="CIT00032 CIT00033" store="617" contenteditable="true">32, 33</xref>). In addition, it might have a direct inhibitory effect on ovarian <xref ref-type="scheme" language="US" store="618" contenteditable="true"><xref ref-type="scheme" language="UK" store="619" contenteditable="true">steroidogenesis</xref></xref> (<xref ref-type="bibr" rid="CIT00034 CIT00035 CIT00036" store="620" contenteditable="true">34, 35, 36</xref>) through inhibition of mitochondrial complex I (<xref ref-type="bibr" rid="CIT00034" title="34. HirschAHahnDKempnáPHoferGNuofferJMMullisPEFlückCE. Metformin inhibits human androgen production by regulating steroidogenic enzymes HSD3B2 and CYP17A1 and complex I activity of the respiratory chain. Endocrinology 2012 153 4354–4366. (https://doi.org/10.1210/en.2012-1145)" store="621" contenteditable="true">34</xref>). Given that an androgen excess plays an important role in favoring the expansion of visceral fat and development of metabolic syndrome and T2D (<xref ref-type="bibr" rid="CIT00037" title="37. PasqualiROrioloC. Obesity and androgens in women. Frontiers of Hormone Research 2019 53 120–134. (https://doi.org/10.1159/000494908)" store="623" contenteditable="true">37</xref>), the improved androgen profile observed throughout long<span class="del cts-1" data-cid="848" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576750428370" title="Deleted by Annapoorni Swamynathan - 12/19/2019 3:43pm" contenteditable="false"> </span><span class="ins cts-1" data-cid="849" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576750428449" title="Inserted by Annapoorni Swamynathan - 12/19/2019 3:43pm" contenteditable="true">-</span>term metformin treatment should be considered as an independent <xref ref-type="scheme" language="US" store="624" contenteditable="true"><xref ref-type="scheme" language="UK" store="625" contenteditable="true">cardiometabolic</xref></xref> risk reduction outcome in these population.</pp1></sec><sec sec-type="H2" store="626" contenteditable="true"><title1 title="H2" store="627" contenteditable="true">Impact on metabolic features</title1><pp1 store="628" contenteditable="true">Few studies aimed to clarify the relationship between PCOS and T2D independent of obesity in longitudinal population-based cohorts. The most recent Australian Longitudinal Study on Women’s Health database reported that women with PCOS are at an increased risk of T2D, irrespective of age and BMI (<xref ref-type="bibr" rid="CIT00002" title="2. KakolyNSEarnestATeedeHJMoranLJJohamAE. The impact of obesity on the incidence of Type 2 diabetes among women with polycystic ovary syndrome. Diabetes Care 2019 42 560–567. (https://doi.org/10.2337/dc18-1738)" store="629" contenteditable="true">2</xref>). There have been very limited studies of the natural history of glucose homeostasis in this population. In an elegant study by <xref ref-type="scheme" language="US" store="630" contenteditable="true"><xref ref-type="scheme" language="UK" store="631" contenteditable="true">Legro</xref></xref> <span class="del cts-1" data-cid="866" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576750543673" title="Deleted by Annapoorni Swamynathan - 12/19/2019 3:45pm" contenteditable="false">a</span><i data-time="1576750547000" data-username="Annapoorni Swamynathan" contenteditable="true"><span class="ins cts-1" data-cid="867" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576750543765" title="Inserted by Annapoorni Swamynathan - 12/19/2019 3:45pm" contenteditable="true">e</span>t al</i>.<span class="ins cts-1" data-cid="868" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576750556459" title="Inserted by Annapoorni Swamynathan - 12/19/2019 3:45pm" contenteditable="true">,</span> there was a nearly <span class="del cts-1" data-cid="338" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576815346644" title="Deleted by Annapoorni Swamynathan - 12/20/2019 9:45am" contenteditable="false">2</span><span class="ins cts-1" data-cid="339" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576815346786" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:45am">two</span>-fold increase in the rates of conversion for subjects with PCOS and baseline NGT compared with the reference population, but there was also a significant chance for a spontaneous reversion rate to normal glucose tolerance (<xref ref-type="bibr" rid="CIT00038" title="38. LegroRSGnatukCLKunselmanARDunaifA. Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study. Journal of Clinical Endocrinology and Metabolism 2005 90 3236–3242. (https://doi.org/10.1210/jc.2004-1843)" store="632" contenteditable="true">38</xref>). Prospective studies investigating the impact of metformin on T2D risk specifically in women with PCOS are lacking (<xref ref-type="bibr" rid="CIT00006" title="6. SamSEhrmannDA. Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome. Diabetologia 2017 60 1656–1661. (https://doi.org/10.1007/s00125-017-4306-3)" store="633" contenteditable="true">6</xref>). Nonetheless, considering that these women are at high risk for developing T2D (<xref ref-type="bibr" rid="CIT00040 CIT00041" store="634" contenteditable="true">40, 41</xref>), it has been suggested that they will benefit from metformin therapy in case of glucose intolerance (<xref ref-type="bibr" rid="CIT00007" title="7. TeedeHJMissoMLCostelloMFDokrasALavenJMoranLPiltonenTNormanRJ &amp; International PCOS Network. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Human Reproduction 2018 33 1602–1618. (https://doi.org/10.1093/humrep/dey256)" store="635" contenteditable="true">7</xref>). One of the longest retrospective study with 50 patients followed by a mean treatment period of 43.<span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731840000_dfound2_regex_style45" common_tag="1576731840000_ifound2_regex_style45" contenteditable="false">3 months </span><span store="1576731840000_i2" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731840000_ifound2_regex_style45" common_tag="1576731840000_ifound2_regex_style45" contenteditable="true">3 months </span>demonstrated a 11-fold decrease in the annual conversion rate from NGT to IGT and complete prevention of the development of T2D (<xref ref-type="bibr" rid="CIT00041" title="41. SharmaSTWickham3rdEPNestlerJE. Changes in glucose tolerance with metformin treatment in polycystic ovary syndrome: a retrospective analysis. Endocrine Practice 2007 13 373–379. (https://doi.org/10.4158/EP.13.4.373)" store="636" contenteditable="true">41</xref>). In our cohort the mean fasting glucose was within normal range throughout the longitudinal follow<span class="del cts-1" data-cid="182" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733204724" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:56am" contenteditable="false"> </span><span class="ins cts-1" data-cid="183" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733204780" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:56am" contenteditable="true">-</span>up. Conversion to IGT and T2D was low, yet OGTT was not performed annually, but as recommended by national guidelines rescreened periodically at 2<span class="del cts-1" data-cid="342" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576815384740" title="Deleted by Annapoorni Swamynathan - 12/20/2019 9:46am" contenteditable="false"> to </span><span class="ins cts-1" data-cid="343" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576815384908" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:46am">–</span>3 years, meaning that this conversion risk could be underestimated.</pp1></sec><sec sec-type="H2" store="637" contenteditable="true"><title1 title="H2" store="638" contenteditable="true">Limitations and strengths</title1><pp1 store="639" contenteditable="true">We acknowledge that our study has several limitations. The major one is its retrospective nature. It is clear that prospective randomized design represents the gold standard, but such a study would be extremely long lasting and laborious to achieve. Lack of randomization with placebo represents another possible bias, yet placebo arm in this group would have hardly been a realistic or possible approach. Moreover, the possible bias might be related to the process of ageing, in particular when interpreting the improvements of menstrual irregularity and <xref ref-type="scheme" language="US" store="640" contenteditable="true"><xref ref-type="scheme" language="UK" store="641" contenteditable="true">hyperandrogenism</xref></xref> as both improve by age. Furthermore, lifestyle measures that had been promoted by the lifestyle advice might contribute <span class="ins cts-1" data-cid="873" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576751869514" title="Inserted by Annapoorni Swamynathan - 12/19/2019 4:07pm" contenteditable="true">to </span>at least some of the benefits including low rates of conversion to IGT and T2DM. Another point of concern is the high rate of drop-outs and the effects that may have on the study outcome. However, this attrition rate was similar to th<span class="del cts-1" data-cid="344" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576815416207" title="Deleted by Annapoorni Swamynathan - 12/20/2019 9:46am" contenteditable="false">ose</span><span class="ins cts-1" data-cid="345" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576815416355" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:46am">at</span> from other studies on PCOS (<xref ref-type="bibr" rid="CIT00016 CIT00030" store="642" contenteditable="true">16, 30</xref>).</pp1><pp1 store="643" contenteditable="true">The main strength of this study is <span class="ins cts-1" data-cid="876" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576751905899" title="Inserted by Annapoorni Swamynathan - 12/19/2019 4:08pm" contenteditable="true">the </span>long<span class="del cts-1" data-cid="854" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576750450698" title="Deleted by Annapoorni Swamynathan - 12/19/2019 3:44pm" contenteditable="false"> </span><span class="ins cts-1" data-cid="855" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576750450774" title="Inserted by Annapoorni Swamynathan - 12/19/2019 3:44pm" contenteditable="true">-</span>term longitudinal follow<span class="del cts-1" data-cid="184" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733211450" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:56am" contenteditable="false"> </span><span class="ins cts-1" data-cid="185" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733211506" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:56am" contenteditable="true">-</span>up assessing the effectiveness of treatment with metformin in real life setting that is insufficiently studied in PCOS. <query data-time="1576815464000" data-username="Annapoorni Swamynathan" id="1576752835000" title="Please check the edit to the sentence &amp;#x0022;Attempts were made to achieve clinical...&amp;#x0022; and amend if necessary." contenteditable="false" class="fa fa-question-circle fa-1x" style="color: red; display: inline-block;" onclick="addQueryText(1576752835000);"></query><span class="del cts-1" data-cid="347" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576815432133" title="Deleted by Annapoorni Swamynathan - 12/20/2019 9:47am" contenteditable="false">The a</span><span class="ins cts-1" data-cid="351" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576815432287" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:47am">A</span>ttempts were made to achieve clinical homogeneity of the included patients by review<span class="ins cts-1" data-cid="958" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576752749866" title="Inserted by Annapoorni Swamynathan - 12/19/2019 4:22pm" contenteditable="true">ing</span><span class="del cts-1" data-cid="961" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576752751855" title="Deleted by Annapoorni Swamynathan - 12/19/2019 4:22pm" contenteditable="false">ed</span><span class="ins cts-1" data-cid="880" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576751950725" title="Inserted by Annapoorni Swamynathan - 12/19/2019 4:09pm" contenteditable="true"> the medical records</span> <span class="ins cts-1" data-cid="900" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576751969990" title="Inserted by Annapoorni Swamynathan - 12/19/2019 4:09pm" contenteditable="true">of all </span>800 <span class="del cts-1" data-cid="907" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576751980565" title="Deleted by Annapoorni Swamynathan - 12/19/2019 4:09pm" contenteditable="false">medical records of all </span>patients that had been referred to our clinics from 2006 to 2008. We included only those with phenotype A, BMI ≥25 kg/m<sup store="644" contenteditable="true">2</sup> with normal baseline fasting glucose level and normal glucose tolerance. All patients were managed in the single center using a standardized treatment protocol with <span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731845000_dfound5_regex_style99" common_tag="1576731845000_ifound5_regex_style99" contenteditable="false">2000 mg </span><span store="1576731845000_i5" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731845000_ifound5_regex_style99" common_tag="1576731845000_ifound5_regex_style99" contenteditable="true">2000 mg </span>metformin that had been introduced in all overweight-obese women regardless of their <xref ref-type="scheme" language="UK" store="646" contenteditable="true">glycemic</xref> status unless contraindicated since 2006, <span class="ins cts-1" data-cid="908" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576752027286" title="Inserted by Annapoorni Swamynathan - 12/19/2019 4:10pm" contenteditable="true">and </span>thus any possible selection bias had been eliminated. This offers very important and rarely available insight into the long<span class="del cts-1" data-cid="856" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576750457720" title="Deleted by Annapoorni Swamynathan - 12/19/2019 3:44pm" contenteditable="false"> </span><span class="ins cts-1" data-cid="857" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576750457796" title="Inserted by Annapoorni Swamynathan - 12/19/2019 3:44pm" contenteditable="true">-</span>term longitudinal follow<span class="del cts-1" data-cid="186" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733213969" title="Deleted by Annapoorni Swamynathan - 12/19/2019 10:56am" contenteditable="false"> </span><span class="ins cts-1" data-cid="187" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576733214000" title="Inserted by Annapoorni Swamynathan - 12/19/2019 10:56am" store="1576733214000_ek" enter_key="success" contenteditable="true">-</span>up in this subset of patients that ha<span class="del cts-1" data-cid="912" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576752044346" title="Deleted by Annapoorni Swamynathan - 12/19/2019 4:10pm" contenteditable="false">s</span><span class="ins cts-1" data-cid="913" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576752044426" title="Inserted by Annapoorni Swamynathan - 12/19/2019 4:10pm" contenteditable="true">ve</span> not been<span class="ins cts-1" data-cid="915" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576752055574" title="Inserted by Annapoorni Swamynathan - 12/19/2019 4:10pm" contenteditable="true">,</span> in general<span class="ins cts-1" data-cid="916" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576752058465" title="Inserted by Annapoorni Swamynathan - 12/19/2019 4:10pm" contenteditable="true">,</span> characterized as candidates for metformin treatment until the latest recommendations update (<xref ref-type="bibr" rid="CIT00007" title="7. TeedeHJMissoMLCostelloMFDokrasALavenJMoranLPiltonenTNormanRJ &amp; International PCOS Network. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Human Reproduction 2018 33 1602–1618. (https://doi.org/10.1093/humrep/dey256)" store="647" contenteditable="true">7</xref>).</pp1></sec></sec><sec sec-type="H1" store="648" contenteditable="true"><title1 title="H1" store="649" contenteditable="true">Conclusions</title1><pp1 store="650" contenteditable="true">We conclude that, in agreement with the latest recommendations (<xref ref-type="bibr" rid="CIT00007" title="7. TeedeHJMissoMLCostelloMFDokrasALavenJMoranLPiltonenTNormanRJ &amp; International PCOS Network. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Human Reproduction 2018 33 1602–1618. (https://doi.org/10.1093/humrep/dey256)" store="651" contenteditable="true">7</xref>), metformin should not be withheld from treatment of PCOS in overweight-obese women with normal fasting glucose and normal glucose tolerance. We suggest that treatment decisions for metformin are based on BMI, <xref ref-type="scheme" language="US" store="652" contenteditable="true"><xref ref-type="scheme" language="UK" store="653" contenteditable="true">oligomenorrhea</xref></xref> and biochemical <xref ref-type="scheme" language="US" store="654" contenteditable="true"><xref ref-type="scheme" language="UK" store="655" contenteditable="true">hyperandrogenism</xref></xref> regardless of the <xref ref-type="scheme" language="UK" store="656" contenteditable="true">glycemic</xref> status. The overweight-obese and <xref ref-type="scheme" language="US" store="657" contenteditable="true"><xref ref-type="scheme" language="UK" store="658" contenteditable="true">oligomenorrheic</xref></xref> women should be prioritized treatment candidates. The high rate of drop out<span class="ins cts-1" data-cid="917" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576752106826" title="Inserted by Annapoorni Swamynathan - 12/19/2019 4:11pm" contenteditable="true">s</span> not related to intolerance and side effects could be decreased in clinical practice by discussing the realistic treatment goals and potential benefits of long-term intervention.</pp1><sec sec-type="H2" store="659" contenteditable="true"><title1 title="H2" store="660" contenteditable="true">Unanswered questions and future perspective</title1><pp1 store="661" contenteditable="true">We encourage future designs to investigate <span class="ins cts-1" data-cid="922" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576752127910" title="Inserted by Annapoorni Swamynathan - 12/19/2019 4:12pm" contenteditable="true">the </span>stabilization of BM through <span class="ins cts-1" data-cid="918" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576752120090" title="Inserted by Annapoorni Swamynathan - 12/19/2019 4:12pm" contenteditable="true">the </span>years as one of the main treatment benefits of long-term treatment with metformin in overweight-obese PCOS. The separate impact of metformin on visceral and <span class="del cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731467000_dfound2_regex_style798" common_tag="1576731467000_ifound2_regex_style798" contenteditable="false">subcutaneous</span><span store="1576731467000_i0" class="ins cts-1" data-cid="2" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576731467000_ifound2_regex_style798" common_tag="1576731467000_ifound2_regex_style798" contenteditable="true">s.c.</span> fat depots is another topic that deserves further attention. The protective effect of <span class="ins cts-1" data-cid="926" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576752150347" title="Inserted by Annapoorni Swamynathan - 12/19/2019 4:12pm" contenteditable="true">the </span>long-term use of metformin in reducing the risk of unopposed endometrial proliferation and endometrium cancer should also be evaluated.</pp1><pp1 store="662" contenteditable="true">The next important question is for how long metformin should be applied to reach the homeostasis that can sustain weight and glucose metabolism after metformin withdrawal. We suggest to compare the consequences of <span class="del cts-1" data-cid="930" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576752187254" title="Deleted by Annapoorni Swamynathan - 12/19/2019 4:13pm" contenteditable="false">the </span>metformin withdrawal after long-term therapy as opposed to the consequences of metformin withdrawal immediately after the maximum treatment effect is achieved, usually after the <span class="del cts-1" data-cid="931" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576752196549" title="Deleted by Annapoorni Swamynathan - 12/19/2019 4:13pm" contenteditable="false">1</span><span class="ins cts-1" data-cid="932" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576752196676" title="Inserted by Annapoorni Swamynathan - 12/19/2019 4:13pm" contenteditable="true">fir</span>st year. Intermittent regimens <xref ref-type="scheme" language="US" store="663" contenteditable="true"><xref ref-type="scheme" language="UK" store="664" contenteditable="true">vs</xref></xref> continuing long<span class="del cts-1" data-cid="858" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576750463242" title="Deleted by Annapoorni Swamynathan - 12/19/2019 3:44pm" contenteditable="false"> </span><span class="ins cts-1" data-cid="859" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576750463321" title="Inserted by Annapoorni Swamynathan - 12/19/2019 3:44pm" contenteditable="true">-</span>term interventions with metformin represent another issue to be addressed.</pp1><pp1 store="665" contenteditable="true">The heterogeneity in response to metformin represents another exciting research field. Traditional as well as <xref ref-type="scheme" language="UK" store="666" contenteditable="true">nontraditional</xref> risk <xref ref-type="scheme" language="US" store="667" contenteditable="true"><xref ref-type="scheme" language="UK" store="668" contenteditable="true">cardiometabolic</xref></xref> markers including chronic inflammation, oxidative stress, homeostasis and fibrinolysis imbalance, gut <xref ref-type="scheme" language="US" store="669" contenteditable="true"><xref ref-type="scheme" language="UK" store="670" contenteditable="true">microbiota</xref></xref> <xref ref-type="scheme" language="US" store="671" contenteditable="true"><xref ref-type="scheme" language="UK" store="672" contenteditable="true">dysbiosis</xref></xref> and epigenetic alterations sympathetic nervous system dysfunction (<xref ref-type="bibr" rid="CIT00042" title="42. ChiuWLBoyleJVincentATeedeHMoranLJ. Cardiometabolic risks in polycystic ovary syndrome: non-traditional risk factors and the impact of obesity. Neuroendocrinology 2017 104 412–424. (doi:10.1159/000455233)" store="673" contenteditable="true">42</xref>) should be considered as potential predictors for responders and non-responders. Furthermore, large-scale genome wide studies are also imperative to identify the best responders.</pp1><pp1 store="674" contenteditable="true">The further research needs to firstly identify and then prioritize those groups who will benefit most from being treated with metformin. The treatment goals and duration of therapy should be clearly defined<span class="ins cts-1" data-cid="935" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576752309762" title="Inserted by Annapoorni Swamynathan - 12/19/2019 4:15pm" contenteditable="true">,</span> in particular<span class="ins cts-1" data-cid="936" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576752311117" title="Inserted by Annapoorni Swamynathan - 12/19/2019 4:15pm" contenteditable="true">,</span> in overweight-obese women with PCOS and normal initial glucose homeostasis where its long-term use is currently more difficult to advocate. Individually tailored approach<span class="ins cts-1" data-cid="937" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576752328376" title="Inserted by Annapoorni Swamynathan - 12/19/2019 4:15pm" contenteditable="true">es</span> might lead to better adherence that would provide better insights into <span class="ins cts-1" data-cid="939" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576752345420" title="Inserted by Annapoorni Swamynathan - 12/19/2019 4:15pm" contenteditable="true">a </span>long<span class="del cts-1" data-cid="860" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576750469571" title="Deleted by Annapoorni Swamynathan - 12/19/2019 3:44pm" contenteditable="false"> </span><span class="ins cts-1" data-cid="861" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576750469682" title="Inserted by Annapoorni Swamynathan - 12/19/2019 3:44pm" contenteditable="true">-</span>term cost<span class="del cts-1" data-cid="352" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576815571141" title="Deleted by Annapoorni Swamynathan - 12/20/2019 9:49am" contenteditable="false"> </span><span class="ins cts-1" data-cid="353" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576815571322" title="Inserted by Annapoorni Swamynathan - 12/20/2019 9:49am">–</span>benefit profile. Continuing follow-ups in randomized prospective trials and in real life settings would provide further information on putative long-term benefits of metformin and whether they are homogeneous across subgroups.</pp1><sec sec-type="H4" store="675" contenteditable="true"><title1 title="H4" store="676" contenteditable="true">Declaration of interest</title1><pp1 store="677" contenteditable="true">The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.</pp1></sec><sec sec-type="H4" store="678" contenteditable="true"><title1 title="H4" store="679" contenteditable="true">Funding</title1><pp1 store="680" contenteditable="true">This research did not receive any specific grant from any funding agency in the public, commercial<span class="ins cts-1" data-cid="941" data-userid="11" data-username="Annapoorni Swamynathan" data-time="1576752368899" title="Inserted by Annapoorni Swamynathan - 12/19/2019 4:16pm" contenteditable="true">,</span> or not-for profit sector.</pp1></sec></sec></sec></body1><back store="681" contenteditable="true"><ref-list store="682" contenteditable="true"><title1 store="683" contenteditable="true">References</title1><ref id="CIT00001" store="684" contenteditable="true"><label1 store="685" contenteditable="true">1. </label1><mixed-citation publication-type="journal" store="686" contenteditable="true"><person-group person-group-type="author" store="687" contenteditable="true"><name store="688" contenteditable="true"><surname store="689" contenteditable="true">Bates</surname><!--punc--> <!--punc--><given-names store="690" contenteditable="true">GW</given-names></name><!--punc--> &amp; <!--punc--><name store="691" contenteditable="true"><surname store="692" contenteditable="true">Legro</surname><!--punc--> <!--punc--><given-names store="693" contenteditable="true">RS</given-names></name></person-group><delimiter store="694" contenteditable="true">. </delimiter><article-title store="695" contenteditable="true">Long-term management of polycystic ovarian syndrome (PCOS)</article-title><delimiter store="696" contenteditable="true">. </delimiter><source1 store="697" contenteditable="true"><i store="698" contenteditable="true">Molecular and Cellular Endocrinology</i></source1><delimiter store="699" contenteditable="true"> </delimiter><year store="700" contenteditable="true">2013</year><delimiter store="701" contenteditable="true"> </delimiter><volume1 store="702" contenteditable="true"><!--punc--><b store="703" contenteditable="true"><!--punc-->373<!--punc--></b><!--punc--></volume1><delimiter store="704" contenteditable="true"> </delimiter><fpage1 store="705" contenteditable="true">91</fpage1><delimiter store="706" contenteditable="true">–</delimiter><lpage1 store="707" contenteditable="true">97</lpage1><delimiter store="708" contenteditable="true">. </delimiter><pub-id store="709" contenteditable="true">(https://doi.org/10.1016/j.mce.2012.10.029)</pub-id></mixed-citation></ref><ref id="CIT00002" store="710" contenteditable="true"><label1 store="711" contenteditable="true">2. </label1><mixed-citation publication-type="journal" store="712" contenteditable="true"><person-group person-group-type="author" store="713" contenteditable="true"><name store="714" contenteditable="true"><surname store="715" contenteditable="true">Kakoly</surname><!--punc--> <!--punc--><given-names store="716" contenteditable="true">NS</given-names></name><!--punc-->, <!--punc--><name store="717" contenteditable="true"><surname store="718" contenteditable="true">Earnest</surname><!--punc--> <!--punc--><given-names store="719" contenteditable="true">A</given-names></name><!--punc-->, <!--punc--><name store="720" contenteditable="true"><surname store="721" contenteditable="true">Teede</surname><!--punc--> <!--punc--><given-names store="722" contenteditable="true">HJ</given-names></name><!--punc-->, <!--punc--><name store="723" contenteditable="true"><surname store="724" contenteditable="true">Moran</surname><!--punc--> <!--punc--><given-names store="725" contenteditable="true">LJ</given-names></name><!--punc--> &amp; <!--punc--><name store="726" contenteditable="true"><surname store="727" contenteditable="true">Joham</surname><!--punc--> <!--punc--><given-names store="728" contenteditable="true">AE</given-names></name></person-group><delimiter store="729" contenteditable="true">. </delimiter><article-title store="730" contenteditable="true">The impact of obesity on the incidence of Type 2 diabetes among women with polycystic ovary syndrome</article-title><delimiter store="731" contenteditable="true">. </delimiter><source1 store="732" contenteditable="true"><i store="733" contenteditable="true">Diabetes Care</i></source1><delimiter store="734" contenteditable="true"> </delimiter><year store="735" contenteditable="true">2019</year><delimiter store="736" contenteditable="true"> </delimiter><volume1 store="737" contenteditable="true"><!--punc--><b store="738" contenteditable="true"><!--punc-->42<!--punc--></b><!--punc--></volume1><delimiter store="739" contenteditable="true"> </delimiter><fpage1 store="740" contenteditable="true">560</fpage1><delimiter store="741" contenteditable="true">–</delimiter><lpage1 store="742" contenteditable="true">567</lpage1><delimiter store="743" contenteditable="true">. </delimiter><pub-id store="744" contenteditable="true">(https://doi.org/10.2337/dc18-1738)</pub-id><delimiter store="745" contenteditable="true"> </delimiter></mixed-citation></ref><ref id="CIT00003" store="746" contenteditable="true"><label1 store="747" contenteditable="true">3. </label1><mixed-citation publication-type="journal" store="748" contenteditable="true"><person-group person-group-type="author" store="749" contenteditable="true"><name store="750" contenteditable="true"><surname store="751" contenteditable="true">Velazquez</surname><!--punc--> <!--punc--><given-names store="752" contenteditable="true">EM</given-names></name><!--punc-->, <!--punc--><name store="753" contenteditable="true"><surname store="754" contenteditable="true">Mendoza</surname><!--punc--> <!--punc--><given-names store="755" contenteditable="true">S</given-names></name><!--punc-->, <!--punc--><name store="756" contenteditable="true"><surname store="757" contenteditable="true">Hamer</surname><!--punc--> <!--punc--><given-names store="758" contenteditable="true">T</given-names></name><!--punc-->, <!--punc--><name store="759" contenteditable="true"><surname store="760" contenteditable="true">Sosa</surname><!--punc--> <!--punc--><given-names store="761" contenteditable="true">F</given-names></name><!--punc--> &amp; <!--punc--><name store="762" contenteditable="true"><surname store="763" contenteditable="true">Glueck</surname><!--punc--> <!--punc--><given-names store="764" contenteditable="true">CJ</given-names></name></person-group><delimiter store="765" contenteditable="true">. </delimiter><article-title store="766" contenteditable="true">Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy</article-title><delimiter store="767" contenteditable="true">. </delimiter><source1 store="768" contenteditable="true"><i store="769" contenteditable="true">Metabolism: Clinical and Experimental</i></source1><delimiter store="770" contenteditable="true"> </delimiter><year store="771" contenteditable="true">1994</year><delimiter store="772" contenteditable="true"> </delimiter><volume1 store="773" contenteditable="true"><!--punc--><b store="774" contenteditable="true"><!--punc-->43<!--punc--></b><!--punc--></volume1><delimiter store="775" contenteditable="true"> </delimiter><fpage1 store="776" contenteditable="true">647</fpage1><delimiter store="777" contenteditable="true">–</delimiter><lpage1 store="778" contenteditable="true">654</lpage1><delimiter store="779" contenteditable="true">. </delimiter><pub-id store="780" contenteditable="true">(https://doi.org/10.1016/0026-0495(94)90209-7)</pub-id><delimiter store="781" contenteditable="true"> </delimiter></mixed-citation></ref><ref id="CIT00004" store="782" contenteditable="true"><label1 store="783" contenteditable="true">4. </label1><mixed-citation publication-type="journal" store="784" contenteditable="true"><person-group person-group-type="author" store="785" contenteditable="true"><name store="786" contenteditable="true"><surname store="787" contenteditable="true">Tang</surname><!--punc--> <!--punc--><given-names store="788" contenteditable="true">T</given-names></name><!--punc-->, <!--punc--><name store="789" contenteditable="true"><surname store="790" contenteditable="true">Glanville</surname><!--punc--> <!--punc--><given-names store="791" contenteditable="true">J</given-names></name><!--punc-->, <!--punc--><name store="792" contenteditable="true"><surname store="793" contenteditable="true">Hayden</surname><!--punc--> <!--punc--><given-names store="794" contenteditable="true">CJ</given-names></name><!--punc-->, <!--punc--><name store="795" contenteditable="true"><surname store="796" contenteditable="true">White</surname><!--punc--> <!--punc--><given-names store="797" contenteditable="true">D</given-names></name><!--punc-->, <!--punc--><name store="798" contenteditable="true"><surname store="799" contenteditable="true">Barth</surname><!--punc--> <!--punc--><given-names store="800" contenteditable="true">JH</given-names></name><!--punc--> &amp; <!--punc--><name store="801" contenteditable="true"><surname store="802" contenteditable="true">Balen</surname><!--punc--> <!--punc--><given-names store="803" contenteditable="true">AH</given-names></name></person-group><delimiter store="804" contenteditable="true">. </delimiter><article-title store="805" contenteditable="true">Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study</article-title><delimiter store="806" contenteditable="true">. </delimiter><source1 store="807" contenteditable="true"><i store="808" contenteditable="true">Human Reproduction</i></source1><delimiter store="809" contenteditable="true"> </delimiter><year store="810" contenteditable="true">2006</year><delimiter store="811" contenteditable="true"> </delimiter><volume1 store="812" contenteditable="true"><!--punc--><b store="813" contenteditable="true"><!--punc-->21<!--punc--></b><!--punc--></volume1><delimiter store="814" contenteditable="true"> </delimiter><fpage1 store="815" contenteditable="true">80</fpage1><delimiter store="816" contenteditable="true">–</delimiter><lpage1 store="817" contenteditable="true">89</lpage1><delimiter store="818" contenteditable="true">. </delimiter><pub-id store="819" contenteditable="true">(https://doi.org/10.1093/humrep/dei311)</pub-id><delimiter store="820" contenteditable="true"> </delimiter></mixed-citation></ref><ref id="CIT00005" store="821" contenteditable="true"><label1 store="822" contenteditable="true">5. </label1><mixed-citation publication-type="journal" store="823" contenteditable="true"><person-group person-group-type="author" store="824" contenteditable="true"><name store="825" contenteditable="true"><surname store="826" contenteditable="true">McCartney</surname><!--punc--> <!--punc--><given-names store="827" contenteditable="true">CR</given-names></name><!--punc--> &amp; <!--punc--><name store="828" contenteditable="true"><surname store="829" contenteditable="true">Marshall</surname><!--punc--> <!--punc--><given-names store="830" contenteditable="true">JC</given-names></name></person-group><delimiter store="831" contenteditable="true">. </delimiter><article-title store="832" contenteditable="true">CLINICAL PRACTICE. Polycystic ovary syndrome</article-title><delimiter store="833" contenteditable="true">. </delimiter><source1 store="834" contenteditable="true"><i store="835" contenteditable="true">New England Journal of Medicine</i></source1><delimiter store="836" contenteditable="true"> </delimiter><year store="837" contenteditable="true">2016</year><delimiter store="838" contenteditable="true"> </delimiter><volume1 store="839" contenteditable="true"><!--punc--><b store="840" contenteditable="true"><!--punc-->375<!--punc--></b><!--punc--></volume1><delimiter store="841" contenteditable="true"> </delimiter><fpage1 store="842" contenteditable="true">54</fpage1><delimiter store="843" contenteditable="true">–</delimiter><lpage1 store="844" contenteditable="true">64</lpage1><delimiter store="845" contenteditable="true">. </delimiter><pub-id store="846" contenteditable="true">(https://doi.org/10.1056/NEJMcp1514916)</pub-id><delimiter store="847" contenteditable="true"> </delimiter></mixed-citation></ref><ref id="CIT00006" store="848" contenteditable="true"><label1 store="849" contenteditable="true">6. </label1><mixed-citation publication-type="journal" store="850" contenteditable="true"><person-group person-group-type="author" store="851" contenteditable="true"><name store="852" contenteditable="true"><surname store="853" contenteditable="true">Sam</surname><!--punc--> <!--punc--><given-names store="854" contenteditable="true">S</given-names></name><!--punc--> &amp; <!--punc--><name store="855" contenteditable="true"><surname store="856" contenteditable="true">Ehrmann</surname><!--punc--> <!--punc--><given-names store="857" contenteditable="true">DA</given-names></name></person-group><delimiter store="858" contenteditable="true">. </delimiter><article-title store="859" contenteditable="true">Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome</article-title><delimiter store="860" contenteditable="true">. </delimiter><source1 store="861" contenteditable="true"><i store="862" contenteditable="true">Diabetologia</i></source1><delimiter store="863" contenteditable="true"> </delimiter><year store="864" contenteditable="true">2017</year><delimiter store="865" contenteditable="true"> </delimiter><volume1 store="866" contenteditable="true"><!--punc--><b store="867" contenteditable="true"><!--punc-->60<!--punc--></b><!--punc--></volume1><delimiter store="868" contenteditable="true"> </delimiter><fpage1 store="869" contenteditable="true">1656</fpage1><delimiter store="870" contenteditable="true">–</delimiter><lpage1 store="871" contenteditable="true">1661</lpage1><delimiter store="872" contenteditable="true">. </delimiter><pub-id store="873" contenteditable="true">(https://doi.org/10.1007/s00125-017-4306-3)</pub-id><delimiter store="874" contenteditable="true"> </delimiter></mixed-citation></ref><ref id="CIT00007" store="875" contenteditable="true"><label1 store="876" contenteditable="true">7. </label1><mixed-citation publication-type="journal" store="877" contenteditable="true"><person-group person-group-type="author" store="878" contenteditable="true"><name store="879" contenteditable="true"><surname store="880" contenteditable="true">Teede</surname><!--punc--> <!--punc--><given-names store="881" contenteditable="true">HJ</given-names></name><!--punc-->, <!--punc--><name store="882" contenteditable="true"><surname store="883" contenteditable="true">Misso</surname><!--punc--> <!--punc--><given-names store="884" contenteditable="true">ML</given-names></name><!--punc-->, <!--punc--><name store="885" contenteditable="true"><surname store="886" contenteditable="true">Costello</surname><!--punc--> <!--punc--><given-names store="887" contenteditable="true">MF</given-names></name><!--punc-->, <!--punc--><name store="888" contenteditable="true"><surname store="889" contenteditable="true">Dokras</surname><!--punc--> <!--punc--><given-names store="890" contenteditable="true">A</given-names></name><!--punc-->, <!--punc--><name store="891" contenteditable="true"><surname store="892" contenteditable="true">Laven</surname><!--punc--> <!--punc--><given-names store="893" contenteditable="true">J</given-names></name><!--punc-->, <!--punc--><name store="894" contenteditable="true"><surname store="895" contenteditable="true">Moran</surname><!--punc--> <!--punc--><given-names store="896" contenteditable="true">L</given-names></name><!--punc-->, <!--punc--><name store="897" contenteditable="true"><surname store="898" contenteditable="true">Piltonen</surname><!--punc--> <!--punc--><given-names store="899" contenteditable="true">T</given-names></name><!--punc-->, <!--punc--><name store="900" contenteditable="true"><surname store="901" contenteditable="true">Norman</surname><!--punc--> <!--punc--><given-names store="902" contenteditable="true">RJ</given-names></name></person-group><delimiter store="903" contenteditable="true"> &amp; </delimiter><collab store="904" contenteditable="true">International PCOS Network</collab><delimiter store="905" contenteditable="true">. </delimiter><article-title store="906" contenteditable="true">Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome</article-title><delimiter store="907" contenteditable="true">. </delimiter><source1 store="908" contenteditable="true"><i store="909" contenteditable="true">Human Reproduction</i></source1><delimiter store="910" contenteditable="true"> </delimiter><year store="911" contenteditable="true">2018</year><delimiter store="912" contenteditable="true"> </delimiter><volume1 store="913" contenteditable="true"><!--punc--><b store="914" contenteditable="true"><!--punc-->33<!--punc--></b><!--punc--></volume1><delimiter store="915" contenteditable="true"> </delimiter><fpage1 store="916" contenteditable="true">1602</fpage1><delimiter store="917" contenteditable="true">–</delimiter><lpage1 store="918" contenteditable="true">1618</lpage1><delimiter store="919" contenteditable="true">. </delimiter><pub-id store="920" contenteditable="true">(https://doi.org/10.1093/humrep/dey256)</pub-id><delimiter store="921" contenteditable="true"> </delimiter></mixed-citation></ref><ref id="CIT00008" store="922" contenteditable="true"><label1 store="923" contenteditable="true">8. </label1><mixed-citation publication-type="journal" store="924" contenteditable="true"><person-group person-group-type="author" store="925" contenteditable="true"><name store="926" contenteditable="true"><surname store="927" contenteditable="true">Legro</surname><!--punc--> <!--punc--><given-names store="928" contenteditable="true">RS</given-names></name><!--punc-->, <!--punc--><name store="929" contenteditable="true"><surname store="930" contenteditable="true">Arslanian</surname><!--punc--> <!--punc--><given-names store="931" contenteditable="true">SA</given-names></name><!--punc-->, <!--punc--><name store="932" contenteditable="true"><surname store="933" contenteditable="true">Ehrmann</surname><!--punc--> <!--punc--><given-names store="934" contenteditable="true">DA</given-names></name><!--punc-->, <!--punc--><name store="935" contenteditable="true"><surname store="936" contenteditable="true">Hoeger</surname><!--punc--> <!--punc--><given-names store="937" contenteditable="true">KM</given-names></name><!--punc-->, <!--punc--><name store="938" contenteditable="true"><surname store="939" contenteditable="true">Murad</surname><!--punc--> <!--punc--><given-names store="940" contenteditable="true">MH</given-names></name><!--punc-->, <!--punc--><name store="941" contenteditable="true"><surname store="942" contenteditable="true">Pasquali</surname><!--punc--> <!--punc--><given-names store="943" contenteditable="true">R</given-names></name><!--punc-->, <!--punc--><name store="944" contenteditable="true"><surname store="945" contenteditable="true">Welt</surname><!--punc--> <!--punc--><given-names store="946" contenteditable="true">CK</given-names></name></person-group><delimiter store="947" contenteditable="true"> &amp; </delimiter><collab store="948" contenteditable="true">Endocrine Society</collab><delimiter store="949" contenteditable="true">. </delimiter><article-title store="950" contenteditable="true">Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline</article-title><delimiter store="951" contenteditable="true">. </delimiter><source1 store="952" contenteditable="true"><i store="953" contenteditable="true">Journal of Clinical Endocrinology and Metabolism</i></source1><delimiter store="954" contenteditable="true"> </delimiter><year store="955" contenteditable="true">2013</year><delimiter store="956" contenteditable="true"> </delimiter><volume1 store="957" contenteditable="true"><!--punc--><b store="958" contenteditable="true"><!--punc-->98<!--punc--></b><!--punc--></volume1><delimiter store="959" contenteditable="true"> </delimiter><fpage1 store="960" contenteditable="true">4565</fpage1><delimiter store="961" contenteditable="true">–</delimiter><lpage1 store="962" contenteditable="true">4592</lpage1><delimiter store="963" contenteditable="true">. </delimiter><pub-id store="964" contenteditable="true">(https://doi.org/10.1210/jc.2013-2350)</pub-id><delimiter store="965" contenteditable="true"> </delimiter></mixed-citation></ref><ref id="CIT00009" store="966" contenteditable="true"><label1 store="967" contenteditable="true">9. </label1><mixed-citation publication-type="journal" store="968" contenteditable="true"><person-group person-group-type="author" store="969" contenteditable="true"><name store="970" contenteditable="true"><surname store="971" contenteditable="true">Goodman</surname><!--punc--> <!--punc--><given-names store="972" contenteditable="true">NF</given-names></name><!--punc-->, <!--punc--><name store="973" contenteditable="true"><surname store="974" contenteditable="true">Cobin</surname><!--punc--> <!--punc--><given-names store="975" contenteditable="true">RH</given-names></name><!--punc-->, <!--punc--><name store="976" contenteditable="true"><surname store="977" contenteditable="true">Futterweit</surname><!--punc--> <!--punc--><given-names store="978" contenteditable="true">W</given-names></name><!--punc-->, <!--punc--><name store="979" contenteditable="true"><surname store="980" contenteditable="true">Glueck</surname><!--punc--> <!--punc--><given-names store="981" contenteditable="true">JS</given-names></name><!--punc-->, <!--punc--><name store="982" contenteditable="true"><surname store="983" contenteditable="true">Legro</surname><!--punc--> <!--punc--><given-names store="984" contenteditable="true">RS</given-names></name><!--punc-->, <!--punc--><name store="985" contenteditable="true"><surname store="986" contenteditable="true">Carmina</surname><!--punc--> <!--punc--><given-names store="987" contenteditable="true">E</given-names></name></person-group><delimiter store="988" contenteditable="true">, </delimiter><collab store="989" contenteditable="true">American Association of Clinical Endocrinologists (AACE)</collab><delimiter store="990" contenteditable="true">, </delimiter><collab store="991" contenteditable="true">American College of Endocrinology (ACE)</collab><delimiter store="992" contenteditable="true"> &amp; </delimiter><collab store="993" contenteditable="true">Androgen Excess and PCOS Society (AES)</collab><delimiter store="994" contenteditable="true">. </delimiter><article-title store="995" contenteditable="true">American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome – Part 1</article-title><delimiter store="996" contenteditable="true">. </delimiter><source1 store="997" contenteditable="true"><i store="998" contenteditable="true">Endocrine Practice</i></source1><delimiter store="999" contenteditable="true"> </delimiter><year store="1000" contenteditable="true">2015</year><delimiter store="1001" contenteditable="true"> </delimiter><volume1 store="1002" contenteditable="true"><!--punc--><b store="1003" contenteditable="true"><!--punc-->21<!--punc--></b><!--punc--></volume1><delimiter store="1004" contenteditable="true"> </delimiter><fpage1 store="1005" contenteditable="true">1291</fpage1><delimiter store="1006" contenteditable="true">–</delimiter><lpage1 store="1007" contenteditable="true">1300</lpage1><delimiter store="1008" contenteditable="true">. </delimiter><pub-id store="1009" contenteditable="true">(https://doi.org/10.4158/EP15748.DSC)</pub-id><delimiter store="1010" contenteditable="true"> </delimiter></mixed-citation></ref><ref id="CIT00010" store="1011" contenteditable="true"><label1 store="1012" contenteditable="true">10. </label1><mixed-citation publication-type="journal" store="1013" contenteditable="true"><person-group person-group-type="author" store="1014" contenteditable="true"><name store="1015" contenteditable="true"><surname store="1016" contenteditable="true">Aroda</surname><!--punc--> <!--punc--><given-names store="1017" contenteditable="true">VR</given-names></name><!--punc-->, <!--punc--><name store="1018" contenteditable="true"><surname store="1019" contenteditable="true">Knowler</surname><!--punc--> <!--punc--><given-names store="1020" contenteditable="true">WC</given-names></name><!--punc-->, <!--punc--><name store="1021" contenteditable="true"><surname store="1022" contenteditable="true">Crandall</surname><!--punc--> <!--punc--><given-names store="1023" contenteditable="true">JP</given-names></name><!--punc-->, <!--punc--><name store="1024" contenteditable="true"><surname store="1025" contenteditable="true">Perreault</surname><!--punc--> <!--punc--><given-names store="1026" contenteditable="true">L</given-names></name><!--punc-->, <!--punc--><name store="1027" contenteditable="true"><surname store="1028" contenteditable="true">Edelstein</surname><!--punc--> <!--punc--><given-names store="1029" contenteditable="true">SL</given-names></name><!--punc-->, <!--punc--><name store="1030" contenteditable="true"><surname store="1031" contenteditable="true">Jeffries</surname><!--punc--> <!--punc--><given-names store="1032" contenteditable="true">SL</given-names></name><!--punc-->, <!--punc--><name store="1033" contenteditable="true"><surname store="1034" contenteditable="true">Molitch</surname><!--punc--> <!--punc--><given-names store="1035" contenteditable="true">ME</given-names></name><!--punc-->, <!--punc--><name store="1036" contenteditable="true"><surname store="1037" contenteditable="true">Pi-Sunyer</surname><!--punc--> <!--punc--><given-names store="1038" contenteditable="true">X</given-names></name><!--punc-->, <!--punc--><name store="1039" contenteditable="true"><surname store="1040" contenteditable="true">Darwin</surname><!--punc--> <!--punc--><given-names store="1041" contenteditable="true">C</given-names></name><!--punc-->, <!--punc--><name store="1042" contenteditable="true"><surname store="1043" contenteditable="true">Heckman-Stoddard</surname><!--punc--> <!--punc--><given-names store="1044" contenteditable="true">BM</given-names></name></person-group><delimiter store="1045" contenteditable="true">, </delimiter><i store="1046" contenteditable="true">et al.</i><delimiter store="1047" contenteditable="true"> </delimiter><article-title store="1048" contenteditable="true">Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study</article-title><delimiter store="1049" contenteditable="true">. </delimiter><source1 store="1050" contenteditable="true"><i store="1051" contenteditable="true">Diabetologia</i></source1><delimiter store="1052" contenteditable="true"> </delimiter><year store="1053" contenteditable="true">2017</year><delimiter store="1054" contenteditable="true"> </delimiter><volume1 store="1055" contenteditable="true"><!--punc--><b store="1056" contenteditable="true"><!--punc-->60<!--punc--></b><!--punc--></volume1><delimiter store="1057" contenteditable="true"> </delimiter><fpage1 store="1058" contenteditable="true">1601</fpage1><delimiter store="1059" contenteditable="true">–</delimiter><lpage1 store="1060" contenteditable="true">1611</lpage1><delimiter store="1061" contenteditable="true">. </delimiter><pub-id store="1062" contenteditable="true">(https://doi.org/10.1007/s00125-017-4361-9)</pub-id><delimiter store="1063" contenteditable="true"> </delimiter></mixed-citation></ref><ref id="CIT00011" store="1064" contenteditable="true"><label1 store="1065" contenteditable="true">11. </label1><mixed-citation publication-type="journal" store="1066" contenteditable="true"><collab store="1067" contenteditable="true">Diabetes Prevention Program Research Group</collab><delimiter store="1068" contenteditable="true">. </delimiter><article-title store="1069" contenteditable="true">Long-term effects of metformin on diabetes prevention: identification of subgroups that benefited most in the diabetes prevention program and diabetes prevention program outcomes study</article-title><delimiter store="1070" contenteditable="true">. </delimiter><source1 store="1071" contenteditable="true"><i store="1072" contenteditable="true">Diabetes Care</i></source1><delimiter store="1073" contenteditable="true"> </delimiter><year store="1074" contenteditable="true">2019</year><delimiter store="1075" contenteditable="true"> </delimiter><volume1 store="1076" contenteditable="true"><!--punc--><b store="1077" contenteditable="true"><!--punc-->42<!--punc--></b><!--punc--></volume1><delimiter store="1078" contenteditable="true"> </delimiter><fpage1 store="1079" contenteditable="true">601</fpage1><delimiter store="1080" contenteditable="true">–</delimiter><lpage1 store="1081" contenteditable="true">608</lpage1><delimiter store="1082" contenteditable="true">. </delimiter><pub-id store="1083" contenteditable="true">(https://doi.org/10.2337/dc18-1970)</pub-id><delimiter store="1084" contenteditable="true"> </delimiter></mixed-citation></ref><ref id="CIT00012" store="1085" contenteditable="true"><label1 store="1086" contenteditable="true">12. </label1><mixed-citation publication-type="journal" store="1087" contenteditable="true"><person-group person-group-type="author" store="1088" contenteditable="true"><name store="1089" contenteditable="true"><surname store="1090" contenteditable="true">Lentferink</surname><!--punc--> <!--punc--><given-names store="1091" contenteditable="true">YE</given-names></name><!--punc-->, <!--punc--><name store="1092" contenteditable="true"><surname store="1093" contenteditable="true">Knibbe</surname><!--punc--> <!--punc--><given-names store="1094" contenteditable="true">CAJ</given-names></name><!--punc--> &amp; <!--punc--><name store="1095" contenteditable="true"><surname store="1096" contenteditable="true">van der Vorst</surname><!--punc--> <!--punc--><given-names store="1097" contenteditable="true">MMJ</given-names></name></person-group><delimiter store="1098" contenteditable="true">. </delimiter><article-title store="1099" contenteditable="true">Efficacy of metformin treatment with respect to weight reduction in children and adults with obesity: a systematic review</article-title><delimiter store="1100" contenteditable="true">. </delimiter><source1 store="1101" contenteditable="true"><i store="1102" contenteditable="true">Drugs</i></source1><delimiter store="1103" contenteditable="true"> </delimiter><year store="1104" contenteditable="true">2018</year><delimiter store="1105" contenteditable="true"> </delimiter><volume1 store="1106" contenteditable="true"><!--punc--><b store="1107" contenteditable="true"><!--punc-->78<!--punc--></b><!--punc--></volume1><delimiter store="1108" contenteditable="true"> </delimiter><fpage1 store="1109" contenteditable="true">1887</fpage1><delimiter store="1110" contenteditable="true">–</delimiter><lpage1 store="1111" contenteditable="true">1901</lpage1><delimiter store="1112" contenteditable="true">. </delimiter><pub-id store="1113" contenteditable="true">(https://doi.org/10.1007/s40265-018-1025-0)</pub-id><delimiter store="1114" contenteditable="true"> </delimiter></mixed-citation></ref><ref id="CIT00013" store="1115" contenteditable="true"><label1 store="1116" contenteditable="true">13. </label1><mixed-citation publication-type="journal" store="1117" contenteditable="true"><person-group person-group-type="author" store="1118" contenteditable="true"><name store="1119" contenteditable="true"><surname store="1120" contenteditable="true">Azziz</surname><!--punc--> <!--punc--><given-names store="1121" contenteditable="true">R</given-names></name></person-group><delimiter store="1122" contenteditable="true">. </delimiter><article-title store="1123" contenteditable="true">Introduction: determinants of polycystic ovary syndrome</article-title><delimiter store="1124" contenteditable="true">. </delimiter><source1 store="1125" contenteditable="true"><i store="1126" contenteditable="true">Fertility and Sterility</i></source1><delimiter store="1127" contenteditable="true"> </delimiter><year store="1128" contenteditable="true">2016</year><delimiter store="1129" contenteditable="true"> </delimiter><volume1 store="1130" contenteditable="true"><!--punc--><b store="1131" contenteditable="true"><!--punc-->106<!--punc--></b><!--punc--></volume1><delimiter store="1132" contenteditable="true"> </delimiter><fpage1 store="1133" contenteditable="true">4</fpage1><delimiter store="1134" contenteditable="true">–</delimiter><lpage1 store="1135" contenteditable="true">5</lpage1><delimiter store="1136" contenteditable="true">. </delimiter><pub-id store="1137" contenteditable="true">(https://doi.org/10.1016/j.fertnstert.2016.05.009)</pub-id><delimiter store="1138" contenteditable="true"> </delimiter></mixed-citation></ref><ref id="CIT00014" store="1139" contenteditable="true"><label1 store="1140" contenteditable="true">14. </label1><mixed-citation publication-type="journal" store="1141" contenteditable="true"><person-group person-group-type="author" store="1142" contenteditable="true"><name store="1143" contenteditable="true"><surname store="1144" contenteditable="true">Jayasena</surname><!--punc--> <!--punc--><given-names store="1145" contenteditable="true">CN</given-names></name><!--punc--> &amp; <!--punc--><name store="1146" contenteditable="true"><surname store="1147" contenteditable="true">Franks</surname><!--punc--> <!--punc--><given-names store="1148" contenteditable="true">S</given-names></name></person-group><delimiter store="1149" contenteditable="true">. </delimiter><article-title store="1150" contenteditable="true">The management of patients with polycystic ovary syndrome</article-title><delimiter store="1151" contenteditable="true">. </delimiter><source1 store="1152" contenteditable="true"><i store="1153" contenteditable="true">Nature Reviews: Endocrinology</i></source1><delimiter store="1154" contenteditable="true"> </delimiter><year store="1155" contenteditable="true">2014</year><delimiter store="1156" contenteditable="true"> </delimiter><volume1 store="1157" contenteditable="true"><!--punc--><b store="1158" contenteditable="true"><!--punc-->10<!--punc--></b><!--punc--></volume1><delimiter store="1159" contenteditable="true"> </delimiter><fpage1 store="1160" contenteditable="true">624</fpage1><delimiter store="1161" contenteditable="true">–</delimiter><lpage1 store="1162" contenteditable="true">636</lpage1><delimiter store="1163" contenteditable="true">. </delimiter><pub-id store="1164" contenteditable="true">(https://doi.org/10.1038/nrendo.2014.102)</pub-id><delimiter store="1165" contenteditable="true"> </delimiter></mixed-citation></ref><ref id="CIT00015" store="1166" contenteditable="true"><label1 store="1167" contenteditable="true">15. </label1><mixed-citation publication-type="journal" store="1168" contenteditable="true"><person-group person-group-type="author" store="1169" contenteditable="true"><name store="1170" contenteditable="true"><surname store="1171" contenteditable="true">Tang</surname><!--punc--> <!--punc--><given-names store="1172" contenteditable="true">T</given-names></name><!--punc-->, <!--punc--><name store="1173" contenteditable="true"><surname store="1174" contenteditable="true">Lord</surname><!--punc--> <!--punc--><given-names store="1175" contenteditable="true">JM</given-names></name><!--punc-->, <!--punc--><name store="1176" contenteditable="true"><surname store="1177" contenteditable="true">Norman</surname><!--punc--> <!--punc--><given-names store="1178" contenteditable="true">RJ</given-names></name><!--punc-->, <!--punc--><name store="1179" contenteditable="true"><surname store="1180" contenteditable="true">Yasmin</surname><!--punc--> <!--punc--><given-names store="1181" contenteditable="true">E</given-names></name><!--punc--> &amp; <!--punc--><name store="1182" contenteditable="true"><surname store="1183" contenteditable="true">Balen</surname><!--punc--> <!--punc--><given-names store="1184" contenteditable="true">AH</given-names></name></person-group><delimiter store="1185" contenteditable="true">. </delimiter><article-title store="1186" contenteditable="true">Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility</article-title><delimiter store="1187" contenteditable="true">. </delimiter><source1 store="1188" contenteditable="true"><i store="1189" contenteditable="true">Cochrane Database of Systematic Reviews</i></source1><delimiter store="1190" contenteditable="true"> </delimiter><year store="1191" contenteditable="true">2012</year><delimiter store="1192" contenteditable="true"> </delimiter><volume1 store="1193" contenteditable="true"><!--punc--><b store="1194" contenteditable="true"><!--punc-->5<!--punc--></b><!--punc--></volume1><delimiter store="1195" contenteditable="true"> </delimiter><fpage1 store="1196" contenteditable="true">CD003053</fpage1><delimiter store="1197" contenteditable="true">. </delimiter><pub-id store="1198" contenteditable="true">(https://doi.org/10.1002/14651858.CD003053.pub5)</pub-id><delimiter store="1199" contenteditable="true"> </delimiter></mixed-citation></ref><ref id="CIT00016" store="1200" contenteditable="true"><label1 store="1201" contenteditable="true">16. </label1><mixed-citation publication-type="journal" store="1202" contenteditable="true"><person-group person-group-type="author" store="1203" contenteditable="true"><name store="1204" contenteditable="true"><surname store="1205" contenteditable="true">Hoeger</surname><!--punc--> <!--punc--><given-names store="1206" contenteditable="true">KM</given-names></name><!--punc-->, <!--punc--><name store="1207" contenteditable="true"><surname store="1208" contenteditable="true">Kochman</surname><!--punc--> <!--punc--><given-names store="1209" contenteditable="true">L</given-names></name><!--punc-->, <!--punc--><name store="1210" contenteditable="true"><surname store="1211" contenteditable="true">Wixom</surname><!--punc--> <!--punc--><given-names store="1212" contenteditable="true" style="" class="">N</given-names></name><!--punc-->, <!--punc--><name store="1213" contenteditable="true"><surname store="1214" contenteditable="true">Craig</surname><!--punc--> <!--punc--><given-names store="1215" contenteditable="true">K</given-names></name><!--punc-->, <!--punc--><name store="1216" contenteditable="true"><surname store="1217" contenteditable="true">Miller</surname><!--punc--> <!--punc--><given-names store="1218" contenteditable="true">RK</given-names></name><!--punc--> &amp; <!--punc--><name store="1219" contenteditable="true"><surname store="1220" contenteditable="true">Guzick</surname><!--punc--> <!--punc--><given-names store="1221" contenteditable="true">DS</given-names></name></person-group><delimiter store="1222" contenteditable="true">. </delimiter><article-title store="1223" contenteditable="true">A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study</article-title><delimiter store="1224" contenteditable="true">. </delimiter><source1 store="1225" contenteditable="true"><i store="1226" contenteditable="true">Fertility and Sterility</i></source1><delimiter store="1227" contenteditable="true"> </delimiter><year store="1228" contenteditable="true">2004</year><delimiter store="1229" contenteditable="true"> </delimiter><volume1 store="1230" contenteditable="true"><!--punc--><b store="1231" contenteditable="true"><!--punc-->82<!--punc--></b><!--punc--></volume1><delimiter store="1232" contenteditable="true"> </delimiter><fpage1 store="1233" contenteditable="true">421</fpage1><delimiter store="1234" contenteditable="true">–</delimiter><lpage1 store="1235" contenteditable="true">429</lpage1><delimiter store="1236" contenteditable="true">. </delimiter><pub-id store="1237" contenteditable="true">(https://doi.org/10.1016/j.fertnstert.2004.02.104)</pub-id><delimiter store="1238" contenteditable="true"> </delimiter></mixed-citation></ref><ref id="CIT00017" store="1239" contenteditable="true"><label1 store="1240" contenteditable="true">17. </label1><mixed-citation publication-type="journal" store="1241" contenteditable="true"><person-group person-group-type="author" store="1242" contenteditable="true"><name store="1243" contenteditable="true"><surname store="1244" contenteditable="true">Naderpoor</surname><!--punc--> <!--punc--><given-names store="1245" contenteditable="true" style="" class="">N</given-names></name><!--punc-->, <!--punc--><name store="1246" contenteditable="true"><surname store="1247" contenteditable="true">Shorakae</surname><!--punc--> <!--punc--><given-names store="1248" contenteditable="true">S</given-names></name><!--punc-->, <!--punc--><name store="1249" contenteditable="true"><surname store="1250" contenteditable="true">de Courten</surname><!--punc--> <!--punc--><given-names store="1251" contenteditable="true">B</given-names></name><!--punc-->, <!--punc--><name store="1252" contenteditable="true"><surname store="1253" contenteditable="true">Misso</surname><!--punc--> <!--punc--><given-names store="1254" contenteditable="true">ML</given-names></name><!--punc-->, <!--punc--><name store="1255" contenteditable="true"><surname store="1256" contenteditable="true">Moran</surname><!--punc--> <!--punc--><given-names store="1257" contenteditable="true">LJ</given-names></name><!--punc--> &amp; <!--punc--><name store="1258" contenteditable="true"><surname store="1259" contenteditable="true">Teede</surname><!--punc--> <!--punc--><given-names store="1260" contenteditable="true">HJ</given-names></name></person-group><delimiter store="1261" contenteditable="true">. </delimiter><article-title store="1262" contenteditable="true">Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis</article-title><delimiter store="1263" contenteditable="true">. </delimiter><source1 store="1264" contenteditable="true"><i store="1265" contenteditable="true">Human Reproduction Update</i></source1><delimiter store="1266" contenteditable="true"> </delimiter><year store="1267" contenteditable="true">2015</year><delimiter store="1268" contenteditable="true"> </delimiter><volume1 store="1269" contenteditable="true"><!--punc--><b store="1270" contenteditable="true"><!--punc-->21<!--punc--></b><!--punc--></volume1><delimiter store="1271" contenteditable="true"> </delimiter><fpage1 store="1272" contenteditable="true">560</fpage1><delimiter store="1273" contenteditable="true">–</delimiter><lpage1 store="1274" contenteditable="true">574</lpage1><delimiter store="1275" contenteditable="true">. </delimiter><pub-id store="1276" contenteditable="true">(https://doi.org/10.1093/humupd/dmv025)</pub-id><delimiter store="1277" contenteditable="true"> </delimiter></mixed-citation></ref><ref id="CIT00018" store="1278" contenteditable="true"><label1 store="1279" contenteditable="true">18. </label1><mixed-citation publication-type="journal" store="1280" contenteditable="true"><person-group person-group-type="author" store="1281" contenteditable="true"><name store="1282" contenteditable="true"><surname store="1283" contenteditable="true">Teede</surname><!--punc--> <!--punc--><given-names store="1284" contenteditable="true">H</given-names></name><!--punc-->, <!--punc--><name store="1285" contenteditable="true"><surname store="1286" contenteditable="true">Tassone</surname><!--punc--> <!--punc--><given-names store="1287" contenteditable="true">EC</given-names></name><!--punc-->, <!--punc--><name store="1288" contenteditable="true"><surname store="1289" contenteditable="true">Piltonen</surname><!--punc--> <!--punc--><given-names store="1290" contenteditable="true">T</given-names></name><!--punc-->, <!--punc--><name store="1291" contenteditable="true"><surname store="1292" contenteditable="true">Malhotra</surname><!--punc--> <!--punc--><given-names store="1293" contenteditable="true">J</given-names></name><!--punc-->, <!--punc--><name store="1294" contenteditable="true"><surname store="1295" contenteditable="true">Mol</surname><!--punc--> <!--punc--><given-names store="1296" contenteditable="true">BW</given-names></name><!--punc-->, <!--punc--><name store="1297" contenteditable="true"><surname store="1298" contenteditable="true">Peña</surname><!--punc--> <!--punc--><given-names store="1299" contenteditable="true">A</given-names></name><!--punc-->, <!--punc--><name store="1300" contenteditable="true"><surname store="1301" contenteditable="true">Witchel</surname><!--punc--> <!--punc--><given-names store="1302" contenteditable="true">SF</given-names></name><!--punc-->, <!--punc--><name store="1303" contenteditable="true"><surname store="1304" contenteditable="true">Joham</surname><!--punc--> <!--punc--><given-names store="1305" contenteditable="true">A</given-names></name><!--punc-->, <!--punc--><name store="1306" contenteditable="true"><surname store="1307" contenteditable="true">McAllister</surname><!--punc--> <!--punc--><given-names store="1308" contenteditable="true">V</given-names></name><!--punc-->, <!--punc--><name store="1309" contenteditable="true"><surname store="1310" contenteditable="true">Romualdi</surname><!--punc--> <!--punc--><given-names store="1311" contenteditable="true">D</given-names></name></person-group><delimiter store="1312" contenteditable="true">, </delimiter><i store="1313" contenteditable="true">et al.</i><delimiter store="1314" contenteditable="true"> </delimiter><article-title store="1315" contenteditable="true">Effect of the combined oral contraceptive pill and/or metformin in the management of polycystic ovary syndrome: a systematic review with meta-analyses</article-title><delimiter store="1316" contenteditable="true">. </delimiter><source1 store="1317" contenteditable="true"><i store="1318" contenteditable="true">Clinical Endocrinology</i></source1><delimiter store="1319" contenteditable="true"> </delimiter><year store="1320" contenteditable="true">2019</year><delimiter store="1321" contenteditable="true"> </delimiter><volume1 store="1322" contenteditable="true"><!--punc--><b store="1323" contenteditable="true"><!--punc-->91<!--punc--></b><!--punc--></volume1><delimiter store="1324" contenteditable="true"> </delimiter><fpage1 store="1325" contenteditable="true">479</fpage1><delimiter store="1326" contenteditable="true">–</delimiter><lpage1 store="1327" contenteditable="true">489</lpage1><delimiter store="1328" contenteditable="true">. </delimiter><pub-id store="1329" contenteditable="true">(https://doi.org/10.1111/cen.14013)</pub-id></mixed-citation></ref><ref id="CIT00019" store="1330" contenteditable="true"><label1 store="1331" contenteditable="true">19. </label1><mixed-citation publication-type="journal" store="1332" contenteditable="true"><person-group person-group-type="author" store="1333" contenteditable="true"><name store="1334" contenteditable="true"><surname store="1335" contenteditable="true">Glueck</surname><!--punc--> <!--punc--><given-names store="1336" contenteditable="true">CJ</given-names></name><!--punc-->, <!--punc--><name store="1337" contenteditable="true"><surname store="1338" contenteditable="true">Aregawi</surname><!--punc--> <!--punc--><given-names store="1339" contenteditable="true">D</given-names></name><!--punc-->, <!--punc--><name store="1340" contenteditable="true"><surname store="1341" contenteditable="true">Agloria</surname><!--punc--> <!--punc--><given-names store="1342" contenteditable="true">M</given-names></name><!--punc-->, <!--punc--><name store="1343" contenteditable="true"><surname store="1344" contenteditable="true">Winiarska</surname><!--punc--> <!--punc--><given-names store="1345" contenteditable="true">M</given-names></name><!--punc-->, <!--punc--><name store="1346" contenteditable="true"><surname store="1347" contenteditable="true">Sieve</surname><!--punc--> <!--punc--><given-names store="1348" contenteditable="true">L</given-names></name><!--punc--> &amp; <!--punc--><name store="1349" contenteditable="true"><surname store="1350" contenteditable="true">Wang</surname><!--punc--> <!--punc--><given-names store="1351" contenteditable="true" style="" class="">P</given-names></name></person-group><delimiter store="1352" contenteditable="true">. </delimiter><article-title store="1353" contenteditable="true">Sustainability of 8% weight loss, reduction of insulin resistance, and amelioration of atherogenic-metabolic risk factors over 4 years by metformin-diet in women with polycystic ovary syndrome</article-title><delimiter store="1354" contenteditable="true">. </delimiter><source1 store="1355" contenteditable="true"><i store="1356" contenteditable="true">Metabolism: Clinical and Experimental</i></source1><delimiter store="1357" contenteditable="true"> </delimiter><year store="1358" contenteditable="true">2006</year><delimiter store="1359" contenteditable="true"> </delimiter><volume1 store="1360" contenteditable="true"><!--punc--><b store="1361" contenteditable="true"><!--punc-->55<!--punc--></b><!--punc--></volume1><delimiter store="1362" contenteditable="true"> </delimiter><fpage1 store="1363" contenteditable="true">1582</fpage1><delimiter store="1364" contenteditable="true">–</delimiter><lpage1 store="1365" contenteditable="true">1589</lpage1><delimiter store="1366" contenteditable="true">. </delimiter><pub-id store="1367" contenteditable="true">(https://doi.org/10.1016/j.metabol.2006.08.001)</pub-id><delimiter store="1368" contenteditable="true"> </delimiter></mixed-citation></ref><ref id="CIT00020" store="1369" contenteditable="true"><label1 store="1370" contenteditable="true">20. </label1><mixed-citation publication-type="journal" store="1371" contenteditable="true"><person-group person-group-type="author" store="1372" contenteditable="true"><name store="1373" contenteditable="true"><surname store="1374" contenteditable="true">Franks</surname><!--punc--> <!--punc--><given-names store="1375" contenteditable="true">S</given-names></name></person-group><delimiter store="1376" contenteditable="true">. </delimiter><article-title store="1377" contenteditable="true">When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?</article-title><delimiter store="1378" contenteditable="true"> </delimiter><source1 store="1379" contenteditable="true"><i store="1380" contenteditable="true">Clinical Endocrinology</i></source1><delimiter store="1381" contenteditable="true"> </delimiter><year store="1382" contenteditable="true">2011</year><delimiter store="1383" contenteditable="true"> </delimiter><volume1 store="1384" contenteditable="true"><!--punc--><b store="1385" contenteditable="true"><!--punc-->74<!--punc--></b><!--punc--></volume1><delimiter store="1386" contenteditable="true"> </delimiter><fpage1 store="1387" contenteditable="true">148</fpage1><delimiter store="1388" contenteditable="true">–</delimiter><lpage1 store="1389" contenteditable="true">151</lpage1><delimiter store="1390" contenteditable="true">. </delimiter><pub-id store="1391" contenteditable="true">(https://doi.org/10.1111/j.1365-2265.2010.03934.x)</pub-id><delimiter store="1392" contenteditable="true"> </delimiter></mixed-citation></ref><ref id="CIT00021" store="1393" contenteditable="true"><label1 store="1394" contenteditable="true">21. </label1><mixed-citation publication-type="journal" store="1395" contenteditable="true"><person-group person-group-type="author" store="1396" contenteditable="true"><name store="1397" contenteditable="true"><surname store="1398" contenteditable="true">Norman</surname><!--punc--> <!--punc--><given-names store="1399" contenteditable="true">RJ</given-names></name><!--punc-->, <!--punc--><name store="1400" contenteditable="true"><surname store="1401" contenteditable="true">Davies</surname><!--punc--> <!--punc--><given-names store="1402" contenteditable="true">MJ</given-names></name><!--punc-->, <!--punc--><name store="1403" contenteditable="true"><surname store="1404" contenteditable="true">Lord</surname><!--punc--> <!--punc--><given-names store="1405" contenteditable="true">J</given-names></name><!--punc--> &amp; <!--punc--><name store="1406" contenteditable="true"><surname store="1407" contenteditable="true">Moran</surname><!--punc--> <!--punc--><given-names store="1408" contenteditable="true">LJ</given-names></name></person-group><delimiter store="1409" contenteditable="true">. </delimiter><article-title store="1410" contenteditable="true">The role of lifestyle modification in polycystic ovary syndrome</article-title><delimiter store="1411" contenteditable="true">. </delimiter><source1 store="1412" contenteditable="true"><i store="1413" contenteditable="true">Trends in Endocrinology and Metabolism</i></source1><delimiter store="1414" contenteditable="true"> </delimiter><year store="1415" contenteditable="true">2002</year><delimiter store="1416" contenteditable="true"> </delimiter><volume1 store="1417" contenteditable="true"><!--punc--><b store="1418" contenteditable="true"><!--punc-->13<!--punc--></b><!--punc--></volume1><delimiter store="1419" contenteditable="true"> </delimiter><fpage1 store="1420" contenteditable="true">251</fpage1><delimiter store="1421" contenteditable="true">–</delimiter><lpage1 store="1422" contenteditable="true">257</lpage1><delimiter store="1423" contenteditable="true">. </delimiter><pub-id store="1424" contenteditable="true">(https://doi.org/10.1016/s1043-2760(02)00612-4)</pub-id><delimiter store="1425" contenteditable="true"> </delimiter></mixed-citation></ref><ref id="CIT00022" store="1426" contenteditable="true"><label1 store="1427" contenteditable="true">22. </label1><mixed-citation publication-type="journal" store="1428" contenteditable="true"><person-group person-group-type="author" store="1429" contenteditable="true"><name store="1430" contenteditable="true"><surname store="1431" contenteditable="true">Velázquez</surname><!--punc--> <!--punc--><given-names store="1432" contenteditable="true">E</given-names></name><!--punc-->, <!--punc--><name store="1433" contenteditable="true"><surname store="1434" contenteditable="true">Acosta</surname><!--punc--> <!--punc--><given-names store="1435" contenteditable="true">A</given-names></name><!--punc--> &amp; <!--punc--><name store="1436" contenteditable="true"><surname store="1437" contenteditable="true">Mendoza</surname><!--punc--> <!--punc--><given-names store="1438" contenteditable="true">SG</given-names></name></person-group><delimiter store="1439" contenteditable="true">. </delimiter><article-title store="1440" contenteditable="true">Menstrual cyclicity after metformin therapy in polycystic ovary syndrome</article-title><delimiter store="1441" contenteditable="true">. </delimiter><source1 store="1442" contenteditable="true"><i store="1443" contenteditable="true">Obstetrics and Gynecology</i></source1><delimiter store="1444" contenteditable="true"> </delimiter><year store="1445" contenteditable="true">1997</year><delimiter store="1446" contenteditable="true"> </delimiter><volume1 store="1447" contenteditable="true"><!--punc--><b store="1448" contenteditable="true"><!--punc-->90<!--punc--></b><!--punc--></volume1><delimiter store="1449" contenteditable="true"> </delimiter><fpage1 store="1450" contenteditable="true">392</fpage1><delimiter store="1451" contenteditable="true">–</delimiter><lpage1 store="1452" contenteditable="true">395</lpage1><delimiter store="1453" contenteditable="true">. </delimiter><pub-id store="1454" contenteditable="true">(https://doi.org/10.1016/s0029-7844(97)00296-2)</pub-id><delimiter store="1455" contenteditable="true"> </delimiter></mixed-citation></ref><ref id="CIT00023" store="1456" contenteditable="true"><label1 store="1457" contenteditable="true">23. </label1><mixed-citation publication-type="journal" store="1458" contenteditable="true"><person-group person-group-type="author" store="1459" contenteditable="true"><name store="1460" contenteditable="true"><surname store="1461" contenteditable="true">Kiddy</surname><!--punc--> <!--punc--><given-names store="1462" contenteditable="true">DS</given-names></name><!--punc-->, <!--punc--><name store="1463" contenteditable="true"><surname store="1464" contenteditable="true">Hamilton-Fairley</surname><!--punc--> <!--punc--><given-names store="1465" contenteditable="true">D</given-names></name><!--punc-->, <!--punc--><name store="1466" contenteditable="true"><surname store="1467" contenteditable="true">Bush</surname><!--punc--> <!--punc--><given-names store="1468" contenteditable="true">A</given-names></name><!--punc-->, <!--punc--><name store="1469" contenteditable="true"><surname store="1470" contenteditable="true">Short</surname><!--punc--> <!--punc--><given-names store="1471" contenteditable="true">F</given-names></name><!--punc-->, <!--punc--><name store="1472" contenteditable="true"><surname store="1473" contenteditable="true">Anyaoku</surname><!--punc--> <!--punc--><given-names store="1474" contenteditable="true">V</given-names></name><!--punc-->, <!--punc--><name store="1475" contenteditable="true"><surname store="1476" contenteditable="true">Reed</surname><!--punc--> <!--punc--><given-names store="1477" contenteditable="true">MJ</given-names></name><!--punc--> &amp; <!--punc--><name store="1478" contenteditable="true"><surname store="1479" contenteditable="true">Franks</surname><!--punc--> <!--punc--><given-names store="1480" contenteditable="true">S</given-names></name></person-group><delimiter store="1481" contenteditable="true">. </delimiter><article-title store="1482" contenteditable="true">Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome</article-title><delimiter store="1483" contenteditable="true">. </delimiter><source1 store="1484" contenteditable="true"><i store="1485" contenteditable="true">Clinical Endocrinology</i></source1><delimiter store="1486" contenteditable="true"> </delimiter><year store="1487" contenteditable="true">1992</year><delimiter store="1488" contenteditable="true"> </delimiter><volume1 store="1489" contenteditable="true"><!--punc--><b store="1490" contenteditable="true"><!--punc-->36<!--punc--></b><!--punc--></volume1><delimiter store="1491" contenteditable="true"> </delimiter><fpage1 store="1492" contenteditable="true">105</fpage1><delimiter store="1493" contenteditable="true">–</delimiter><lpage1 store="1494" contenteditable="true">111</lpage1><delimiter store="1495" contenteditable="true">. </delimiter><pub-id store="1496" contenteditable="true">(https://doi.org/10.1111/j.1365-2265.1992.tb02909.x)</pub-id><delimiter store="1497" contenteditable="true"> </delimiter></mixed-citation></ref><ref id="CIT00024" store="1498" contenteditable="true"><label1 store="1499" contenteditable="true">24. </label1><mixed-citation publication-type="journal" store="1500" contenteditable="true"><collab store="1501" contenteditable="true">Look AHEAD Research Group</collab><delimiter store="1502" contenteditable="true">, </delimiter><person-group person-group-type="author" store="1503" contenteditable="true"><name store="1504" contenteditable="true"><surname store="1505" contenteditable="true">Wing</surname><!--punc--> <!--punc--><given-names store="1506" contenteditable="true">RR</given-names></name><!--punc-->, <!--punc--><name store="1507" contenteditable="true"><surname store="1508" contenteditable="true">Bolin</surname><!--punc--> <!--punc--><given-names store="1509" contenteditable="true" style="" class="">P</given-names></name><!--punc-->, <!--punc--><name store="1510" contenteditable="true"><surname store="1511" contenteditable="true">Brancati</surname><!--punc--> <!--punc--><given-names store="1512" contenteditable="true">FL</given-names></name><!--punc-->, <!--punc--><name store="1513" contenteditable="true"><surname store="1514" contenteditable="true">Bray</surname><!--punc--> <!--punc--><given-names store="1515" contenteditable="true">GA</given-names></name><!--punc-->, <!--punc--><name store="1516" contenteditable="true"><surname store="1517" contenteditable="true">Clark</surname><!--punc--> <!--punc--><given-names store="1518" contenteditable="true">JM</given-names></name><!--punc-->, <!--punc--><name store="1519" contenteditable="true"><surname store="1520" contenteditable="true">Coday</surname><!--punc--> <!--punc--><given-names store="1521" contenteditable="true">M</given-names></name><!--punc-->, <!--punc--><name store="1522" contenteditable="true"><surname store="1523" contenteditable="true">Crow</surname><!--punc--> <!--punc--><given-names store="1524" contenteditable="true">RS</given-names></name><!--punc-->, <!--punc--><name store="1525" contenteditable="true"><surname store="1526" contenteditable="true">Curtis</surname><!--punc--> <!--punc--><given-names store="1527" contenteditable="true">JM</given-names></name><!--punc-->, <!--punc--><name store="1528" contenteditable="true"><surname store="1529" contenteditable="true">Egan</surname><!--punc--> <!--punc--><given-names store="1530" contenteditable="true">CM</given-names></name></person-group><delimiter store="1531" contenteditable="true">, </delimiter><i store="1532" contenteditable="true">et al.</i><delimiter store="1533" contenteditable="true"> </delimiter><article-title store="1534" contenteditable="true">Cardiovascular effects of intensive lifestyle intervention in Type 2 diabetes</article-title><delimiter store="1535" contenteditable="true">. </delimiter><source1 store="1536" contenteditable="true"><i store="1537" contenteditable="true">New England Journal of Medicine</i></source1><delimiter store="1538" contenteditable="true"> </delimiter><year store="1539" contenteditable="true">2013</year><delimiter store="1540" contenteditable="true"> </delimiter><volume1 store="1541" contenteditable="true"><!--punc--><b store="1542" contenteditable="true"><!--punc-->369<!--punc--></b><!--punc--></volume1><delimiter store="1543" contenteditable="true"> </delimiter><fpage1 store="1544" contenteditable="true">145</fpage1><delimiter store="1545" contenteditable="true">–</delimiter><lpage1 store="1546" contenteditable="true">154</lpage1><delimiter store="1547" contenteditable="true">. </delimiter><pub-id store="1548" contenteditable="true">(https://doi.org/10.1056/NEJMoa1212914)</pub-id><delimiter store="1549" contenteditable="true"> </delimiter></mixed-citation></ref><ref id="CIT00025" store="1550" contenteditable="true"><label1 store="1551" contenteditable="true">25. </label1><mixed-citation publication-type="journal" store="1552" contenteditable="true"><person-group person-group-type="author" store="1553" contenteditable="true"><name store="1554" contenteditable="true"><surname store="1555" contenteditable="true">Glueck</surname><!--punc--> <!--punc--><given-names store="1556" contenteditable="true">CJ</given-names></name><!--punc-->, <!--punc--><name store="1557" contenteditable="true"><surname store="1558" contenteditable="true">Dharashivkar</surname><!--punc--> <!--punc--><given-names store="1559" contenteditable="true">S</given-names></name><!--punc-->, <!--punc--><name store="1560" contenteditable="true"><surname store="1561" contenteditable="true">Wang</surname><!--punc--> <!--punc--><given-names store="1562" contenteditable="true" style="" class="">P</given-names></name><!--punc-->, <!--punc--><name store="1563" contenteditable="true"><surname store="1564" contenteditable="true">Zhu</surname><!--punc--> <!--punc--><given-names store="1565" contenteditable="true">B</given-names></name><!--punc-->, <!--punc--><name store="1566" contenteditable="true"><surname store="1567" contenteditable="true">Gartside</surname><!--punc--> <!--punc--><given-names store="1568" contenteditable="true">PS</given-names></name><!--punc-->, <!--punc--><name store="1569" contenteditable="true"><surname store="1570" contenteditable="true">Tracy</surname><!--punc--> <!--punc--><given-names store="1571" contenteditable="true">T</given-names></name><!--punc--> &amp; <!--punc--><name store="1572" contenteditable="true"><surname store="1573" contenteditable="true">Sieve</surname><!--punc--> <!--punc--><given-names store="1574" contenteditable="true">L</given-names></name></person-group><delimiter store="1575" contenteditable="true">. </delimiter><article-title store="1576" contenteditable="true">Obesity and extreme obesity, manifest by ages 20–24 years, continuing through 32–41 years in women, should alert physicians to the diagnostic likelihood of polycystic ovary syndrome as a reversible underlying endocrinopathy</article-title><delimiter store="1577" contenteditable="true">. </delimiter><source1 store="1578" contenteditable="true"><i store="1579" contenteditable="true">European Journal of Obstetrics, Gynecology, and Reproductive Biology</i></source1><delimiter store="1580" contenteditable="true"> </delimiter><year store="1581" contenteditable="true">2005</year><delimiter store="1582" contenteditable="true"> </delimiter><volume1 store="1583" contenteditable="true"><!--punc--><b store="1584" contenteditable="true"><!--punc-->122<!--punc--></b><!--punc--></volume1><delimiter store="1585" contenteditable="true"> </delimiter><fpage1 store="1586" contenteditable="true">206</fpage1><delimiter store="1587" contenteditable="true">–</delimiter><lpage1 store="1588" contenteditable="true">212</lpage1><delimiter store="1589" contenteditable="true">. </delimiter><pub-id store="1590" contenteditable="true">(https://doi.org/10.1016/j.ejogrb.2005.03.010)</pub-id><delimiter store="1591" contenteditable="true"> </delimiter></mixed-citation></ref><ref id="CIT00026" store="1592" contenteditable="true"><label1 store="1593" contenteditable="true">26. </label1><mixed-citation publication-type="journal" store="1594" contenteditable="true"><person-group person-group-type="author" store="1595" contenteditable="true"><name store="1596" contenteditable="true"><surname store="1597" contenteditable="true">Glueck</surname><!--punc--> <!--punc--><given-names store="1598" contenteditable="true">CJ</given-names></name><!--punc-->, <!--punc--><name store="1599" contenteditable="true"><surname store="1600" contenteditable="true">Wang</surname><!--punc--> <!--punc--><given-names store="1601" contenteditable="true" style="" class="">P</given-names></name><!--punc-->, <!--punc--><name store="1602" contenteditable="true"><surname store="1603" contenteditable="true">Fontaine</surname><!--punc--> <!--punc--><given-names store="1604" contenteditable="true">R</given-names></name><!--punc-->, <!--punc--><name store="1605" contenteditable="true"><surname store="1606" contenteditable="true">Tracy</surname><!--punc--> <!--punc--><given-names store="1607" contenteditable="true">T</given-names></name><!--punc--> &amp; <!--punc--><name store="1608" contenteditable="true"><surname store="1609" contenteditable="true">Sieve-Smith</surname><!--punc--> <!--punc--><given-names store="1610" contenteditable="true">L</given-names></name></person-group><delimiter store="1611" contenteditable="true">. </delimiter><article-title store="1612" contenteditable="true">Metformin to restore normal menses in oligo-amenorrheic teenage girls with polycystic ovary syndrome (PCOS)</article-title><delimiter store="1613" contenteditable="true">. </delimiter><source1 store="1614" contenteditable="true"><i store="1615" contenteditable="true">Journal of Adolescent Health</i></source1><delimiter store="1616" contenteditable="true"> </delimiter><year store="1617" contenteditable="true">2001</year><delimiter store="1618" contenteditable="true"> </delimiter><volume1 store="1619" contenteditable="true"><!--punc--><b store="1620" contenteditable="true"><!--punc-->29<!--punc--></b><!--punc--></volume1><delimiter store="1621" contenteditable="true"> </delimiter><fpage1 store="1622" contenteditable="true">160</fpage1><delimiter store="1623" contenteditable="true">–</delimiter><lpage1 store="1624" contenteditable="true">169</lpage1><delimiter store="1625" contenteditable="true">. </delimiter><pub-id store="1626" contenteditable="true">(https://doi.org/10.1016/s1054-139x(01)00202-6)</pub-id><delimiter store="1627" contenteditable="true"> </delimiter></mixed-citation></ref><ref id="CIT00027" store="1628" contenteditable="true"><label1 store="1629" contenteditable="true">27. </label1><mixed-citation publication-type="journal" store="1630" contenteditable="true"><person-group person-group-type="author" store="1631" contenteditable="true"><name store="1632" contenteditable="true"><surname store="1633" contenteditable="true">Ollila</surname><!--punc--> <!--punc--><given-names store="1634" contenteditable="true">MM</given-names></name><!--punc-->, <!--punc--><name store="1635" contenteditable="true"><surname store="1636" contenteditable="true">Piltonen</surname><!--punc--> <!--punc--><given-names store="1637" contenteditable="true">T</given-names></name><!--punc-->, <!--punc--><name store="1638" contenteditable="true"><surname store="1639" contenteditable="true">Puukka</surname><!--punc--> <!--punc--><given-names store="1640" contenteditable="true">K</given-names></name><!--punc-->, <!--punc--><name store="1641" contenteditable="true"><surname store="1642" contenteditable="true">Ruokonen</surname><!--punc--> <!--punc--><given-names store="1643" contenteditable="true">A</given-names></name><!--punc-->, <!--punc--><name store="1644" contenteditable="true"><surname store="1645" contenteditable="true">Järvelin</surname><!--punc--> <!--punc--><given-names store="1646" contenteditable="true">MR</given-names></name><!--punc-->, <!--punc--><name store="1647" contenteditable="true"><surname store="1648" contenteditable="true">Tapanainen</surname><!--punc--> <!--punc--><given-names store="1649" contenteditable="true">JS</given-names></name><!--punc-->, <!--punc--><name store="1650" contenteditable="true"><surname store="1651" contenteditable="true">Franks</surname><!--punc--> <!--punc--><given-names store="1652" contenteditable="true">S</given-names></name><!--punc--> &amp; <!--punc--><name store="1653" contenteditable="true"><surname store="1654" contenteditable="true">Morin-Papunen</surname><!--punc--> <!--punc--><given-names store="1655" contenteditable="true">L</given-names></name></person-group><delimiter store="1656" contenteditable="true">. </delimiter><article-title store="1657" contenteditable="true">Weight gain and dyslipidemia in early adulthood associate with polycystic ovary syndrome: prospective cohort study</article-title><delimiter store="1658" contenteditable="true">. </delimiter><source1 store="1659" contenteditable="true"><i store="1660" contenteditable="true">Journal of Clinical Endocrinology and Metabolism</i></source1><delimiter store="1661" contenteditable="true"> </delimiter><year store="1662" contenteditable="true">2016</year><delimiter store="1663" contenteditable="true"> </delimiter><volume1 store="1664" contenteditable="true"><!--punc--><b store="1665" contenteditable="true"><!--punc-->101<!--punc--></b><!--punc--></volume1><delimiter store="1666" contenteditable="true"> </delimiter><fpage1 store="1667" contenteditable="true">739</fpage1><delimiter store="1668" contenteditable="true">–</delimiter><lpage1 store="1669" contenteditable="true">747</lpage1><delimiter store="1670" contenteditable="true">. </delimiter><pub-id store="1671" contenteditable="true">(https://doi.org/10.1210/jc.2015-3543)</pub-id></mixed-citation></ref><ref id="CIT00028" store="1672" contenteditable="true"><label1 store="1673" contenteditable="true">28. </label1><mixed-citation publication-type="journal" store="1674" contenteditable="true"><person-group person-group-type="author" store="1675" contenteditable="true"><name store="1676" contenteditable="true"><surname store="1677" contenteditable="true">Seifarth</surname><!--punc--> <!--punc--><given-names store="1678" contenteditable="true">C</given-names></name><!--punc-->, <!--punc--><name store="1679" contenteditable="true"><surname store="1680" contenteditable="true">Schehler</surname><!--punc--> <!--punc--><given-names store="1681" contenteditable="true">B</given-names></name><!--punc--> &amp; <!--punc--><name store="1682" contenteditable="true"><surname store="1683" contenteditable="true">Schneider</surname><!--punc--> <!--punc--><given-names store="1684" contenteditable="true">HJ</given-names></name></person-group><delimiter store="1685" contenteditable="true">. </delimiter><article-title store="1686" contenteditable="true">Effectiveness of metformin on weight loss in non-diabetic individuals with obesity</article-title><delimiter store="1687" contenteditable="true">. </delimiter><source1 store="1688" contenteditable="true"><i store="1689" contenteditable="true">Experimental and Clinical Endocrinology and Diabetes</i></source1><delimiter store="1690" contenteditable="true"> </delimiter><year store="1691" contenteditable="true">2013</year><delimiter store="1692" contenteditable="true"> </delimiter><volume1 store="1693" contenteditable="true"><!--punc--><b store="1694" contenteditable="true"><!--punc-->121<!--punc--></b><!--punc--></volume1><delimiter store="1695" contenteditable="true"> </delimiter><fpage1 store="1696" contenteditable="true">27</fpage1><delimiter store="1697" contenteditable="true">–</delimiter><lpage1 store="1698" contenteditable="true">31</lpage1><delimiter store="1699" contenteditable="true">. </delimiter><pub-id store="1700" contenteditable="true">(https://doi.org/10.1055/s-0032-1327734)</pub-id><delimiter store="1701" contenteditable="true"> </delimiter></mixed-citation></ref><ref id="CIT00029" store="1702" contenteditable="true"><label1 store="1703" contenteditable="true">29. </label1><mixed-citation publication-type="journal" store="1704" contenteditable="true"><person-group person-group-type="author" store="1705" contenteditable="true"><name store="1706" contenteditable="true"><surname store="1707" contenteditable="true">Tosi</surname><!--punc--> <!--punc--><given-names store="1708" contenteditable="true">F</given-names></name><!--punc-->, <!--punc--><name store="1709" contenteditable="true"><surname store="1710" contenteditable="true">Di Sarra</surname><!--punc--> <!--punc--><given-names store="1711" contenteditable="true">D</given-names></name><!--punc-->, <!--punc--><name store="1712" contenteditable="true"><surname store="1713" contenteditable="true">Kaufman</surname><!--punc--> <!--punc--><given-names store="1714" contenteditable="true">JM</given-names></name><!--punc-->, <!--punc--><name store="1715" contenteditable="true"><surname store="1716" contenteditable="true">Bonin</surname><!--punc--> <!--punc--><given-names store="1717" contenteditable="true">C</given-names></name><!--punc-->, <!--punc--><name store="1718" contenteditable="true"><surname store="1719" contenteditable="true">Moretta</surname><!--punc--> <!--punc--><given-names store="1720" contenteditable="true">R</given-names></name><!--punc-->, <!--punc--><name store="1721" contenteditable="true"><surname store="1722" contenteditable="true">Bonora</surname><!--punc--> <!--punc--><given-names store="1723" contenteditable="true">E</given-names></name><!--punc-->, <!--punc--><name store="1724" contenteditable="true"><surname store="1725" contenteditable="true">Zanolin</surname><!--punc--> <!--punc--><given-names store="1726" contenteditable="true">E</given-names></name><!--punc--> &amp; <!--punc--><name store="1727" contenteditable="true"><surname store="1728" contenteditable="true">Moghetti</surname><!--punc--> <!--punc--><given-names store="1729" contenteditable="true" style="" class="">P</given-names></name></person-group><delimiter store="1730" contenteditable="true">. </delimiter><article-title store="1731" contenteditable="true">Total body fat and central fat mass independently predict insulin resistance but not hyperandrogenemia in women with polycystic ovary syndrome</article-title><delimiter store="1732" contenteditable="true">. </delimiter><source1 store="1733" contenteditable="true"><i store="1734" contenteditable="true">Journal of Clinical Endocrinology and Metabolism</i></source1><delimiter store="1735" contenteditable="true"> </delimiter><year store="1736" contenteditable="true">2015</year><delimiter store="1737" contenteditable="true"> </delimiter><volume1 store="1738" contenteditable="true"><!--punc--><b store="1739" contenteditable="true"><!--punc-->100<!--punc--></b><!--punc--></volume1><delimiter store="1740" contenteditable="true"> </delimiter><fpage1 store="1741" contenteditable="true">661</fpage1><delimiter store="1742" contenteditable="true">–</delimiter><lpage1 store="1743" contenteditable="true">669</lpage1><delimiter store="1744" contenteditable="true">. </delimiter><pub-id store="1745" contenteditable="true">(https://doi.org/10.1210/jc.2014-2786)</pub-id></mixed-citation></ref><ref id="CIT00030" store="1746" contenteditable="true"><label1 store="1747" contenteditable="true">30. </label1><mixed-citation publication-type="journal" store="1748" contenteditable="true"><person-group person-group-type="author" store="1749" contenteditable="true"><name store="1750" contenteditable="true"><surname store="1751" contenteditable="true">Yang</surname><!--punc--> <!--punc--><given-names store="1752" contenteditable="true">PK</given-names></name><!--punc-->, <!--punc--><name store="1753" contenteditable="true"><surname store="1754" contenteditable="true">Hsu</surname><!--punc--> <!--punc--><given-names store="1755" contenteditable="true">CY</given-names></name><!--punc-->, <!--punc--><name store="1756" contenteditable="true"><surname store="1757" contenteditable="true">Chen</surname><!--punc--> <!--punc--><given-names store="1758" contenteditable="true">MJ</given-names></name><!--punc-->, <!--punc--><name store="1759" contenteditable="true"><surname store="1760" contenteditable="true">Lai</surname><!--punc--> <!--punc--><given-names store="1761" contenteditable="true">MY</given-names></name><!--punc-->, <!--punc--><name store="1762" contenteditable="true"><surname store="1763" contenteditable="true">Li</surname><!--punc--> <!--punc--><given-names store="1764" contenteditable="true">ZR</given-names></name><!--punc-->, <!--punc--><name store="1765" contenteditable="true"><surname store="1766" contenteditable="true">Chen</surname><!--punc--> <!--punc--><given-names store="1767" contenteditable="true">CH</given-names></name><!--punc-->, <!--punc--><name store="1768" contenteditable="true"><surname store="1769" contenteditable="true">Chen</surname><!--punc--> <!--punc--><given-names store="1770" contenteditable="true">SU</given-names></name><!--punc--> &amp; <!--punc--><name store="1771" contenteditable="true"><surname store="1772" contenteditable="true">Ho</surname><!--punc--> <!--punc--><given-names store="1773" contenteditable="true">HN</given-names></name></person-group><delimiter store="1774" contenteditable="true">. </delimiter><article-title store="1775" contenteditable="true">The efficacy of 24-month metformin for improving menses, hormones, and metabolic profiles in polycystic ovary syndrome</article-title><delimiter store="1776" contenteditable="true">. </delimiter><source1 store="1777" contenteditable="true"><i store="1778" contenteditable="true">Journal of Clinical Endocrinology and Metabolism</i></source1><delimiter store="1779" contenteditable="true"> </delimiter><year store="1780" contenteditable="true">2018</year><delimiter store="1781" contenteditable="true"> </delimiter><volume1 store="1782" contenteditable="true"><!--punc--><b store="1783" contenteditable="true"><!--punc-->103<!--punc--></b><!--punc--></volume1><delimiter store="1784" contenteditable="true"> </delimiter><fpage1 store="1785" contenteditable="true">890</fpage1><delimiter store="1786" contenteditable="true">–</delimiter><lpage1 store="1787" contenteditable="true">899</lpage1><delimiter store="1788" contenteditable="true">. </delimiter><pub-id store="1789" contenteditable="true">(https://doi.org/10.1210/jc.2017-01739)</pub-id><delimiter store="1790" contenteditable="true"> </delimiter></mixed-citation></ref><ref id="CIT00031" store="1791" contenteditable="true"><label1 store="1792" contenteditable="true">31. </label1><mixed-citation publication-type="journal" store="1793" contenteditable="true"><person-group person-group-type="author" store="1794" contenteditable="true"><name store="1795" contenteditable="true"><surname store="1796" contenteditable="true">Van Anders</surname><!--punc--> <!--punc--><given-names store="1797" contenteditable="true">SM</given-names></name><!--punc--> &amp; <!--punc--><name store="1798" contenteditable="true"><surname store="1799" contenteditable="true">Watson</surname><!--punc--> <!--punc--><given-names store="1800" contenteditable="true">NV</given-names></name></person-group><delimiter store="1801" contenteditable="true">. </delimiter><article-title store="1802" contenteditable="true">Menstrual cycle irregularities are associated with testosterone levels in healthy premenopausal women</article-title><delimiter store="1803" contenteditable="true">. </delimiter><source1 store="1804" contenteditable="true"><i store="1805" contenteditable="true">American Journal of Human Biology</i></source1><delimiter store="1806" contenteditable="true"> </delimiter><year store="1807" contenteditable="true">2006</year><delimiter store="1808" contenteditable="true"> </delimiter><volume1 store="1809" contenteditable="true"><!--punc--><b store="1810" contenteditable="true"><!--punc-->18<!--punc--></b><!--punc--></volume1><delimiter store="1811" contenteditable="true"> </delimiter><fpage1 store="1812" contenteditable="true">841</fpage1><delimiter store="1813" contenteditable="true">–</delimiter><lpage1 store="1814" contenteditable="true">844</lpage1><delimiter store="1815" contenteditable="true">. </delimiter><pub-id store="1816" contenteditable="true">(https://doi.org/10.1002/ajhb.20555)</pub-id><delimiter store="1817" contenteditable="true"> </delimiter></mixed-citation></ref><ref id="CIT00032" store="1818" contenteditable="true"><label1 store="1819" contenteditable="true">32. </label1><mixed-citation publication-type="journal" store="1820" contenteditable="true"><person-group person-group-type="author" store="1821" contenteditable="true"><name store="1822" contenteditable="true"><surname store="1823" contenteditable="true">Nestler</surname><!--punc--> <!--punc--><given-names store="1824" contenteditable="true">JE</given-names></name><!--punc--> &amp; <!--punc--><name store="1825" contenteditable="true"><surname store="1826" contenteditable="true">Jakubowicz</surname><!--punc--> <!--punc--><given-names store="1827" contenteditable="true">DJ</given-names></name></person-group><delimiter store="1828" contenteditable="true">. </delimiter><article-title store="1829" contenteditable="true">Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome</article-title><delimiter store="1830" contenteditable="true">. </delimiter><source1 store="1831" contenteditable="true"><i store="1832" contenteditable="true">New England Journal of Medicine</i></source1><delimiter store="1833" contenteditable="true"> </delimiter><year store="1834" contenteditable="true">1996</year><delimiter store="1835" contenteditable="true"> </delimiter><volume1 store="1836" contenteditable="true"><!--punc--><b store="1837" contenteditable="true"><!--punc-->335<!--punc--></b><!--punc--></volume1><delimiter store="1838" contenteditable="true"> </delimiter><fpage1 store="1839" contenteditable="true">617</fpage1><delimiter store="1840" contenteditable="true">–</delimiter><lpage1 store="1841" contenteditable="true">623</lpage1><delimiter store="1842" contenteditable="true">. </delimiter><pub-id store="1843" contenteditable="true">(https://doi.org/10.1056/NEJM199608293350902)</pub-id><delimiter store="1844" contenteditable="true"> </delimiter></mixed-citation></ref><ref id="CIT00033" store="1845" contenteditable="true"><label1 store="1846" contenteditable="true">33. </label1><mixed-citation publication-type="journal" store="1847" contenteditable="true"><person-group person-group-type="author" store="1848" contenteditable="true"><name store="1849" contenteditable="true"><surname store="1850" contenteditable="true">Nestler</surname><!--punc--> <!--punc--><given-names store="1851" contenteditable="true">JE</given-names></name><!--punc--> &amp; <!--punc--><name store="1852" contenteditable="true"><surname store="1853" contenteditable="true">Jakubowicz</surname><!--punc--> <!--punc--><given-names store="1854" contenteditable="true">DJ</given-names></name></person-group><delimiter store="1855" contenteditable="true">. </delimiter><article-title store="1856" contenteditable="true">Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens</article-title><delimiter store="1857" contenteditable="true">. </delimiter><source1 store="1858" contenteditable="true"><i store="1859" contenteditable="true">Journal of Clinical Endocrinology and Metabolism</i></source1><delimiter store="1860" contenteditable="true"> </delimiter><year store="1861" contenteditable="true">1997</year><delimiter store="1862" contenteditable="true"> </delimiter><volume1 store="1863" contenteditable="true"><!--punc--><b store="1864" contenteditable="true"><!--punc-->82<!--punc--></b><!--punc--></volume1><delimiter store="1865" contenteditable="true"> </delimiter><fpage1 store="1866" contenteditable="true">4075</fpage1><delimiter store="1867" contenteditable="true">–</delimiter><lpage1 store="1868" contenteditable="true">4079</lpage1><delimiter store="1869" contenteditable="true">. </delimiter><pub-id store="1870" contenteditable="true">(https://doi.org/10.1210/jcem.82.12.4431)</pub-id><delimiter store="1871" contenteditable="true"> </delimiter></mixed-citation></ref><ref id="CIT00034" store="1872" contenteditable="true"><label1 store="1873" contenteditable="true">34. </label1><mixed-citation publication-type="journal" store="1874" contenteditable="true"><person-group person-group-type="author" store="1875" contenteditable="true"><name store="1876" contenteditable="true"><surname store="1877" contenteditable="true">Hirsch</surname><!--punc--> <!--punc--><given-names store="1878" contenteditable="true">A</given-names></name><!--punc-->, <!--punc--><name store="1879" contenteditable="true"><surname store="1880" contenteditable="true">Hahn</surname><!--punc--> <!--punc--><given-names store="1881" contenteditable="true">D</given-names></name><!--punc-->, <!--punc--><name store="1882" contenteditable="true"><surname store="1883" contenteditable="true">Kempná</surname><!--punc--> <!--punc--><given-names store="1884" contenteditable="true" style="" class="">P</given-names></name><!--punc-->, <!--punc--><name store="1885" contenteditable="true"><surname store="1886" contenteditable="true">Hofer</surname><!--punc--> <!--punc--><given-names store="1887" contenteditable="true">G</given-names></name><!--punc-->, <!--punc--><name store="1888" contenteditable="true"><surname store="1889" contenteditable="true">Nuoffer</surname><!--punc--> <!--punc--><given-names store="1890" contenteditable="true">JM</given-names></name><!--punc-->, <!--punc--><name store="1891" contenteditable="true"><surname store="1892" contenteditable="true">Mullis</surname><!--punc--> <!--punc--><given-names store="1893" contenteditable="true">PE</given-names></name><!--punc--> &amp; <!--punc--><name store="1894" contenteditable="true"><surname store="1895" contenteditable="true">Flück</surname><!--punc--> <!--punc--><given-names store="1896" contenteditable="true">CE</given-names></name></person-group><delimiter store="1897" contenteditable="true">. </delimiter><article-title store="1898" contenteditable="true">Metformin inhibits human androgen production by regulating steroidogenic enzymes H<span class="" contenteditable="true">SD</span>3B2 and CYP17A1 and complex I activity of the respiratory chain</article-title><delimiter store="1899" contenteditable="true">. </delimiter><source1 store="1900" contenteditable="true"><i store="1901" contenteditable="true">Endocrinology</i></source1><delimiter store="1902" contenteditable="true"> </delimiter><year store="1903" contenteditable="true">2012</year><delimiter store="1904" contenteditable="true"> </delimiter><volume1 store="1905" contenteditable="true"><!--punc--><b store="1906" contenteditable="true"><!--punc-->153<!--punc--></b><!--punc--></volume1><delimiter store="1907" contenteditable="true"> </delimiter><fpage1 store="1908" contenteditable="true">4354</fpage1><delimiter store="1909" contenteditable="true">–</delimiter><lpage1 store="1910" contenteditable="true">4366</lpage1><delimiter store="1911" contenteditable="true">. </delimiter><pub-id store="1912" contenteditable="true">(https://doi.org/10.1210/en.2012-1145)</pub-id><delimiter store="1913" contenteditable="true"> </delimiter></mixed-citation></ref><ref id="CIT00035" store="1914" contenteditable="true"><label1 store="1915" contenteditable="true">35. </label1><mixed-citation publication-type="journal" store="1916" contenteditable="true"><person-group person-group-type="author" store="1917" contenteditable="true"><name store="1918" contenteditable="true"><surname store="1919" contenteditable="true">Mansfield</surname><!--punc--> <!--punc--><given-names store="1920" contenteditable="true">R</given-names></name><!--punc-->, <!--punc--><name store="1921" contenteditable="true"><surname store="1922" contenteditable="true">Galea</surname><!--punc--> <!--punc--><given-names store="1923" contenteditable="true">R</given-names></name><!--punc-->, <!--punc--><name store="1924" contenteditable="true"><surname store="1925" contenteditable="true">Brincat</surname><!--punc--> <!--punc--><given-names store="1926" contenteditable="true">M</given-names></name><!--punc-->, <!--punc--><name store="1927" contenteditable="true"><surname store="1928" contenteditable="true">Hole</surname><!--punc--> <!--punc--><given-names store="1929" contenteditable="true">D</given-names></name><!--punc--> &amp; <!--punc--><name store="1930" contenteditable="true"><surname store="1931" contenteditable="true">Mason</surname><!--punc--> <!--punc--><given-names store="1932" contenteditable="true">H</given-names></name></person-group><delimiter store="1933" contenteditable="true">. </delimiter><article-title store="1934" contenteditable="true">Metformin has direct effects on human ovarian steroidogenesis</article-title><delimiter store="1935" contenteditable="true">. </delimiter><source1 store="1936" contenteditable="true"><i store="1937" contenteditable="true">Fertility and Sterility</i></source1><delimiter store="1938" contenteditable="true"> </delimiter><year store="1939" contenteditable="true">2003</year><delimiter store="1940" contenteditable="true"> </delimiter><volume1 store="1941" contenteditable="true"><!--punc--><b store="1942" contenteditable="true"><!--punc-->79<!--punc--></b><!--punc--></volume1><delimiter store="1943" contenteditable="true"> </delimiter><fpage1 store="1944" contenteditable="true">956</fpage1><delimiter store="1945" contenteditable="true">–</delimiter><lpage1 store="1946" contenteditable="true">962</lpage1><delimiter store="1947" contenteditable="true">. </delimiter><pub-id store="1948" contenteditable="true">(https://doi.org/10.1016/s0015-0282(02)04925-7)</pub-id><delimiter store="1949" contenteditable="true"> </delimiter></mixed-citation></ref><ref id="CIT00036" store="1950" contenteditable="true"><label1 store="1951" contenteditable="true">36. </label1><mixed-citation publication-type="journal" store="1952" contenteditable="true"><person-group person-group-type="author" store="1953" contenteditable="true"><name store="1954" contenteditable="true"><surname store="1955" contenteditable="true">Attia</surname><!--punc--> <!--punc--><given-names store="1956" contenteditable="true">GR</given-names></name><!--punc-->, <!--punc--><name store="1957" contenteditable="true"><surname store="1958" contenteditable="true">Rainey</surname><!--punc--> <!--punc--><given-names store="1959" contenteditable="true">WE</given-names></name><!--punc--> &amp; <!--punc--><name store="1960" contenteditable="true"><surname store="1961" contenteditable="true">Carr</surname><!--punc--> <!--punc--><given-names store="1962" contenteditable="true">BR</given-names></name></person-group><delimiter store="1963" contenteditable="true">. </delimiter><article-title store="1964" contenteditable="true">Metformin directly inhibits androgen production in human thecal cells</article-title><delimiter store="1965" contenteditable="true">. </delimiter><source1 store="1966" contenteditable="true"><i store="1967" contenteditable="true">Fertility and Sterility</i></source1><delimiter store="1968" contenteditable="true"> </delimiter><year store="1969" contenteditable="true">2001</year><delimiter store="1970" contenteditable="true"> </delimiter><volume1 store="1971" contenteditable="true"><!--punc--><b store="1972" contenteditable="true"><!--punc-->76<!--punc--></b><!--punc--></volume1><delimiter store="1973" contenteditable="true"> </delimiter><fpage1 store="1974" contenteditable="true">517</fpage1><delimiter store="1975" contenteditable="true">–</delimiter><lpage1 store="1976" contenteditable="true">524</lpage1><delimiter store="1977" contenteditable="true">. </delimiter><pub-id store="1978" contenteditable="true">(https://doi.org/10.1016/s0015-0282(01)01975-6)</pub-id><delimiter store="1979" contenteditable="true"> </delimiter></mixed-citation></ref><ref id="CIT00037" store="1980" contenteditable="true"><label1 store="1981" contenteditable="true">37. </label1><mixed-citation publication-type="journal" store="1982" contenteditable="true"><person-group person-group-type="author" store="1983" contenteditable="true"><name store="1984" contenteditable="true"><surname store="1985" contenteditable="true">Pasquali</surname><!--punc--> <!--punc--><given-names store="1986" contenteditable="true">R</given-names></name><!--punc--> &amp; <!--punc--><name store="1987" contenteditable="true"><surname store="1988" contenteditable="true">Oriolo</surname><!--punc--> <!--punc--><given-names store="1989" contenteditable="true">C</given-names></name></person-group><delimiter store="1990" contenteditable="true">. </delimiter><article-title store="1991" contenteditable="true">Obesity and androgens in women</article-title><delimiter store="1992" contenteditable="true">. </delimiter><source1 store="1993" contenteditable="true"><i store="1994" contenteditable="true">Frontiers of Hormone Research</i></source1><delimiter store="1995" contenteditable="true"> </delimiter><year store="1996" contenteditable="true">2019</year><delimiter store="1997" contenteditable="true"> </delimiter><volume1 store="1998" contenteditable="true"><!--punc--><b store="1999" contenteditable="true"><!--punc-->53<!--punc--></b><!--punc--></volume1><delimiter store="2000" contenteditable="true"> </delimiter><fpage1 store="2001" contenteditable="true">120</fpage1><delimiter store="2002" contenteditable="true">–</delimiter><lpage1 store="2003" contenteditable="true">134</lpage1><delimiter store="2004" contenteditable="true">. </delimiter><pub-id store="2005" contenteditable="true">(https://doi.org/10.1159/000494908)</pub-id><delimiter store="2006" contenteditable="true"> </delimiter></mixed-citation></ref><ref id="CIT00038" store="2007" contenteditable="true"><label1 store="2008" contenteditable="true">38. </label1><mixed-citation publication-type="journal" store="2009" contenteditable="true"><person-group person-group-type="author" store="2010" contenteditable="true"><name store="2011" contenteditable="true"><surname store="2012" contenteditable="true">Legro</surname><!--punc--> <!--punc--><given-names store="2013" contenteditable="true">RS</given-names></name><!--punc-->, <!--punc--><name store="2014" contenteditable="true"><surname store="2015" contenteditable="true">Gnatuk</surname><!--punc--> <!--punc--><given-names store="2016" contenteditable="true">CL</given-names></name><!--punc-->, <!--punc--><name store="2017" contenteditable="true"><surname store="2018" contenteditable="true">Kunselman</surname><!--punc--> <!--punc--><given-names store="2019" contenteditable="true">AR</given-names></name><!--punc--> &amp; <!--punc--><name store="2020" contenteditable="true"><surname store="2021" contenteditable="true">Dunaif</surname><!--punc--> <!--punc--><given-names store="2022" contenteditable="true">A</given-names></name></person-group><delimiter store="2023" contenteditable="true">. </delimiter><article-title store="2024" contenteditable="true">Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study</article-title><delimiter store="2025" contenteditable="true">. </delimiter><source1 store="2026" contenteditable="true"><i store="2027" contenteditable="true">Journal of Clinical Endocrinology and Metabolism</i></source1><delimiter store="2028" contenteditable="true"> </delimiter><year store="2029" contenteditable="true">2005</year><delimiter store="2030" contenteditable="true"> </delimiter><volume1 store="2031" contenteditable="true"><!--punc--><b store="2032" contenteditable="true"><!--punc-->90<!--punc--></b><!--punc--></volume1><delimiter store="2033" contenteditable="true"> </delimiter><fpage1 store="2034" contenteditable="true">3236</fpage1><delimiter store="2035" contenteditable="true">–</delimiter><lpage1 store="2036" contenteditable="true">3242</lpage1><delimiter store="2037" contenteditable="true">. </delimiter><pub-id store="2038" contenteditable="true">(https://doi.org/10.1210/jc.2004-1843)</pub-id><delimiter store="2039" contenteditable="true"> </delimiter></mixed-citation></ref><ref id="CIT00039" store="2040" contenteditable="true"><label1 store="2041" contenteditable="true">39. </label1><mixed-citation publication-type="journal" store="2042" contenteditable="true"><person-group person-group-type="author" store="2043" contenteditable="true"><name store="2044" contenteditable="true"><surname store="2045" contenteditable="true">Legro</surname><!--punc--> <!--punc--><given-names store="2046" contenteditable="true">RS</given-names></name><!--punc-->, <!--punc--><name store="2047" contenteditable="true"><surname store="2048" contenteditable="true">Kunselman</surname><!--punc--> <!--punc--><given-names store="2049" contenteditable="true">AR</given-names></name><!--punc-->, <!--punc--><name store="2050" contenteditable="true"><surname store="2051" contenteditable="true">Dodson</surname><!--punc--> <!--punc--><given-names store="2052" contenteditable="true">WC</given-names></name><!--punc--> &amp; <!--punc--><name store="2053" contenteditable="true"><surname store="2054" contenteditable="true">Dunaif</surname><!--punc--> <!--punc--><given-names store="2055" contenteditable="true">A</given-names></name></person-group><delimiter store="2056" contenteditable="true">. </delimiter><article-title store="2057" contenteditable="true">Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women<query title="Please provide the in-text citation for the reference (39)." data-time="1576308922" data-username="Editor" id="6" contenteditable="false" changetime="14/12/2019 13:05:16" store="2058"><i class="fa fa-question-circle fa-1x fa-1x" style="color:red;" onclick="addQueryText(6);" contenteditable="true" store="2059"></i></query></article-title><delimiter store="2060" contenteditable="true">. </delimiter><source1 store="2061" contenteditable="true"><i store="2062" contenteditable="true">Journal of Clinical Endocrinology and Metabolism</i></source1><delimiter store="2063" contenteditable="true"> </delimiter><year store="2064" contenteditable="true">1999</year><delimiter store="2065" contenteditable="true"> </delimiter><volume1 store="2066" contenteditable="true"><!--punc--><b store="2067" contenteditable="true"><!--punc-->84<!--punc--></b><!--punc--></volume1><delimiter store="2068" contenteditable="true"> </delimiter><fpage1 store="2069" contenteditable="true">165</fpage1><delimiter store="2070" contenteditable="true">–</delimiter><lpage1 store="2071" contenteditable="true">169</lpage1><delimiter store="2072" contenteditable="true">. </delimiter><pub-id store="2073" contenteditable="true">(https://doi.org/10.1210/jcem.84.1.5393)</pub-id><delimiter store="2074" contenteditable="true"> </delimiter></mixed-citation></ref><ref id="CIT00040" store="2075" contenteditable="true"><label1 store="2076" contenteditable="true">40. </label1><mixed-citation publication-type="journal" store="2077" contenteditable="true"><person-group person-group-type="author" store="2078" contenteditable="true"><name store="2079" contenteditable="true"><surname store="2080" contenteditable="true">Ehrmann</surname><!--punc--> <!--punc--><given-names store="2081" contenteditable="true">DA</given-names></name><!--punc-->, <!--punc--><name store="2082" contenteditable="true"><surname store="2083" contenteditable="true">Barnes</surname><!--punc--> <!--punc--><given-names store="2084" contenteditable="true">RB</given-names></name><!--punc-->, <!--punc--><name store="2085" contenteditable="true"><surname store="2086" contenteditable="true">Rosenfield</surname><!--punc--> <!--punc--><given-names store="2087" contenteditable="true">RL</given-names></name><!--punc-->, <!--punc--><name store="2088" contenteditable="true"><surname store="2089" contenteditable="true">Cavaghan</surname><!--punc--> <!--punc--><given-names store="2090" contenteditable="true">MK</given-names></name><!--punc--> &amp; <!--punc--><name store="2091" contenteditable="true"><surname store="2092" contenteditable="true">Imperial</surname><!--punc--> <!--punc--><given-names store="2093" contenteditable="true">J</given-names></name></person-group><delimiter store="2094" contenteditable="true">. </delimiter><article-title store="2095" contenteditable="true">Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome</article-title><delimiter store="2096" contenteditable="true">. </delimiter><source1 store="2097" contenteditable="true"><i store="2098" contenteditable="true">Diabetes Care</i></source1><delimiter store="2099" contenteditable="true"> </delimiter><year store="2100" contenteditable="true">1999</year><delimiter store="2101" contenteditable="true"> </delimiter><volume1 store="2102" contenteditable="true"><!--punc--><b store="2103" contenteditable="true"><!--punc-->22<!--punc--></b><!--punc--></volume1><delimiter store="2104" contenteditable="true"> </delimiter><fpage1 store="2105" contenteditable="true">141</fpage1><delimiter store="2106" contenteditable="true">–</delimiter><lpage1 store="2107" contenteditable="true">146</lpage1><delimiter store="2108" contenteditable="true">. </delimiter><pub-id store="2109" contenteditable="true">(https://doi.org/10.2337/diacare.22.1.141)</pub-id><delimiter store="2110" contenteditable="true"> </delimiter></mixed-citation></ref><ref id="CIT00041" store="2111" contenteditable="true"><label1 store="2112" contenteditable="true">41. </label1><mixed-citation publication-type="journal" store="2113" contenteditable="true"><person-group person-group-type="author" store="2114" contenteditable="true"><name store="2115" contenteditable="true"><surname store="2116" contenteditable="true">Sharma</surname><!--punc--> <!--punc--><given-names store="2117" contenteditable="true">ST</given-names></name><!--punc-->, <!--punc--><name store="2118" contenteditable="true"><surname store="2119" contenteditable="true">Wickham</surname><!--punc--> <!--punc--><suffix store="2120" contenteditable="true">3rd</suffix><!--punc--> <!--punc--><given-names store="2121" contenteditable="true">EP</given-names></name><!--punc--> &amp; <!--punc--><name store="2122" contenteditable="true"><surname store="2123" contenteditable="true">Nestler</surname><!--punc--> <!--punc--><given-names store="2124" contenteditable="true">JE</given-names></name></person-group><delimiter store="2125" contenteditable="true">. </delimiter><article-title store="2126" contenteditable="true">Changes in glucose tolerance with metformin treatment in polycystic ovary syndrome: a retrospective analysis</article-title><delimiter store="2127" contenteditable="true">. </delimiter><source1 store="2128" contenteditable="true"><i store="2129" contenteditable="true">Endocrine Practice</i></source1><delimiter store="2130" contenteditable="true"> </delimiter><year store="2131" contenteditable="true">2007</year><delimiter store="2132" contenteditable="true"> </delimiter><volume1 store="2133" contenteditable="true"><!--punc--><b store="2134" contenteditable="true"><!--punc-->13<!--punc--></b><!--punc--></volume1><delimiter store="2135" contenteditable="true"> </delimiter><fpage1 store="2136" contenteditable="true">373</fpage1><delimiter store="2137" contenteditable="true">–</delimiter><lpage1 store="2138" contenteditable="true">379</lpage1><delimiter store="2139" contenteditable="true">. </delimiter><pub-id store="2140" contenteditable="true">(https://doi.org/10.4158/EP.13.4.373)</pub-id><delimiter store="2141" contenteditable="true"> </delimiter></mixed-citation></ref><ref id="CIT00042" store="2142" contenteditable="true"><label1 store="2143" contenteditable="true">42. </label1><mixed-citation publication-type="journal" store="2144" contenteditable="true"><person-group person-group-type="author" store="2145" contenteditable="true"><name store="2146" contenteditable="true"><surname store="2147" contenteditable="true">Chiu</surname><!--punc--> <!--punc--><given-names store="2148" contenteditable="true">WL</given-names></name><!--punc-->, <!--punc--><name store="2149" contenteditable="true"><surname store="2150" contenteditable="true">Boyle</surname><!--punc--> <!--punc--><given-names store="2151" contenteditable="true">J</given-names></name><!--punc-->, <!--punc--><name store="2152" contenteditable="true"><surname store="2153" contenteditable="true">Vincent</surname><!--punc--> <!--punc--><given-names store="2154" contenteditable="true">A</given-names></name><!--punc-->, <!--punc--><name store="2155" contenteditable="true"><surname store="2156" contenteditable="true">Teede</surname><!--punc--> <!--punc--><given-names store="2157" contenteditable="true">H</given-names></name><!--punc--> &amp; <!--punc--><name store="2158" contenteditable="true"><surname store="2159" contenteditable="true">Moran</surname><!--punc--> <!--punc--><given-names store="2160" contenteditable="true">LJ</given-names></name></person-group><delimiter store="2161" contenteditable="true">. </delimiter><article-title store="2162" contenteditable="true">Cardiometabolic risks in polycystic ovary syndrome: non-traditional risk factors and the impact of obesity.</article-title><delimiter store="2163" contenteditable="true"> </delimiter><source1 store="2164" contenteditable="true"><i store="2165" contenteditable="true">Neuroendocrinology</i></source1><delimiter store="2166" contenteditable="true"> </delimiter><year store="2167" contenteditable="true">2017</year><delimiter store="2168" contenteditable="true"> </delimiter><volume1 store="2169" contenteditable="true"><!--punc--><b store="2170" contenteditable="true"><!--punc-->104<!--punc--></b><!--punc--></volume1><delimiter store="2171" contenteditable="true"> </delimiter><fpage1 store="2172" contenteditable="true">412</fpage1><delimiter store="2173" contenteditable="true">–</delimiter><lpage1 store="2174" contenteditable="true">424</lpage1><delimiter store="2175" contenteditable="true">. (</delimiter><pub-id store="2176" contenteditable="true">doi:10.1159/000455233</pub-id><delimiter store="2177" contenteditable="true">)</delimiter></mixed-citation></ref></ref-list></back><spellingerrors store="2178" contenteditable="true"><spellingerror language="US" store="2179" contenteditable="true"><word store="2180" contenteditable="true"><text store="2181" contenteditable="true">hyperandrogenism</text><suggestions store="2182" contenteditable="true"></suggestions></word><word store="2183" contenteditable="true"><text store="2184" contenteditable="true">cardiometabolic</text><suggestions store="2185" contenteditable="true"><suggestion store="2186" contenteditable="true">cardio metabolic</suggestion></suggestions></word><word store="2187" contenteditable="true"><text store="2188" contenteditable="true">hyperandrogenism</text><suggestions store="2189" contenteditable="true"></suggestions></word><word store="2190" contenteditable="true"><text store="2191" contenteditable="true">hyperandrogenism</text><suggestions store="2192" contenteditable="true"></suggestions></word><word store="2193" contenteditable="true"><text store="2194" contenteditable="true">hyperandrogenism</text><suggestions store="2195" contenteditable="true"></suggestions></word><word store="2196" contenteditable="true"><text store="2197" contenteditable="true">nonhyperandrogenic</text><suggestions store="2198" contenteditable="true"></suggestions></word><word store="2199" contenteditable="true"><text store="2200" contenteditable="true">monotherapy</text><suggestions store="2201" contenteditable="true"><suggestion store="2202" contenteditable="true">immunotherapy</suggestion></suggestions></word><word store="2203" contenteditable="true"><text store="2204" contenteditable="true">androstenedione</text><suggestions store="2205" contenteditable="true"></suggestions></word><word store="2206" contenteditable="true"><text store="2207" contenteditable="true">dehydroepiandrosterone</text><suggestions store="2208" contenteditable="true"></suggestions></word><word store="2209" contenteditable="true"><text store="2210" contenteditable="true">sulphate</text><suggestions store="2211" contenteditable="true"></suggestions></word><word store="2212" contenteditable="true"><text store="2213" contenteditable="true">Ferriman</text><suggestions store="2214" contenteditable="true"><suggestion store="2215" contenteditable="true">Ferryman</suggestion><suggestion store="2216" contenteditable="true">Ferrymen</suggestion></suggestions></word><word store="2217" contenteditable="true"><text store="2218" contenteditable="true">Gallwey</text><suggestions store="2219" contenteditable="true"><suggestion store="2220" contenteditable="true">Galley</suggestion><suggestion store="2221" contenteditable="true">Galway</suggestion><suggestion store="2222" contenteditable="true">Galleys</suggestion><suggestion store="2223" contenteditable="true">Galloway</suggestion></suggestions></word><word store="2224" contenteditable="true"><text store="2225" contenteditable="true">Inc</text><suggestions store="2226" contenteditable="true"><suggestion store="2227" contenteditable="true">Inc.</suggestion><suggestion store="2228" contenteditable="true">Ink</suggestion><suggestion store="2229" contenteditable="true">Inca</suggestion><suggestion store="2230" contenteditable="true">Inch</suggestion><suggestion store="2231" contenteditable="true">In</suggestion><suggestion store="2232" contenteditable="true">Inco</suggestion><suggestion store="2233" contenteditable="true">IN</suggestion><suggestion store="2234" contenteditable="true">Ins</suggestion><suggestion store="2235" contenteditable="true">Inn</suggestion></suggestions></word><word store="2236" contenteditable="true"><text store="2237" contenteditable="true">Androstenedione</text><suggestions store="2238" contenteditable="true"></suggestions></word><word store="2239" contenteditable="true"><text store="2240" contenteditable="true">Tx</text><suggestions store="2241" contenteditable="true"><suggestion store="2242" contenteditable="true">TX</suggestion><suggestion store="2243" contenteditable="true">Tax</suggestion><suggestion store="2244" contenteditable="true">Tux</suggestion></suggestions></word><word store="2245" contenteditable="true"><text store="2246" contenteditable="true">DiaSorin</text><suggestions store="2247" contenteditable="true"><suggestion store="2248" contenteditable="true">Dias Orin</suggestion><suggestion store="2249" contenteditable="true">Disorient</suggestion><suggestion store="2250" contenteditable="true">Diesoline</suggestion><suggestion store="2251" contenteditable="true">Diasporas</suggestion></suggestions></word><word store="2252" contenteditable="true"><text store="2253" contenteditable="true">Salluggia</text><suggestions store="2254" contenteditable="true"></suggestions></word><word store="2255" contenteditable="true"><text store="2256" contenteditable="true">immunometric</text><suggestions store="2257" contenteditable="true"></suggestions></word><word store="2258" contenteditable="true"><text store="2259" contenteditable="true">androstenedione</text><suggestions store="2260" contenteditable="true"></suggestions></word><word store="2261" contenteditable="true"><text store="2262" contenteditable="true">mmol</text><suggestions store="2263" contenteditable="true"><suggestion store="2264" contenteditable="true">moll</suggestion><suggestion store="2265" contenteditable="true">mom</suggestion><suggestion store="2266" contenteditable="true">mold</suggestion><suggestion store="2267" contenteditable="true">mole</suggestion><suggestion store="2268" contenteditable="true">molt</suggestion><suggestion store="2269" contenteditable="true">moms</suggestion><suggestion store="2270" contenteditable="true">memo</suggestion><suggestion store="2271" contenteditable="true">moil</suggestion><suggestion store="2272" contenteditable="true">moly</suggestion><suggestion store="2273" contenteditable="true">mop</suggestion></suggestions></word><word store="2274" contenteditable="true"><text store="2275" contenteditable="true">mmol</text><suggestions store="2276" contenteditable="true"><suggestion store="2277" contenteditable="true">moll</suggestion><suggestion store="2278" contenteditable="true">mom</suggestion><suggestion store="2279" contenteditable="true">mold</suggestion><suggestion store="2280" contenteditable="true">mole</suggestion><suggestion store="2281" contenteditable="true">molt</suggestion><suggestion store="2282" contenteditable="true">moms</suggestion><suggestion store="2283" contenteditable="true">memo</suggestion><suggestion store="2284" contenteditable="true">moil</suggestion><suggestion store="2285" contenteditable="true">moly</suggestion><suggestion store="2286" contenteditable="true">mop</suggestion></suggestions></word><word store="2287" contenteditable="true"><text store="2288" contenteditable="true">mmol</text><suggestions store="2289" contenteditable="true"><suggestion store="2290" contenteditable="true">moll</suggestion><suggestion store="2291" contenteditable="true">mom</suggestion><suggestion store="2292" contenteditable="true">mold</suggestion><suggestion store="2293" contenteditable="true">mole</suggestion><suggestion store="2294" contenteditable="true">molt</suggestion><suggestion store="2295" contenteditable="true">moms</suggestion><suggestion store="2296" contenteditable="true">memo</suggestion><suggestion store="2297" contenteditable="true">moil</suggestion><suggestion store="2298" contenteditable="true">moly</suggestion><suggestion store="2299" contenteditable="true">mop</suggestion></suggestions></word><word store="2300" contenteditable="true"><text store="2301" contenteditable="true">mmol</text><suggestions store="2302" contenteditable="true"><suggestion store="2303" contenteditable="true">moll</suggestion><suggestion store="2304" contenteditable="true">mom</suggestion><suggestion store="2305" contenteditable="true">mold</suggestion><suggestion store="2306" contenteditable="true">mole</suggestion><suggestion store="2307" contenteditable="true">molt</suggestion><suggestion store="2308" contenteditable="true">moms</suggestion><suggestion store="2309" contenteditable="true">memo</suggestion><suggestion store="2310" contenteditable="true">moil</suggestion><suggestion store="2311" contenteditable="true">moly</suggestion><suggestion store="2312" contenteditable="true">mop</suggestion></suggestions></word><word store="2313" contenteditable="true"><text store="2314" contenteditable="true">mmol</text><suggestions store="2315" contenteditable="true"><suggestion store="2316" contenteditable="true">moll</suggestion><suggestion store="2317" contenteditable="true">mom</suggestion><suggestion store="2318" contenteditable="true">mold</suggestion><suggestion store="2319" contenteditable="true">mole</suggestion><suggestion store="2320" contenteditable="true">molt</suggestion><suggestion store="2321" contenteditable="true">moms</suggestion><suggestion store="2322" contenteditable="true">memo</suggestion><suggestion store="2323" contenteditable="true">moil</suggestion><suggestion store="2324" contenteditable="true">moly</suggestion><suggestion store="2325" contenteditable="true">mop</suggestion></suggestions></word><word store="2326" contenteditable="true"><text store="2327" contenteditable="true">mmol</text><suggestions store="2328" contenteditable="true"><suggestion store="2329" contenteditable="true">moll</suggestion><suggestion store="2330" contenteditable="true">mom</suggestion><suggestion store="2331" contenteditable="true">mold</suggestion><suggestion store="2332" contenteditable="true">mole</suggestion><suggestion store="2333" contenteditable="true">molt</suggestion><suggestion store="2334" contenteditable="true">moms</suggestion><suggestion store="2335" contenteditable="true">memo</suggestion><suggestion store="2336" contenteditable="true">moil</suggestion><suggestion store="2337" contenteditable="true">moly</suggestion><suggestion store="2338" contenteditable="true">mop</suggestion></suggestions></word><word store="2339" contenteditable="true"><text store="2340" contenteditable="true">mmol</text><suggestions store="2341" contenteditable="true"><suggestion store="2342" contenteditable="true">moll</suggestion><suggestion store="2343" contenteditable="true">mom</suggestion><suggestion store="2344" contenteditable="true">mold</suggestion><suggestion store="2345" contenteditable="true">mole</suggestion><suggestion store="2346" contenteditable="true">molt</suggestion><suggestion store="2347" contenteditable="true">moms</suggestion><suggestion store="2348" contenteditable="true">memo</suggestion><suggestion store="2349" contenteditable="true">moil</suggestion><suggestion store="2350" contenteditable="true">moly</suggestion><suggestion store="2351" contenteditable="true">mop</suggestion></suggestions></word><word store="2352" contenteditable="true"><text store="2353" contenteditable="true">Kruskal</text><suggestions store="2354" contenteditable="true"><suggestion store="2355" contenteditable="true">Kreskas</suggestion><suggestion store="2356" contenteditable="true">Kristal</suggestion><suggestion store="2357" contenteditable="true">Crustal</suggestion><suggestion store="2358" contenteditable="true">Ruska</suggestion><suggestion store="2359" contenteditable="true">Krystal</suggestion><suggestion store="2360" contenteditable="true">Rascal</suggestion><suggestion store="2361" contenteditable="true">Kuala</suggestion></suggestions></word><word store="2362" contenteditable="true"><text store="2363" contenteditable="true">androstenedione</text><suggestions store="2364" contenteditable="true"></suggestions></word><word store="2365" contenteditable="true"><text store="2366" contenteditable="true">androstenedione</text><suggestions store="2367" contenteditable="true"></suggestions></word><word store="2368" contenteditable="true"><text store="2369" contenteditable="true">vs</text><suggestions store="2370" contenteditable="true"><suggestion store="2371" contenteditable="true">vs.</suggestion><suggestion store="2372" contenteditable="true">vest</suggestion></suggestions></word><word store="2373" contenteditable="true"><text store="2374" contenteditable="true">μmol</text><suggestions store="2375" contenteditable="true"><suggestion store="2376" contenteditable="true">moll</suggestion><suggestion store="2377" contenteditable="true">mold</suggestion><suggestion store="2378" contenteditable="true">mole</suggestion><suggestion store="2379" contenteditable="true">molt</suggestion><suggestion store="2380" contenteditable="true">moil</suggestion><suggestion store="2381" contenteditable="true">moly</suggestion><suggestion store="2382" contenteditable="true">mop</suggestion><suggestion store="2383" contenteditable="true">oil</suggestion><suggestion store="2384" contenteditable="true">molls</suggestion><suggestion store="2385" contenteditable="true">molly</suggestion></suggestions></word><word store="2386" contenteditable="true"><text store="2387" contenteditable="true">mmol</text><suggestions store="2388" contenteditable="true"><suggestion store="2389" contenteditable="true">moll</suggestion><suggestion store="2390" contenteditable="true">mom</suggestion><suggestion store="2391" contenteditable="true">mold</suggestion><suggestion store="2392" contenteditable="true">mole</suggestion><suggestion store="2393" contenteditable="true">molt</suggestion><suggestion store="2394" contenteditable="true">moms</suggestion><suggestion store="2395" contenteditable="true">memo</suggestion><suggestion store="2396" contenteditable="true">moil</suggestion><suggestion store="2397" contenteditable="true">moly</suggestion><suggestion store="2398" contenteditable="true">mop</suggestion></suggestions></word><word store="2399" contenteditable="true"><text store="2400" contenteditable="true">androstenedione</text><suggestions store="2401" contenteditable="true"></suggestions></word><word store="2402" contenteditable="true"><text store="2403" contenteditable="true">androstenedione</text><suggestions store="2404" contenteditable="true"></suggestions></word><word store="2405" contenteditable="true"><text store="2406" contenteditable="true">androstenedione</text><suggestions store="2407" contenteditable="true"></suggestions></word><word store="2408" contenteditable="true"><text store="2409" contenteditable="true">androstenedione</text><suggestions store="2410" contenteditable="true"></suggestions></word><word store="2411" contenteditable="true"><text store="2412" contenteditable="true">androstenedione</text><suggestions store="2413" contenteditable="true"></suggestions></word><word store="2414" contenteditable="true"><text store="2415" contenteditable="true">androstenedione</text><suggestions store="2416" contenteditable="true"></suggestions></word><word store="2417" contenteditable="true"><text store="2418" contenteditable="true">androstenedione</text><suggestions store="2419" contenteditable="true"></suggestions></word><word store="2420" contenteditable="true"><text store="2421" contenteditable="true">androstenedione</text><suggestions store="2422" contenteditable="true"></suggestions></word><word store="2423" contenteditable="true"><text store="2424" contenteditable="true">androstenedione</text><suggestions store="2425" contenteditable="true"></suggestions></word><word store="2426" contenteditable="true"><text store="2427" contenteditable="true">nmol</text><suggestions store="2428" contenteditable="true"><suggestion store="2429" contenteditable="true">moll</suggestion><suggestion store="2430" contenteditable="true">no</suggestion><suggestion store="2431" contenteditable="true">noel</suggestion><suggestion store="2432" contenteditable="true">mold</suggestion><suggestion store="2433" contenteditable="true">mole</suggestion><suggestion store="2434" contenteditable="true">unmold</suggestion><suggestion store="2435" contenteditable="true">molt</suggestion><suggestion store="2436" contenteditable="true">not</suggestion><suggestion store="2437" contenteditable="true">now</suggestion><suggestion store="2438" contenteditable="true">moil</suggestion></suggestions></word><word store="2439" contenteditable="true"><text store="2440" contenteditable="true">androstenedione</text><suggestions store="2441" contenteditable="true"></suggestions></word><word store="2442" contenteditable="true"><text store="2443" contenteditable="true">nmol</text><suggestions store="2444" contenteditable="true"><suggestion store="2445" contenteditable="true">moll</suggestion><suggestion store="2446" contenteditable="true">no</suggestion><suggestion store="2447" contenteditable="true">noel</suggestion><suggestion store="2448" contenteditable="true">mold</suggestion><suggestion store="2449" contenteditable="true">mole</suggestion><suggestion store="2450" contenteditable="true">unmold</suggestion><suggestion store="2451" contenteditable="true">molt</suggestion><suggestion store="2452" contenteditable="true">not</suggestion><suggestion store="2453" contenteditable="true">now</suggestion><suggestion store="2454" contenteditable="true">moil</suggestion></suggestions></word><word store="2455" contenteditable="true"><text store="2456" contenteditable="true">Cohrane</text><suggestions store="2457" contenteditable="true"><suggestion store="2458" contenteditable="true">Cochrane</suggestion><suggestion store="2459" contenteditable="true">Chorine</suggestion></suggestions></word><word store="2460" contenteditable="true"><text store="2461" contenteditable="true">androstenedione</text><suggestions store="2462" contenteditable="true"></suggestions></word><word store="2463" contenteditable="true"><text store="2464" contenteditable="true">androstenedione</text><suggestions store="2465" contenteditable="true"></suggestions></word><word store="2466" contenteditable="true"><text store="2467" contenteditable="true">hyperandogenism</text><suggestions store="2468" contenteditable="true"></suggestions></word><word store="2469" contenteditable="true"><text store="2470" contenteditable="true">hyperinsulinemia</text><suggestions store="2471" contenteditable="true"></suggestions></word><word store="2472" contenteditable="true"><text store="2473" contenteditable="true">steroidogenesis</text><suggestions store="2474" contenteditable="true"><suggestion store="2475" contenteditable="true">steroid genesis</suggestion></suggestions></word><word store="2476" contenteditable="true"><text store="2477" contenteditable="true">cardiometabolic</text><suggestions store="2478" contenteditable="true"><suggestion store="2479" contenteditable="true">cardio metabolic</suggestion></suggestions></word><word store="2480" contenteditable="true"><text store="2481" contenteditable="true">Legro</text><suggestions store="2482" contenteditable="true"><suggestion store="2483" contenteditable="true">Largo</suggestion><suggestion store="2484" contenteditable="true">Lego</suggestion><suggestion store="2485" contenteditable="true">Legroom</suggestion><suggestion store="2486" contenteditable="true">Allegro</suggestion><suggestion store="2487" contenteditable="true">Leroy</suggestion><suggestion store="2488" contenteditable="true">LeBron</suggestion><suggestion store="2489" contenteditable="true">Logo</suggestion><suggestion store="2490" contenteditable="true">Ergo</suggestion><suggestion store="2491" contenteditable="true">Legos</suggestion><suggestion store="2492" contenteditable="true">Léger</suggestion></suggestions></word><word store="2493" contenteditable="true"><text store="2494" contenteditable="true">hyperandrogenism</text><suggestions store="2495" contenteditable="true"></suggestions></word><word store="2496" contenteditable="true"><text store="2497" contenteditable="true">oligomenorrhea</text><suggestions store="2498" contenteditable="true"></suggestions></word><word store="2499" contenteditable="true"><text store="2500" contenteditable="true">hyperandrogenism</text><suggestions store="2501" contenteditable="true"></suggestions></word><word store="2502" contenteditable="true"><text store="2503" contenteditable="true">oligomenorrheic</text><suggestions store="2504" contenteditable="true"></suggestions></word><word store="2505" contenteditable="true"><text store="2506" contenteditable="true">vs</text><suggestions store="2507" contenteditable="true"><suggestion store="2508" contenteditable="true">vs.</suggestion><suggestion store="2509" contenteditable="true">vest</suggestion></suggestions></word><word store="2510" contenteditable="true"><text store="2511" contenteditable="true">cardiometabolic</text><suggestions store="2512" contenteditable="true"><suggestion store="2513" contenteditable="true">cardio metabolic</suggestion></suggestions></word><word store="2514" contenteditable="true"><text store="2515" contenteditable="true">microbiota</text><suggestions store="2516" contenteditable="true"><suggestion store="2517" contenteditable="true">micro biota</suggestion><suggestion store="2518" contenteditable="true">macrobiotic</suggestion></suggestions></word><word store="2519" contenteditable="true"><text store="2520" contenteditable="true">dysbiosis</text><suggestions store="2521" contenteditable="true"><suggestion store="2522" contenteditable="true">symbiosis</suggestion></suggestions></word></spellingerror><spellingerror language="UK" store="2523" contenteditable="true"><word store="2524" contenteditable="true"><text store="2525" contenteditable="true">hyperandrogenism</text><suggestions store="2526" contenteditable="true"></suggestions></word><word store="2527" contenteditable="true"><text store="2528" contenteditable="true">cardiometabolic</text><suggestions store="2529" contenteditable="true"><suggestion store="2530" contenteditable="true">cardio metabolic</suggestion></suggestions></word><word store="2531" contenteditable="true"><text store="2532" contenteditable="true">glycemic</text><suggestions store="2533" contenteditable="true"><suggestion store="2534" contenteditable="true">glycaemic</suggestion></suggestions></word><word store="2535" contenteditable="true"><text store="2536" contenteditable="true">hyperandrogenism</text><suggestions store="2537" contenteditable="true"></suggestions></word><word store="2538" contenteditable="true"><text store="2539" contenteditable="true">hyperandrogenism</text><suggestions store="2540" contenteditable="true"></suggestions></word><word store="2541" contenteditable="true"><text store="2542" contenteditable="true">hyperandrogenism</text><suggestions store="2543" contenteditable="true"></suggestions></word><word store="2544" contenteditable="true"><text store="2545" contenteditable="true">nonhyperandrogenic</text><suggestions store="2546" contenteditable="true"></suggestions></word><word store="2547" contenteditable="true"><text store="2548" contenteditable="true">monotherapy</text><suggestions store="2549" contenteditable="true"><suggestion store="2550" contenteditable="true">immunotherapy</suggestion></suggestions></word><word store="2551" contenteditable="true"><text store="2552" contenteditable="true">androstenedione</text><suggestions store="2553" contenteditable="true"></suggestions></word><word store="2554" contenteditable="true"><text store="2555" contenteditable="true">dehydroepiandrosterone</text><suggestions store="2556" contenteditable="true"></suggestions></word><word store="2557" contenteditable="true"><text store="2558" contenteditable="true">Ferriman</text><suggestions store="2559" contenteditable="true"><suggestion store="2560" contenteditable="true">Ferryman</suggestion><suggestion store="2561" contenteditable="true">Ferrymen</suggestion></suggestions></word><word store="2562" contenteditable="true"><text store="2563" contenteditable="true">Gallwey</text><suggestions store="2564" contenteditable="true"><suggestion store="2565" contenteditable="true">Galley</suggestion><suggestion store="2566" contenteditable="true">Galway</suggestion><suggestion store="2567" contenteditable="true">Galleys</suggestion><suggestion store="2568" contenteditable="true">Galloway</suggestion></suggestions></word><word store="2569" contenteditable="true"><text store="2570" contenteditable="true">Analyzer</text><suggestions store="2571" contenteditable="true"><suggestion store="2572" contenteditable="true">Analyser</suggestion><suggestion store="2573" contenteditable="true">Analysers</suggestion></suggestions></word><word store="2574" contenteditable="true"><text store="2575" contenteditable="true">Inc</text><suggestions store="2576" contenteditable="true"><suggestion store="2577" contenteditable="true">Inc.</suggestion><suggestion store="2578" contenteditable="true">Ink</suggestion><suggestion store="2579" contenteditable="true">Inca</suggestion><suggestion store="2580" contenteditable="true">Inch</suggestion><suggestion store="2581" contenteditable="true">In</suggestion><suggestion store="2582" contenteditable="true">Inco</suggestion><suggestion store="2583" contenteditable="true">IN</suggestion><suggestion store="2584" contenteditable="true">Ins</suggestion><suggestion store="2585" contenteditable="true">Inn</suggestion></suggestions></word><word store="2586" contenteditable="true"><text store="2587" contenteditable="true">Androstenedione</text><suggestions store="2588" contenteditable="true"></suggestions></word><word store="2589" contenteditable="true"><text store="2590" contenteditable="true">labeled</text><suggestions store="2591" contenteditable="true"><suggestion store="2592" contenteditable="true">labelled</suggestion><suggestion store="2593" contenteditable="true">libelled</suggestion></suggestions></word><word store="2594" contenteditable="true"><text store="2595" contenteditable="true">Tx</text><suggestions store="2596" contenteditable="true"><suggestion store="2597" contenteditable="true">TX</suggestion><suggestion store="2598" contenteditable="true">Tax</suggestion><suggestion store="2599" contenteditable="true">Tux</suggestion></suggestions></word><word store="2600" contenteditable="true"><text store="2601" contenteditable="true">DiaSorin</text><suggestions store="2602" contenteditable="true"></suggestions></word><word store="2603" contenteditable="true"><text store="2604" contenteditable="true">Salluggia</text><suggestions store="2605" contenteditable="true"></suggestions></word><word store="2606" contenteditable="true"><text store="2607" contenteditable="true">immunometric</text><suggestions store="2608" contenteditable="true"></suggestions></word><word store="2609" contenteditable="true"><text store="2610" contenteditable="true">androstenedione</text><suggestions store="2611" contenteditable="true"></suggestions></word><word store="2612" contenteditable="true"><text store="2613" contenteditable="true">mmol</text><suggestions store="2614" contenteditable="true"><suggestion store="2615" contenteditable="true">moll</suggestion><suggestion store="2616" contenteditable="true">mom</suggestion><suggestion store="2617" contenteditable="true">mole</suggestion><suggestion store="2618" contenteditable="true">moms</suggestion><suggestion store="2619" contenteditable="true">memo</suggestion><suggestion store="2620" contenteditable="true">moil</suggestion><suggestion store="2621" contenteditable="true">moly</suggestion><suggestion store="2622" contenteditable="true">mop</suggestion><suggestion store="2623" contenteditable="true">memos</suggestion><suggestion store="2624" contenteditable="true">molls</suggestion></suggestions></word><word store="2625" contenteditable="true"><text store="2626" contenteditable="true">mmol</text><suggestions store="2627" contenteditable="true"><suggestion store="2628" contenteditable="true">moll</suggestion><suggestion store="2629" contenteditable="true">mom</suggestion><suggestion store="2630" contenteditable="true">mole</suggestion><suggestion store="2631" contenteditable="true">moms</suggestion><suggestion store="2632" contenteditable="true">memo</suggestion><suggestion store="2633" contenteditable="true">moil</suggestion><suggestion store="2634" contenteditable="true">moly</suggestion><suggestion store="2635" contenteditable="true">mop</suggestion><suggestion store="2636" contenteditable="true">memos</suggestion><suggestion store="2637" contenteditable="true">molls</suggestion></suggestions></word><word store="2638" contenteditable="true"><text store="2639" contenteditable="true">mmol</text><suggestions store="2640" contenteditable="true"><suggestion store="2641" contenteditable="true">moll</suggestion><suggestion store="2642" contenteditable="true">mom</suggestion><suggestion store="2643" contenteditable="true">mole</suggestion><suggestion store="2644" contenteditable="true">moms</suggestion><suggestion store="2645" contenteditable="true">memo</suggestion><suggestion store="2646" contenteditable="true">moil</suggestion><suggestion store="2647" contenteditable="true">moly</suggestion><suggestion store="2648" contenteditable="true">mop</suggestion><suggestion store="2649" contenteditable="true">memos</suggestion><suggestion store="2650" contenteditable="true">molls</suggestion></suggestions></word><word store="2651" contenteditable="true"><text store="2652" contenteditable="true">mmol</text><suggestions store="2653" contenteditable="true"><suggestion store="2654" contenteditable="true">moll</suggestion><suggestion store="2655" contenteditable="true">mom</suggestion><suggestion store="2656" contenteditable="true">mole</suggestion><suggestion store="2657" contenteditable="true">moms</suggestion><suggestion store="2658" contenteditable="true">memo</suggestion><suggestion store="2659" contenteditable="true">moil</suggestion><suggestion store="2660" contenteditable="true">moly</suggestion><suggestion store="2661" contenteditable="true">mop</suggestion><suggestion store="2662" contenteditable="true">memos</suggestion><suggestion store="2663" contenteditable="true">molls</suggestion></suggestions></word><word store="2664" contenteditable="true"><text store="2665" contenteditable="true">mmol</text><suggestions store="2666" contenteditable="true"><suggestion store="2667" contenteditable="true">moll</suggestion><suggestion store="2668" contenteditable="true">mom</suggestion><suggestion store="2669" contenteditable="true">mole</suggestion><suggestion store="2670" contenteditable="true">moms</suggestion><suggestion store="2671" contenteditable="true">memo</suggestion><suggestion store="2672" contenteditable="true">moil</suggestion><suggestion store="2673" contenteditable="true">moly</suggestion><suggestion store="2674" contenteditable="true">mop</suggestion><suggestion store="2675" contenteditable="true">memos</suggestion><suggestion store="2676" contenteditable="true">molls</suggestion></suggestions></word><word store="2677" contenteditable="true"><text store="2678" contenteditable="true">mmol</text><suggestions store="2679" contenteditable="true"><suggestion store="2680" contenteditable="true">moll</suggestion><suggestion store="2681" contenteditable="true">mom</suggestion><suggestion store="2682" contenteditable="true">mole</suggestion><suggestion store="2683" contenteditable="true">moms</suggestion><suggestion store="2684" contenteditable="true">memo</suggestion><suggestion store="2685" contenteditable="true">moil</suggestion><suggestion store="2686" contenteditable="true">moly</suggestion><suggestion store="2687" contenteditable="true">mop</suggestion><suggestion store="2688" contenteditable="true">memos</suggestion><suggestion store="2689" contenteditable="true">molls</suggestion></suggestions></word><word store="2690" contenteditable="true"><text store="2691" contenteditable="true">mmol</text><suggestions store="2692" contenteditable="true"><suggestion store="2693" contenteditable="true">moll</suggestion><suggestion store="2694" contenteditable="true">mom</suggestion><suggestion store="2695" contenteditable="true">mole</suggestion><suggestion store="2696" contenteditable="true">moms</suggestion><suggestion store="2697" contenteditable="true">memo</suggestion><suggestion store="2698" contenteditable="true">moil</suggestion><suggestion store="2699" contenteditable="true">moly</suggestion><suggestion store="2700" contenteditable="true">mop</suggestion><suggestion store="2701" contenteditable="true">memos</suggestion><suggestion store="2702" contenteditable="true">molls</suggestion></suggestions></word><word store="2703" contenteditable="true"><text store="2704" contenteditable="true">counseled</text><suggestions store="2705" contenteditable="true"><suggestion store="2706" contenteditable="true">counselled</suggestion><suggestion store="2707" contenteditable="true">counselee</suggestion></suggestions></word><word store="2708" contenteditable="true"><text store="2709" contenteditable="true">Kruskal</text><suggestions store="2710" contenteditable="true"><suggestion store="2711" contenteditable="true">Kreskas</suggestion><suggestion store="2712" contenteditable="true">Kristal</suggestion><suggestion store="2713" contenteditable="true">Crustal</suggestion><suggestion store="2714" contenteditable="true">Ruska</suggestion><suggestion store="2715" contenteditable="true">Krystal</suggestion><suggestion store="2716" contenteditable="true">Rascal</suggestion><suggestion store="2717" contenteditable="true">Kuala</suggestion></suggestions></word><word store="2718" contenteditable="true"><text store="2719" contenteditable="true">androstenedione</text><suggestions store="2720" contenteditable="true"></suggestions></word><word store="2721" contenteditable="true"><text store="2722" contenteditable="true">androstenedione</text><suggestions store="2723" contenteditable="true"></suggestions></word><word store="2724" contenteditable="true"><text store="2725" contenteditable="true">vs</text><suggestions store="2726" contenteditable="true"><suggestion store="2727" contenteditable="true">vs.</suggestion><suggestion store="2728" contenteditable="true">vest</suggestion></suggestions></word><word store="2729" contenteditable="true"><text store="2730" contenteditable="true">μmol</text><suggestions store="2731" contenteditable="true"><suggestion store="2732" contenteditable="true">moll</suggestion><suggestion store="2733" contenteditable="true">mole</suggestion><suggestion store="2734" contenteditable="true">moil</suggestion><suggestion store="2735" contenteditable="true">moly</suggestion><suggestion store="2736" contenteditable="true">mop</suggestion><suggestion store="2737" contenteditable="true">oil</suggestion><suggestion store="2738" contenteditable="true">molls</suggestion><suggestion store="2739" contenteditable="true">molly</suggestion><suggestion store="2740" contenteditable="true">mob</suggestion><suggestion store="2741" contenteditable="true">mom</suggestion></suggestions></word><word store="2742" contenteditable="true"><text store="2743" contenteditable="true">mmol</text><suggestions store="2744" contenteditable="true"><suggestion store="2745" contenteditable="true">moll</suggestion><suggestion store="2746" contenteditable="true">mom</suggestion><suggestion store="2747" contenteditable="true">mole</suggestion><suggestion store="2748" contenteditable="true">moms</suggestion><suggestion store="2749" contenteditable="true">memo</suggestion><suggestion store="2750" contenteditable="true">moil</suggestion><suggestion store="2751" contenteditable="true">moly</suggestion><suggestion store="2752" contenteditable="true">mop</suggestion><suggestion store="2753" contenteditable="true">memos</suggestion><suggestion store="2754" contenteditable="true">molls</suggestion></suggestions></word><word store="2755" contenteditable="true"><text store="2756" contenteditable="true">androstenedione</text><suggestions store="2757" contenteditable="true"></suggestions></word><word store="2758" contenteditable="true"><text store="2759" contenteditable="true">androstenedione</text><suggestions store="2760" contenteditable="true"></suggestions></word><word store="2761" contenteditable="true"><text store="2762" contenteditable="true">androstenedione</text><suggestions store="2763" contenteditable="true"></suggestions></word><word store="2764" contenteditable="true"><text store="2765" contenteditable="true">androstenedione</text><suggestions store="2766" contenteditable="true"></suggestions></word><word store="2767" contenteditable="true"><text store="2768" contenteditable="true">androstenedione</text><suggestions store="2769" contenteditable="true"></suggestions></word><word store="2770" contenteditable="true"><text store="2771" contenteditable="true">androstenedione</text><suggestions store="2772" contenteditable="true"></suggestions></word><word store="2773" contenteditable="true"><text store="2774" contenteditable="true">androstenedione</text><suggestions store="2775" contenteditable="true"></suggestions></word><word store="2776" contenteditable="true"><text store="2777" contenteditable="true">androstenedione</text><suggestions store="2778" contenteditable="true"></suggestions></word><word store="2779" contenteditable="true"><text store="2780" contenteditable="true">androstenedione</text><suggestions store="2781" contenteditable="true"></suggestions></word><word store="2782" contenteditable="true"><text store="2783" contenteditable="true">nmol</text><suggestions store="2784" contenteditable="true"><suggestion store="2785" contenteditable="true">moll</suggestion><suggestion store="2786" contenteditable="true">no</suggestion><suggestion store="2787" contenteditable="true">noel</suggestion><suggestion store="2788" contenteditable="true">mole</suggestion><suggestion store="2789" contenteditable="true">not</suggestion><suggestion store="2790" contenteditable="true">now</suggestion><suggestion store="2791" contenteditable="true">moil</suggestion><suggestion store="2792" contenteditable="true">moly</suggestion><suggestion store="2793" contenteditable="true">nod</suggestion><suggestion store="2794" contenteditable="true">nor</suggestion></suggestions></word><word store="2795" contenteditable="true"><text store="2796" contenteditable="true">androstenedione</text><suggestions store="2797" contenteditable="true"></suggestions></word><word store="2798" contenteditable="true"><text store="2799" contenteditable="true">nmol</text><suggestions store="2800" contenteditable="true"><suggestion store="2801" contenteditable="true">moll</suggestion><suggestion store="2802" contenteditable="true">no</suggestion><suggestion store="2803" contenteditable="true">noel</suggestion><suggestion store="2804" contenteditable="true">mole</suggestion><suggestion store="2805" contenteditable="true">not</suggestion><suggestion store="2806" contenteditable="true">now</suggestion><suggestion store="2807" contenteditable="true">moil</suggestion><suggestion store="2808" contenteditable="true">moly</suggestion><suggestion store="2809" contenteditable="true">nod</suggestion><suggestion store="2810" contenteditable="true">nor</suggestion></suggestions></word><word store="2811" contenteditable="true"><text store="2812" contenteditable="true">diarrhea</text><suggestions store="2813" contenteditable="true"><suggestion store="2814" contenteditable="true">diarrheal</suggestion><suggestion store="2815" contenteditable="true">diarrhoea</suggestion><suggestion store="2816" contenteditable="true">diarrheic</suggestion></suggestions></word><word store="2817" contenteditable="true"><text store="2818" contenteditable="true">anemia</text><suggestions store="2819" contenteditable="true"><suggestion store="2820" contenteditable="true">anaemia</suggestion><suggestion store="2821" contenteditable="true">anomia</suggestion><suggestion store="2822" contenteditable="true">anomie</suggestion><suggestion store="2823" contenteditable="true">animi</suggestion></suggestions></word><word store="2824" contenteditable="true"><text store="2825" contenteditable="true">anemia</text><suggestions store="2826" contenteditable="true"><suggestion store="2827" contenteditable="true">anaemia</suggestion><suggestion store="2828" contenteditable="true">anomia</suggestion><suggestion store="2829" contenteditable="true">anomie</suggestion><suggestion store="2830" contenteditable="true">animi</suggestion></suggestions></word><word store="2831" contenteditable="true"><text store="2832" contenteditable="true">Cohrane</text><suggestions store="2833" contenteditable="true"><suggestion store="2834" contenteditable="true">Cochrane</suggestion><suggestion store="2835" contenteditable="true">Chorine</suggestion></suggestions></word><word store="2836" contenteditable="true"><text store="2837" contenteditable="true">androstenedione</text><suggestions store="2838" contenteditable="true"></suggestions></word><word store="2839" contenteditable="true"><text store="2840" contenteditable="true">androstenedione</text><suggestions store="2841" contenteditable="true"></suggestions></word><word store="2842" contenteditable="true"><text store="2843" contenteditable="true">hyperandogenism</text><suggestions store="2844" contenteditable="true"></suggestions></word><word store="2845" contenteditable="true"><text store="2846" contenteditable="true">hyperinsulinemia</text><suggestions store="2847" contenteditable="true"></suggestions></word><word store="2848" contenteditable="true"><text store="2849" contenteditable="true">steroidogenesis</text><suggestions store="2850" contenteditable="true"><suggestion store="2851" contenteditable="true">steroid genesis</suggestion></suggestions></word><word store="2852" contenteditable="true"><text store="2853" contenteditable="true">favoring</text><suggestions store="2854" contenteditable="true"><suggestion store="2855" contenteditable="true">favouring</suggestion><suggestion store="2856" contenteditable="true">fevering</suggestion></suggestions></word><word store="2857" contenteditable="true"><text store="2858" contenteditable="true">cardiometabolic</text><suggestions store="2859" contenteditable="true"><suggestion store="2860" contenteditable="true">cardio metabolic</suggestion></suggestions></word><word store="2861" contenteditable="true"><text store="2862" contenteditable="true">Legro</text><suggestions store="2863" contenteditable="true"><suggestion store="2864" contenteditable="true">Largo</suggestion><suggestion store="2865" contenteditable="true">Lego</suggestion><suggestion store="2866" contenteditable="true">Legroom</suggestion><suggestion store="2867" contenteditable="true">Allegro</suggestion><suggestion store="2868" contenteditable="true">Leroy</suggestion><suggestion store="2869" contenteditable="true">Logo</suggestion><suggestion store="2870" contenteditable="true">Ergo</suggestion><suggestion store="2871" contenteditable="true">Legos</suggestion><suggestion store="2872" contenteditable="true">Léger</suggestion><suggestion store="2873" contenteditable="true">Largos</suggestion></suggestions></word><word store="2874" contenteditable="true"><text store="2875" contenteditable="true">hyperandrogenism</text><suggestions store="2876" contenteditable="true"></suggestions></word><word store="2877" contenteditable="true"><text store="2878" contenteditable="true">center</text><suggestions store="2879" contenteditable="true"><suggestion store="2880" contenteditable="true">centre</suggestion><suggestion store="2881" contenteditable="true">canter</suggestion><suggestion store="2882" contenteditable="true">censer</suggestion><suggestion store="2883" contenteditable="true">centred</suggestion><suggestion store="2884" contenteditable="true">centres</suggestion><suggestion store="2885" contenteditable="true">Centre</suggestion></suggestions></word><word store="2886" contenteditable="true"><text store="2887" contenteditable="true">glycemic</text><suggestions store="2888" contenteditable="true"><suggestion store="2889" contenteditable="true">glycaemic</suggestion></suggestions></word><word store="2890" contenteditable="true"><text store="2891" contenteditable="true">oligomenorrhea</text><suggestions store="2892" contenteditable="true"></suggestions></word><word store="2893" contenteditable="true"><text store="2894" contenteditable="true">hyperandrogenism</text><suggestions store="2895" contenteditable="true"></suggestions></word><word store="2896" contenteditable="true"><text store="2897" contenteditable="true">glycemic</text><suggestions store="2898" contenteditable="true"><suggestion store="2899" contenteditable="true">glycaemic</suggestion></suggestions></word><word store="2900" contenteditable="true"><text store="2901" contenteditable="true">oligomenorrheic</text><suggestions store="2902" contenteditable="true"></suggestions></word><word store="2903" contenteditable="true"><text store="2904" contenteditable="true">vs</text><suggestions store="2905" contenteditable="true"><suggestion store="2906" contenteditable="true">vs.</suggestion><suggestion store="2907" contenteditable="true">vest</suggestion></suggestions></word><word store="2908" contenteditable="true"><text store="2909" contenteditable="true">nontraditional</text><suggestions store="2910" contenteditable="true"><suggestion store="2911" contenteditable="true">non-traditional</suggestion></suggestions></word><word store="2912" contenteditable="true"><text store="2913" contenteditable="true">cardiometabolic</text><suggestions store="2914" contenteditable="true"><suggestion store="2915" contenteditable="true">cardio metabolic</suggestion></suggestions></word><word store="2916" contenteditable="true"><text store="2917" contenteditable="true">microbiota</text><suggestions store="2918" contenteditable="true"><suggestion store="2919" contenteditable="true">micro biota</suggestion><suggestion store="2920" contenteditable="true">macrobiotic</suggestion></suggestions></word><word store="2921" contenteditable="true"><text store="2922" contenteditable="true">dysbiosis</text><suggestions store="2923" contenteditable="true"><suggestion store="2924" contenteditable="true">symbiosis</suggestion></suggestions></word></spellingerror></spellingerrors><history store="2925" contenteditable="true"><date-cont store="2926" contenteditable="true"><!--punc-->Received in final form <!--punc--><date date-type="received" store="2927" contenteditable="true"><day store="2928" contenteditable="true">19</day> <month store="2929" contenteditable="true">November</month> <year store="2930" contenteditable="true">2019</year></date></date-cont><date-cont store="2931" contenteditable="true"><!--punc-->Accepted <!--punc--><date date-type="accepted" store="2932" contenteditable="true"><day store="2933" contenteditable="true">11</day> <month store="2934" contenteditable="true">December</month> <year store="2935" contenteditable="true">2019</year></date></date-cont><date-cont store="2936" contenteditable="true"><!--punc-->Accepted Manuscript published online <!--punc--><date date-type="accepted" store="2937" contenteditable="true"><day store="2938" contenteditable="true">11</day> <month store="2939" contenteditable="true">December</month> <year store="2940" contenteditable="true">2019</year></date></date-cont></history></article></journal>